US20130268062A1 - Composite prosthetic devices - Google Patents

Composite prosthetic devices Download PDF

Info

Publication number
US20130268062A1
US20130268062A1 US13/803,892 US201313803892A US2013268062A1 US 20130268062 A1 US20130268062 A1 US 20130268062A1 US 201313803892 A US201313803892 A US 201313803892A US 2013268062 A1 US2013268062 A1 US 2013268062A1
Authority
US
United States
Prior art keywords
electrospun
tetrafluoroethylene
polymer
layer
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/803,892
Inventor
Sabrina D. Puckett
Joshua Manasco
Robert L. Ballard
Bruce L. Anneaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeus Industrial Products Inc
Original Assignee
Zeus Industrial Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeus Industrial Products Inc filed Critical Zeus Industrial Products Inc
Priority to US13/803,892 priority Critical patent/US20130268062A1/en
Priority to CN201380017906.8A priority patent/CN104203150B/en
Priority to CN201710978132.5A priority patent/CN107736952A/en
Priority to JP2015504605A priority patent/JP6490575B2/en
Priority to EP13772707.9A priority patent/EP2833826B1/en
Priority to PCT/US2013/032771 priority patent/WO2013151778A1/en
Assigned to ZEUS INDUSTRIAL PRODUCTS, INC. reassignment ZEUS INDUSTRIAL PRODUCTS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANASCO, JOSHUA L., PUCKETT, Sabrina D., ANNEAUX, BRUCE L., BALLARD, ROBERT L.
Publication of US20130268062A1 publication Critical patent/US20130268062A1/en
Priority to US14/520,368 priority patent/US10010395B2/en
Priority to US14/858,556 priority patent/US20160067374A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146Porous materials, e.g. foams or sponges
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D10/00Physical treatment of artificial filaments or the like during manufacture, i.e. during a continuous production process before the filaments have been collected
    • D01D10/02Heat treatment
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/08Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of halogenated hydrocarbons
    • D01F6/12Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of halogenated hydrocarbons from polymers of fluorinated hydrocarbons
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • A61F2002/0086Special surfaces of prostheses, e.g. for improving ingrowth for preferentially controlling or promoting the growth of specific types of cells or tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/04Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of halogenated hydrocarbons
    • D10B2321/042Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of halogenated hydrocarbons polymers of fluorinated hydrocarbons, e.g. polytetrafluoroethene [PTFE]
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/06Vascular grafts; stents

Definitions

  • the invention is generally related to prosthetic devices and to methods of making and using such prosthetic devices.
  • ePTFE expanded polytetrafluoroethylene
  • An ePTFE-based vascular prosthesis having a specific IND range can be developed with a given porosity and/or pore size range to enhance tissue ingrowth and cell endothelialization along the inner and outer surface of the prosthesis.
  • the IND range is generally small enough to prevent transmural blood flow and thrombosis but is generally not less than the maximum dimension of the average red blood cell (e.g., between about 6 and 8 ⁇ m).
  • Vascular prostheses based on ePTFE are thus inherently porous.
  • the porosity of an ePTFE vascular prosthesis is controlled by the mechanical formation of the IND and/or the microporous structure of the tube.
  • One exemplary vascular prosthesis is a stent, which is a medical device commonly used to restore and maintain body passages, such as blood vessels.
  • biocompatible materials can be provided on the inner and/or outer surfaces of the stent to reduce reactions associated with contact between the stent and the body.
  • it is difficult with conventional devices to manipulate certain properties such as mechanical properties, cellular proliferation, cellular permeability, fluid permeability, adhesion to a structural frame, and/or incorporation of one or more active therapeutic components.
  • coverings can sometimes be used to alter the properties of devices, stents generally have complex geometries that cannot be readily covered with covering materials such as ePTFE.
  • ePTFE covering materials and processes that address these concerns.
  • composite prosthetic devices comprising one or more porous layers of electrospun polymeric materials are provided.
  • Such porous layers can be, for example, on the inner diameter surface of a tubular prosthetic device, on the outer diameter surface of a tubular prosthetic device, or on both the inner diameter surface and outer diameter surfaces of a tubular prosthetic device.
  • Composite devices can be provided having 2 layers, 3 layers, 4 layers, 5 layers, or more.
  • a structural frame e.g., a stent or other device
  • At least one layer within the composite prosthetic device can, in some embodiments, comprise electrospun poly(tetrafluoroethylene) (PTFE).
  • PTFE electrospun poly(tetrafluoroethylene)
  • the composite prosthetic device exhibits some degree of porosity.
  • a multi-layered tubular composite prosthetic device comprising at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer.
  • the makeup of the second electrospun polymer can be, for example, a solution-electrospun polymer (e.g., a thermoplastic polymer or a thermoset polymer, such as polyurethane, a silicone (e.g., PDMS), polyether block amide (PEBA), a polyamide, ultra-high molecular weight polyethylene (UHMWPE), a polyester, fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a tetrafluoroethylene/hexafluoropropylene/vinylidene fluoride copolymer (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlor
  • the second electrospun polymer can be a dispersion-electrospun polymer, e.g., poly(tetrafluoroethylene).
  • the porous layer comprising a second electrospun polymer penetrates the pores of the porous layer comprising electrospun poly(tetrafluoroethylene).
  • non-porous layers typically exhibits some degree of porosity, for certain applications, it may be desirable to provide one or more non-porous layers.
  • Such non-porous layers may in some embodiments, be prepared by electrospinning or by other methods as described herein. Accordingly, in certain embodiments of the application are provided a multi-layered tubular composite prosthetic device comprising at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one non-porous layer comprising a second electrospun polymer. The preparation and use of non-porous as well as porous electrospun polymers will be described more thoroughly herein.
  • the composite prosthetic devices described herein can further comprise a structural frame (e.g., a stent).
  • a structural frame e.g., a stent
  • such structural frames can comprise open spaces and, in some embodiments, the second electrospun polymer can penetrate through the open spaces of the structural frame.
  • a device which comprises at least two porous layers comprising electrospun poly(tetrafluoroethylene). In some embodiments, a device is provided which comprises at least two porous layers comprising the second electrospun polymer. In certain embodiments, at least one of the inner diameter and the outer diameter of the tubular device comprises a porous layer comprising electrospun poly(tetrafluoroethylene). In certain embodiments, the device can further comprise a non-porous polymeric layer.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer, between said first and second layers.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); and a second porous layer comprising a second electrospun polymer on the device outer diameter surface.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(ethylene terephthalate) on the device outer diameter surface; and a third layer between said structural frame and said second layer comprising a different electrospun polymer, wherein the structural frame comprises open spaces through which the different electrospun polymer penetrates.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer between said first and second layers, wherein a layer comprising the different electrospun polymer is adjacent to the structural frame and the structural frame comprises open spaces through which the different electrospun polymer penetrates.
  • a tubular composite prosthetic device wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer, wherein a structural frame is embedded in the third layer.
  • a method for producing a composite prosthetic device comprising: combining at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer to give a composite prosthetic device precursor; and applying pressure, heat, or both pressure and heat to the composite prosthetic device precursor to provide a composite prosthetic device.
  • the combining step can, in some embodiments, comprise wrapping the porous layer comprising the second electrospun polymer around the porous layer comprising the electrospun poly(tetrafluoroethylene).
  • the combining step can, in some embodiments, comprise electrospinning the porous layer comprising a second electrospun polymer onto the porous layer comprising electrospun poly(tetrafluoroethylene).
  • the methods described herein can provide composite prosthetic devices with varying compositions and properties.
  • the second electrospun polymer comprises a solution-electrospun polymer.
  • the second electrospun polymer comprises unsintered poly(tetrafluoroethylene).
  • the method further comprises sintering the composite prosthetic device following the applying step.
  • the applying step can, in some embodiments, comprise applying heat, pressure, or both heat and pressure for a time sufficient to result in the penetration of the second electrospun polymer into the pores of the at least one porous layer comprising electrospun poly(tetrafluoroethylene).
  • heat and pressure are applied sequentially or simultaneously.
  • the pressure and/or temperature can vary. In certain embodiments, the pressure is between about 200 and about 2000 PSI (e.g., between about 500 PSI and about 1500 PSI) and the temperature is between about 100° C. and about 400° C.
  • the applying step can be conducted, for example, in a pressure vessel. Further exemplary discussion of materials and methods as disclosed herein is provided in U.S. provisional patent application No. 61/620,633, filed Apr. 5, 2012 and U.S. provisional patent application No. 61/724,731, filed Nov. 9, 2012, which are both incorporated herein by reference in their entireties.
  • FIG. 1 is a schematic cross-sectional view of a wall of a mono-component composite device in accordance with the present disclosure
  • FIG. 2 is a schematic cross-sectional view of a wall of a mono-component composite device comprising a structural frame in accordance with the present disclosure
  • FIG. 3 is a schematic cross-sectional view of a wall of a multi-component composite device in accordance with the present disclosure
  • FIG. 4 is a schematic cross-sectional view of a wall of a multi-component composite device comprising a structural frame in accordance with the present disclosure
  • FIG. 5 is a schematic cross-sectional view of a wall of a multi-component composite device in accordance with the present disclosure
  • FIG. 6 is a schematic cross-sectional view of a wall of a multi-component composite device comprising a structural frame in accordance with the present disclosure
  • FIGS. 7A-F are schematic cross-sectional views of exemplary multi-component composite devices comprising structural frames in accordance with the present disclosure
  • FIG. 8 is a schematic illustrating one exemplary process for the preparation of the exemplary composite devices of FIG. 7A and/or FIG. 7B ;
  • FIG. 9 is a schematic illustrating one exemplary process for the preparation of the exemplary composite device of FIG. 7C ;
  • FIG. 10 is a schematic illustrating one exemplary process for the preparation of the exemplary composite devices of FIGS. 7D and 7E ;
  • FIG. 11 is a schematic illustrating one exemplary process for the preparation of the exemplary composite device of FIG. 7F .
  • the present disclosure provides composite prosthetic devices comprising one or more layers of electrospun (also referred to herein as “espun”) fibers around a central lumen and methods of preparation thereof, wherein at least one layer comprises a dispersion-spun polymer.
  • the one or more layers of espun fibers can comprise the inner diameter surface, the outer diameter surface, or both the inner and outer diameter surfaces of a tubular composite prosthetic device.
  • the focus of the application is on multi-layered structures comprising at least one layer of espun fibers on the inner diameter surface and at least one layer of espun fibers on the outer diameter surface; however, the disclosure is intended to also relate to structures comprising only one of these.
  • a structural frame having a single layer of espun fibers on the inner diameter surface is intended to be encompassed by the present disclosure and a structural frame having a single layer of espun fibers on the outer diameter surface is also intended to be encompassed by the present disclosure.
  • the composite prosthetic devices described herein can, in certain embodiments, offer a number of advantages over conventional devices.
  • the composite prosthetic devices provided herein advantageously exhibit one or more of: 1) the ability to incorporate layers with vastly different pore structures and sizes (allowing for the manipulation of various properties such as mechanical properties, cellular proliferation, cellular permeability, fluid permeability, adhesion to a structural frame, and/or possible incorporation of one or more active therapeutic components within different structural layers); 2) the ability to make a composite construction comprising at least two different components (even vastly different components, thus enabling a broad range of therapeutic uses and structures); 3) improved bonding between various layers, including the one or more espun layers, the optional structural frame, and/or other optional layers of the composite device; 4) the inclusion of a material (e.g., electrospun poly(tetrafluoroethylene) (PTFE)) that closely mimics that of the extracellular matrix, thus affording greater control of cellular response; and 5) the ability to provide a covering (layer)
  • PTFE
  • prosthetic device can vary and the device can be tailored so as to be used for any given purpose.
  • prosthetic devices as intended herein are tubular prosthetic devices.
  • tubular prosthetic device is meant that the device has a 3-dimensional shape and this term is intended to cover devices of varying sizes (e.g., length, thickness, and/or diameter), shapes, and compositions.
  • Such tubular prosthetic devices are generally characterized as having a central lumen.
  • a tubular prosthetic device can generally be described as having both an inner diameter (“ID”) and an outer diameter (“OD”).
  • “Tubular devices” is intended to be broadly construed to include stents, grafts, and stent grafts having typical cylindrical-shaped structures as well as structures having shapes including, but not limited to, non-linear-shaped, petal-shaped, saddle-shaped, Y-shaped, mushroom-shaped, flared shaped, bell-shaped, single horn-shaped, double horn-shaped, hourglass-shaped, single cup-mouth shaped, twin cup-mouth shaped, cup mouth-ball shaped, and the like.
  • One or both ends of the prosthetic device can be coiled or otherwise shaped to prevent migration of the device within the body.
  • prosthetic devices are devices that can be placed into an artery, blood vessel, or other duct to hold the duct open or to redirect blood flow within the duct, or the like.
  • the present disclosure is directed to vascular prosthetic devices (also referred to herein as “vascular prostheses”).
  • vascular prostheses can be vascular stents or vascular stent grafts.
  • Representative vascular prostheses include coronary stents, coronary artery by-pass grafts, blood vessel stents, artificial by-pass grafts, by-pass shunts, arteriovenous grafts, homografts, pulmonary allografts, and/or pulmonary shunts.
  • tubular prosthetic devices that may be provided according to the invention include, but are not limited to, hemodialysis tubes, ureteral stents, urethral or prostatic stents, prostatic/sphincter stents, esophageal stents, laryngeal stents, tracheal stents, biliary stents, duodenal stents, colonic stents, pancreatic stents, tracheobronchial stents, and gastrointestinal stents.
  • hemodialysis tubes ureteral stents, urethral or prostatic stents, prostatic/sphincter stents, esophageal stents, laryngeal stents, tracheal stents, biliary stents, duodenal stents, colonic stents, pancreatic stents, tracheobronchial
  • the composite prosthetic devices of the present disclosure can have varying compositions.
  • the composite prosthetic devices described herein comprise one or more electrospun layers (including two or more electrospun layers). Electrospun layers are understood to be polymeric layers prepared via an electrospinning process as described herein. Electrospun layers typically comprise a plurality of fibers, which in some embodiments are in random orientation with respect to one another. In certain embodiments, electrospun layers can be described as fibrous and/or porous.
  • the diameter of the fibers within an espun mat according to the present disclosure can vary. In certain embodiments, espun layers can comprise fibers having average diameters of at least about 0.01 ⁇ m.
  • the average diameter of fibers in each of the one or more espun layers of the composite devices can, in some embodiments, range from about 10 nm to about 2000 nm in size.
  • one or more of the espun layers, in final form have fibers deposited in a density such that there is a range of distances of about 0.1 ⁇ m to about 50 ⁇ m between points of contact.
  • pore size is intended to refer to effective pore size (rather than actual pore size) as measured, for example, by air flow and/or water flow (e.g., as defined by ASTM F316 Pore Size Characterization by Bubble Point, which is incorporated herein by this reference). It is noted that, given the nature of the espun fiber mats, it is generally not possible to measure actual pore size of such materials using microscopy methods.
  • the effective pore size of a given espun layer within a composite device as described herein can range from about 0.0 ⁇ m (e.g., a non-porous film) to about 50 ⁇ m, e.g., from about 0.05 ⁇ m to about 20 ⁇ m.
  • the effective pore size of each layer is greater than about 0.0 ⁇ m as, in certain embodiments, it is desired to provide a composite device exhibiting some degree of porosity. It is noted that, in some embodiments, the effective pore size of a given layer may not be accurately known, such as, for example, where layers are applied and subsequently compressed and/or sintered within the composite device.
  • the individual layers comprising a composite prosthetic device as described herein can have varying thicknesses.
  • each layer can have an average thickness ranging from about 0.0001 inches to about 0.25 inches.
  • layers with thicknesses at the low end of this range are desirable (e.g., about 0.0001 inches to about 0.0010 inches, such as about 0.0003 inches to about 0.0005 inches)
  • the thickness of a given layer can depend, in part, on the method of preparation of the layer and on the makeup of the layer.
  • very thin espun layers of PU e.g., between about 0.0001 inches and about 0.0005 inches are readily obtained.
  • Very thin espun layers of PTFE are generally achieved only through direct application to a construct (i.e., by spin coating, as described below) although sheets of PTFE for lamination onto constructs as described herein may, for example, be prepared with thicknesses as low as about 0.0005 inches. Sheets or tubes prepared by electrospinning typically cannot exhibit such low thicknesses and generally exhibit thicknesses of about 0.0008 inches or greater.
  • the thickness of a given layer is relatively uniform throughout. The thickness of a given layer can also depend on the method by which the composite device is produced. For example, a polymeric sheet can be wrapped once, twice, three times, four times, five times, or more times around the device (or on the interior of the device) to obtain varying thicknesses of that layer.
  • the wall thickness of the composite devices disclosed herein can vary accordingly, depending on the number of layers and on the thickness of each layer.
  • a 2-layer composite device can have a wall thickness ranging from about 0.0002 inches to about 0.50 inches, such as from about 0.001 inches to about 0.05 inches, including from about 0.003 inches to about 0.02 inches. It is to be understood that layers of varying thicknesses can be combined within the device.
  • the overall wall thickness of the composite device is relatively uniform throughout the length of the device and around the circumference of the device.
  • the frame typically comprises an open structure formed from wires or struts and having spaces in between, and it is noted that the wire or strut diameter can impact the wall thickness where the wire or strut is present.
  • the layer thickness at one position on a composite must be compared to the layer thickness at a comparable position on that composite (i.e., by comparing a point at which the wire or strut is present with another point at which the wire or strut is present, or by comparing two points at which the wire or strut is not present).
  • a seam may be present where one or more layers is wrapped around the device, which can be dependent on the processing conditions used to produce the composite device. Accordingly, in some embodiments, there may be one or more indentations (e.g., lines) or raised portions (e.g., lines) on the outer diameter surface of the device, and such embodiments are intended to be encompassed by “substantially uniform” as described herein.
  • indentations e.g., lines
  • raised portions e.g., lines
  • the overall outer diameter of the device can vary.
  • the overall outer diameter can, in certain embodiments, range from about 0.005 inches to about 2 inches, although larger and smaller composites can be prepared without departing from the present disclosure.
  • the final length can vary greatly as the composites can be produced as sheets or tubes at continuous roll lengths.
  • the composite devices described herein can have varying numbers of polymeric layers (e.g., 2-layered, 3-layered, 4-layered, 5-layered, 6-layered, 7 layered, 8-layered, 9-layered, 10-layered, or having even more layers).
  • a layer on the inner diameter surface of a composite device may comprise between about 1 and about 5 wrappings (e.g., about 2 wrappings).
  • a layer on the outer diameter surface of a composite device may comprise between about 2 and about 10 wrappings (e.g., about 4-8 wrappings or about 5-7 wrappings). It is noted that, although the components of the composite prosthetic devices described herein are described as comprising “layers,” these layers may not always be discrete layers.
  • layers are advantageously continuous layers, in some embodiments, they may not always be continuous layers. Further, in some embodiments, the composites may exhibit some ingress of one “layer” into another “layer.” These scenarios are still intended to be encompassed by the term “layered.”
  • a tie layer is a layer that is incorporated into the composite device in a form such that it serves to adhere and/or bond two or more layers together. To fulfill this requirement, the tie layer component must exhibit some degree of flow, tackiness, and/or moldability at ambient temperature and/or at elevated temperature when it is incorporated within the device.
  • a composite prosthetic device precursor comprising all layers to be included in the final device, is prepared and the precursor is treated before use (i.e., by applying heat and/or pressure) such that the tie layer may not maintain these properties in the final composite device provided herein.
  • the tie layer comprises the same polymer type as the one or more layers adjacent thereto and, in some layers, the tie layer comprises a different polymer type.
  • the tie layer can comprise, for example, any of the polymer types and in certain embodiments, may comprise PTFE, PU, or a silicone (e.g., PDMS).
  • the tie layer penetrates the pores of one or both of the layers with which it is in contact and thus can provide a mechanical-type connection between the layers.
  • the tie layer advantageously can penetrate at least a portion of the open spaces in a structural frame, where present.
  • a tie layer may, in some embodiments, serve to connect and/or bond the material comprising the inner diameter surface of the composite device to the outer diameter surface (e.g., through the structural frame). The incorporation of such a layer will be described in greater detail herein.
  • the presently described devices comprise two or more polymeric layers
  • a wide range of composite devices having varying properties are provided.
  • layers with different properties e.g., composition, thickness, effective pore size, fiber size, etc.
  • devices with various combinations of properties are afforded. Means for adjusting these and other properties are described further herein.
  • the chemical makeup of the individual layers can provide an additional degree of tailoring. Due to the layered, “sandwich”-type construction of the composite devices of the present disclosure, physical properties such as thickness and pore size can vary from layer to layer within the cross section of the composite device, depending on the construction. An example would be an asymmetrical construction where pores change in size from large to small based on layer evaluations from surface to surface throughout the material.
  • At least one layer of the device generally comprises a fibrous mat prepared via dispersion-based electrospinning (i.e., a “dispersion-spun component”). Exemplary materials and methods involved in dispersion-based electrospinning are described in greater detail below.
  • the fibrous mat prepared via dispersion-based electrospinning is an electrospun fibrous mat comprising a fluorinated polymer (e.g., poly(tetrafluoroethylene) (PTFE)).
  • a fluorinated polymer e.g., poly(tetrafluoroethylene) (PTFE)
  • PTFE poly(tetrafluoroethylene)
  • fluorinated polymers that can be incorporated as a dispersion-spun component of the composite prosthetic devices described herein include, but are not limited to, fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a copolymer of tetrafluoroethylene, hexafluoropropylene and vinylidene fluoride (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlorotrifluoroethylene (ECTFE), PCTFE (polychlorotrifluoroethylene), and copolymers, blends, and derivatives thereof.
  • FEP fluorinated ethylene propylene
  • PVDF polyvinylidene fluoride
  • PFA perfluoroalkoxy
  • THV hexafluoropropylene and vinylidene fluoride
  • ETFE poly(ethylene-co-tetrafluoroethylene)
  • dispersion-spun component comprises a fluorinated polymer
  • other polymers that can be spun from a dispersion can alternatively or additionally be employed as a dispersion-spun component.
  • a composite prosthetic device wherein the two or more electrospun layers consist of one type of material, i.e., the same type of material (giving a “mono-component composite” prosthetic device), optionally in combination with a structural frame (e.g., a stent).
  • the composite prosthetic device comprises two or more layers of a dispersion-spun polymeric component.
  • the tie layer of such devices thus consists of the same type of polymeric material as that of the one or more additional layers.
  • an electrospun PTFE-based composite device is provided, wherein each of the two or more polymeric layers of the composite prosthetic device comprises electrospun PTFE.
  • the properties (e.g., thickness, pore size, fiber diameter, etc.) of each layer can vary such that different PTFE layers of the composite device can exhibit different properties.
  • PTFE is exemplified, it is noted that other prosthetic composites consisting of or consisting essentially of one polymeric material other than PTFE may also be provided according to the present disclosure.
  • FIG. 1 illustrates a cross-sectional view of a wall of a composite prosthetic device 10 , wherein the coverings on the inner ( 12 ) and outer ( 16 ) diameter surfaces of the device comprise the same dispersion-spun polymer (e.g., PTFE).
  • Layer 14 is a tie layer, comprising the same type of polymer (e.g., PTFE), but layer 14 is initially incorporated into the structure in unsintered (tacky and moldable) form.
  • FIG. 2 illustrates a cross-sectional view of a wall of a composite prosthetic device 20 , which is similar but further incorporates a structural frame 24 .
  • layers 22 , 26 , and 28 comprise the same type of polymer (e.g., PTFE) and the tie layer ( 26 ) is initially incorporated in unsintered form.
  • the application of heating and pressure to the device precursor preferably causes the tie layer 26 to penetrate through interstices in structural frame 24 , as well as into the pores of layer 22 and/or 28 .
  • the application of heating and pressure can cause tie layer 26 to bond the material comprising the inner diameter surface of the composite device to the material comprising the outer diameter surface of the device.
  • the composite device precursor is preferably heated prior to use to provide layer 26 in sintered form in the final composite device (e.g., where the layer comprises PTFE).
  • multi-component composite devices have at least two types of electrospun polymeric layers and can have any number of different types of polymeric materials therein (e.g., at least 2, at least 3, or at least 4).
  • Each polymer type within the multi-component composite devices as described herein can be represented in one layer or more than one layer.
  • a composite device can have: one layer of a given first electrospun material and one layer of a given second electrospun material; two or more layers of a given first electrospun material and one layer of a given second electrospun material; or two or more layers of a given first electrospun material and two or more layers of a given second electrospun material.
  • the multi-component composite devices provided herein in addition to comprising one or more dispersion-spun layers, comprise one or more additional layers, which can be prepared via dispersion-based electrospinning, melt-based electrospinning, and/or solution-based electrospinning.
  • the one or more additional electrospun layers of the prosthetic device comprise an electrospun thermoplastic or thermoset polymer.
  • a thermoplastic is understood to be any polymer that becomes moldable above a specific temperature and returns to a solid state upon cooling.
  • a thermoset is understood to be a polymeric material that is initially moldable, but can cured (usually irreversibly) to give a solid (e.g., by the application of heat or radiation).
  • the thermoplastic or thermoset polymer is an elastomer.
  • An elastomer is a polymer that can be repeatedly stretched and/or deformed without permanently deforming the shape thereof.
  • polyurethanes PU
  • silicones e.g., polydimethylsiloxane
  • Other polymers useful for this purpose include, but are not limited to, polyether block amide (PEBA, e.g., PEBAX®), polyamides, polyethylene (e.g., ultra-high molecular weight polyethylene, UHMWPE), polyesters, and copolymers, blends, and derivatives thereof.
  • PEBA polyether block amide
  • polyamides polyethylene (e.g., ultra-high molecular weight polyethylene, UHMWPE), polyesters, and copolymers, blends, and derivatives thereof.
  • fluorinated polymers such as fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a copolymer of tetrafluoroethylene, hexafluoropropylene and vinylidene fluoride (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlorotrifluoroethylene (ECTFE), PCTFE (polychlorotrifluoroethylene), and copolymers, blends, and derivatives thereof which can be electrospun can be used.
  • FEP fluorinated ethylene propylene
  • PVDF polyvinylidene fluoride
  • PFA perfluoroalkoxy
  • THV hexafluoropropylene and vinylidene fluoride
  • ETFE poly(ethylene-co-tetrafluoroethylene)
  • ECTFE ethylene chlorotrifluoroethylene
  • PCTFE polychlorotri
  • any thermoplastic or thermoset polymer that forms fibers upon electrospinning can be used in this regard as an additional polymeric component (in addition to the one or more dispersion-spun layers).
  • the additional polymeric component is selected such that the electrospun mat produced therefrom retains some degree of porosity when it is combined with the other component(s) of the multi-component composite device and when the resulting device precursor is treated (i.e., when it is exposed to elevated temperature and/or pressure) to provide a final composite device.
  • one or more polymeric layers is a non-porous layer (which can be prepared in various ways as described herein, including, but not limited to, by electrospinning and/or by film formation).
  • Certain multi-component devices described herein exhibit enhanced properties relative to commercially available devices and/or to mono-component devices described herein.
  • Properties that may be enhanced in certain embodiments include, but are not limited to, robustness, flexibility, strength (e.g., radial strength and burst strength), crush/bend/kink resistance, and compression resistance, for example, as evaluated by testing methods including, but not limited to, air flow testing, torsion testing, tension/compression testing, abrasion resistance testing, burst strength testing, WEP testing, radial force expansion testing, kink resistant testing, 3-point bend testing, flex testing, crush resistance testing, recoil testing, and general physical evaluation.
  • FIG. 3 illustrates a cross-sectional view of a wall of a composite prosthetic device 30 , wherein the coverings on the inner ( 32 ) and outer ( 36 ) diameter surfaces of the device comprise the same electrospun polymer (e.g., PTFE).
  • Layer 34 is a tie layer, which comprises a different electrospun polymer than layers 32 and 36 (e.g., PU or PDMS). If layer 34 is a dispersion-spun material, layer 34 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used.
  • FIG. 4 illustrates a cross-sectional view of a wall of a composite prosthetic device 40 , which is similar but further incorporates a structural frame 44 .
  • Layers 42 and 48 comprise the same electrospun polymer (e.g., PTFE) and the tie layer ( 46 ) comprises a different material.
  • tie layer 46 is a dispersion-spun material
  • layer 46 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If tie layer 46 is a solution-spun or melt-spun material, no sintering is required prior to use. However, in all embodiments, the device precursor will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 46 into the pores of layer 42 and/or layer 48 ).
  • FIG. 5 illustrates a cross-sectional view of a wall of a composite prosthetic device 50 , wherein the coverings on the inner ( 52 ) and outer ( 56 ) diameter surfaces of the device comprise different polymers.
  • Layer 54 is a tie layer, which may comprise the same polymer as layer 52 or 56 or may comprise a different material. If layer 54 is a dispersion-spun material, layer 54 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If layer 34 is a solution-spun or melt-spun material, no sintering is required prior to use.
  • FIG. 6 illustrates a cross-sectional view of a wall of a composite prosthetic device 60 , which is similar but further incorporates a structural frame 64 .
  • Layers 62 and 68 comprise different polymers and the tie layer ( 66 ) can comprise the same polymer as layer 62 or 68 or may comprise a different material.
  • tie layer 64 is a dispersion-spun material (e.g., PTFE)
  • layer 64 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used.
  • tie layer 64 is a solution-spun or melt-spun material, no sintering is required prior to use.
  • the device precursor will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 64 into the pores of layer 62 and/or layer 68 ).
  • FIGS. 7A-7F are schematic cross-sections of representative multi-component prosthetic devices according to the present disclosure, having greater than two layers.
  • two polymeric components are present; the grey layers represent the dispersion-spun component (e.g., PTFE) and the black layers represent a different type of polymeric material (e.g., PU or PDMS).
  • the dashed lines represent structural frames.
  • FIGS. 7A-7F a wide range of embodiments having different cross-sections can be provided according to the methods and materials disclosed herein.
  • Structural frames can take various forms including, but not limited to, stents, occlusion coils or frames, regenerative medicine scaffolds, structural reinforcements, pacing or monitoring leads, tissue anchors or tacks, biological stimulation devices, biomimetic implants, signal receivers or transmitters, orthopedic fixation devices or any other metallic, polymeric, ceramic or other therapeutic devices.
  • Various stent types and stent constructions may be employed in the present disclosure, including, but not limited to, self-expanding stents and balloon expandable stents.
  • the stents may be capable of radially contracting as well.
  • Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
  • the structural frame is a metal structural frame, which can generally comprise any biocompatible metal.
  • the metal structural frame can comprise stainless steel, platinum, gold, titanium, or a mixture thereof.
  • the metal structural frame can comprise cobalt, chrome, or magnesium alloy.
  • Nickel titanium alloy (“Nitinol”) is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature and thus may be useful in certain embodiments of the invention.
  • the structural frame can comprise another type of material, such as a ceramic.
  • the configuration of the structural frame may also be chosen from any suitable geometry.
  • wire stents can be fastened into a continuous helical pattern, with or without a wave-like feature or zig-zag in the wire, to form a radially deformable stent.
  • Individual rings or circular members can be linked together by struts, sutures, welding, or interlacing or locking to form a single tubular stent.
  • Individual rings or circular members may have no link and thus may serve as individual units in the composite that is provided upon the combination of such a frame with one or more layers of polymeric material according to the invention. In such cases, multiple ring segments are embedded and held in place by the composite material to comprise a single tubular composite device.
  • Tubular prosthetic devices useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such devices are often referred to as “slotted” devices (e.g., slotted stents). Furthermore, devices may be formed by etching a pattern into a material or mold and depositing device material in the pattern, such as by chemical vapor deposition or the like. As will be apparent based on the disclosure herein, there may be some limit on the configuration of a structural frame in order to achieve enhanced bonding between adjacent polymeric layers through the structural frame in certain embodiments.
  • FIG. 7A-7F contain a structural frame; however, this is not necessary.
  • a 100% electrospun polymer-based device is provided.
  • a device is provided consisting only of a structural frame and electrospun polymeric layers.
  • Composite devices comprising additional types of materials, however, are not intended to be excluded from the present disclosure. It is possible according to the present invention to incorporate various additional non-electrospun components into the mono-component prosthetic devices and multi-component prosthetic devices described herein.
  • melt-processable polymers e.g., polyamides, polyurethanes, and the like (including, but not limited to, perfluoroalkoxy (PFA), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), or tetrafluoroethylene hexafluoropropylene vinylidene fluoride (THV)) (which can provide a non-porous layer, e.g., as a self-sealing thermoplastic or elastomeric film); woven or nonwoven fabrics of natural or man-made fibers; plastic or ceramic membranes; metal, ceramic, or plastic meshes; expanded PTFE (ePTFE) layers as discussed for example in U.S. Patent Application Publication Nos. 2011/0030885 and 2011/0031656 to Anneaux et al., which are both incorporated herein by this reference in their entireties or combinations thereof.
  • PFA perfluoroalkoxy
  • FEP fluorin
  • the composite devices provided herein can comprise one or more bioactive agents.
  • bioactive agents that can be utilized in connection with the devices of the present disclosure include, but are not limited to: antibiotics, antifungals, and antivirals (such as erythromycin, tetracycline, aminoglycosides, cephalosporins, quinolones, penicillins, sulfonamides, ketoconazole, miconazole, acyclovir, ganciclovir, azidothymidine, and interferons); vitamins; anticonvulsants (such as phenytoin and valproic acid); antidepressants (such as amitriptyline and trazodone); antiparkinsonism drugs; cardiovascular agents (such as calcium channel blockers, antiarrhythmics, and beta blockers); antineoplastics (such as cisplatin and methotrexate), corticosteroids (such as dexamethasone, hydrocortisone,
  • Bioactive agents can, in some embodiments, be as described in U.S. application Ser. No. 13/272,412 to Ballard et al., filed Oct. 13, 2011, which is incorporated herein by this reference in its entirety.
  • the amount of optional bioactive agent incorporated within the tubular composite devices can vary but is generally that amount sufficient to elicit a desired response in the patient in whom the device is to be implanted.
  • a bioactive agent can be incorporated within only one layer or within more than one layer of the composite prosthetic device.
  • the properties and characteristics of the final composite prosthetic devices of the present disclosure are a compilation of the properties of the one or more espun polymer layers and any other optional material(s) contained within the composite device (e.g., the optional one or more additional espun polymeric layers and the optional structural frame).
  • the final composite devices of the present disclosure can, in certain embodiments, be prepared with controlled fiber sizes and the mechanical properties of the device can be tailored so as to improve such features as bond strength between components (e.g., layers) of the device, elongation properties, and tensile strength.
  • different pore sizes of the layers can be targeted for different intended application.
  • the individual layers exhibit little to no delamination, indicative of strong adhesion of layers to each other.
  • the composite devices of the present disclosure can, in some embodiments, exhibit additional desirable characteristics of enhanced radial tensile strength, suture hole tearing resistance and enhanced axial tear resistance as compared with commercially available products.
  • the ability to tailor such properties of the composite device of the present disclosure can have implications in designing prosthetic devices for particular applications.
  • the properties of individual layers of the composite device can be modified to tailor the overall properties of the composite device for a given application.
  • modifying the pore sizes and/or thicknesses of the polymeric layers can serve to enhance or inhibit cellular ingrowth or attachment.
  • the device interior surface, or ID surface generally the fluid-, e.g., blood-contacting region
  • the device exterior surface, or OD surface which is generally the tissue-contacting region
  • a composite can comprise a layer having a large pore size on the exterior of the device to facilitate ingrowth and a layer having a smaller pore size on the interior of the device.
  • the inverse is desired (i.e., a composite with minimal to no ingrowth on the exterior and enhanced ingrowth on the interior), which can be achieved by providing a composite comprising a layer having a small pore size on the exterior of the device and a layer having a larger pore size on the interior of the device.
  • Electrospun mats useful according to the present disclosure can be prepared by drawing material by electrical charge from a polymer solution, from a polymer suspension/dispersion, or from a polymer melt.
  • the fibers thus produced are typically collected in a random fashion to produce nonwoven materials.
  • Various specific techniques are known for the production of electrospun fibers and electrospun materials (e.g., mats and/or coverings).
  • Dispersion-spun layers can be prepared, for example, according to the following procedure.
  • a dispersion comprising the desired polymeric particles is provided or prepared.
  • the solids content of PTFE resins is preferably between 50% to about 80% by weight, and more preferably between about 55% and about 65% by weight.
  • an exemplary commercially available PTFE dispersion, Daikin D 210 PTFE is used, which comprises about 59-61 wt % PTFE solids (measured according to ASTM D 4441), 6.0-7.2% wt % surfactant, a pH at 25° C.
  • the properties of the PTFE can vary.
  • the average particle size of the PTFE can be between about 0.05 ⁇ m and about 1 ⁇ m (for example, between about 0.1 ⁇ m and about 0.5 ⁇ m). In some embodiments, the average particle size is less than about 0.5 ⁇ m, less than about 0.4 ⁇ m, less than about 0.3 ⁇ m, or less than about 0.2 ⁇ m.
  • the average particle size in certain embodiments may be about 0.13 ⁇ m, about 0.16 ⁇ m, about 0.23 ⁇ m, or about 0.25 ⁇ m.
  • the solvent can be any solvent suitable for creating a dispersion; suitable such solvents include, but are not limited to, aqueous solutions or alcohol solutions (e.g., methanol, ethanol, or isopropanol).
  • a fiberizing polymer is typically added to the dispersion to facilitate fiber formation and is generally removed following the espinning process.
  • the fiberizing polymer (or polymers) are typically selected such that they have a high solubility in the solvent of the dispersion (e.g., where the dispersion comprises water, any water-soluble polymer can be used, including, but not limited to, poly(ethylene oxide)).
  • the amount of fiberizing polymer present in the dispersion can vary; for example, in certain embodiments, the dispersion comprises about 1% to about 10% by weight of a fiberizing polymer, based on the total weight of the dispersion.
  • the weight ratio of fiberizing polymer to PTFE varies. For example, the amount of fiberizing polymer can be about 3.0% to about 5.5% that of the PTFE in the dispersion by weight.
  • the amount of fiberizing polymer required according to the present invention may vary depending on the chemical makeup of the polymer.
  • the viscosity of the dispersion is within a certain desirable range to allow for the formation of uniform and consistent fibers therefrom (e.g., greater than about 50,000 cP, such as between about 50,000 cP and about 300,000 cP or between about 70,000 cP and about 150,000 cP, as measured with a Brookfield Viscometer.
  • the desired viscosity of the dispersion may vary depending on whether a free surfaced-based apparatus or an orifice (needle)-based apparatus (which requires a somewhat higher viscosity) is used.
  • free surface electrospinning from a wire, a cylinder in a trough i.e., open bath
  • a cylinder in a trough i.e., open bath
  • the ejection volume is dependent upon the viscosity of the dispersion, the conductivity of the dispersion, the surface tension of the dispersion, the distance from bath to target, and the voltage. These factors can also affect the thickness of the fabric and the fiber diameter.
  • the charge source is preferably connected to the positive side of a precision DC power supply.
  • the negative side of the power supply is preferably connected to the collection surface. Alternatively, the collection surface can be at ground. The polarity can be reversed but this is not preferred.
  • Voltage is applied (e.g., typically from about 40,000 volts to about 120,000 volts (e.g., about 40,000 to about 80,000 volts) over a typical collection distance of about 100 to about 400 mm) to uniformly draw out the dispersion and attract it to a collection surface.
  • the collection surface/target can be placed, for example, above the cylinder in the dispersion trough or the dispersion-coated wire and is typically moved in at least one direction such that the entire surface or the desired portion thereof becomes uniformly covered with fibers.
  • orifice or needle spinning is used. This method is similar to that described above; however, the polymeric dispersion passes through one, two, or several orifices and forms espun fibers and fabrics in this way.
  • the voltage on the power supply is increased to the desired voltage (usually from about 2,000 to about 20,000 volts) to uniformly draw out the dispersion and attract it to the collection surface.
  • the collection surface is preferably placed perpendicular to the orifice and is rotated such that the entire surface is uniformly covered, with the fibers drawn towards the collection surface.
  • electrospinning of PTFE may be based at least in part, on the process described in detail in U.S. Patent Appl. Publ. Nos. 2010/0193999 to Anneaux et al. and 2012/0114722 to Ballard et al., which are both incorporated herein by reference in their entireties.
  • Various parameters of the nanofiber production process can be modified to alter the properties of the resulting dispersion-spun (e.g., PTFE) material. For example, increasing the length of time generally increase the thickness of the espun material.
  • the composite devices described herein can, in some embodiments be multi-component composite devices comprising at least one solution-spun or melt-spun component.
  • Solution electrospinning is generally known in the art and, in some embodiments, can be conducted in a similar way as the dispersion-based electrospinning described above. Similar to dispersion-based electrospinning, an electrical charge is used to draw polymeric fibers from the solution, which are deposited, generally in a random fashion, on a collection surface.
  • the solvent in which the polymer is dissolved and the parameters required to produce fibrous mats via electrospinning can vary, depending upon the nature of the polymer.
  • any solution in which the polymer is dissolvable e.g., tetrahydrofuran (THF), dimethylformamide (DMF), dimethylacetamide (DMAc), and combinations thereof
  • THF tetrahydrofuran
  • DMF dimethylformamide
  • DMAc dimethylacetamide
  • concentration of polymer in the solution can vary, but is generally relatively low (e.g., less than about 25% by weight, less than about 10% by weight, such as between about 1% and about 10% by weight).
  • Parameters such as makeup of the solution e.g., the solvent, the composition and molecular weight of the polymer used, any additives, the concentration of the polymer in the solution, the solubility of the polymer in the solvent, etc.
  • the charge applied to the solution can impact the fibrous mat thus produced.
  • Exemplary methods are described, for example, in U.S. Pat. Nos. 1,975,504; 2,160,962; and 2,187,306, all to Formhals; Demi et al., Polymer 43: 3303-3309 (2002); Greiner et al., Angew. Chem. Int. Ed. Engl.
  • Melt electrospinning is similar to dispersion and solution electrospinning, but involves electrospinning fibers from melted polymer. Any polymer that can be placed in melt form has the potential to be electrospun by this method.
  • a melted polymer sample to be spun can be prepared, for example, by heating from resistance heating, circulating fluids, air heating, or lasers. The temperature at which melt spinning is conducted will vary depending upon the melting point of the polymer or polymers used.
  • the collection surface onto which the spun fibers are deposited can vary and can be dependent upon the type of electrospinning setup used.
  • the collection surface is a sheet, the surface of which can be, e.g., any metal or polymeric material, with stainless steel being a particularly preferred material.
  • the collection surface is a tubular prosthetic device (e.g., in the form of a stent, stent-graft, or graft).
  • the collection surface is a drum (i.e., a cylinder around which a collection sheet can be wrapped), which may be rotated during collection to generate a tubular structure.
  • the tubular structure can be cut along the length of the tube to provide a sheet.
  • the collection surface is a rod or tube (i.e., a mandrel around which a collection sheet may be wrapped or on which the fibers may be collected directly) which may be rotated during the collection to generate a tubular structure.
  • a tubular structure can, in certain embodiments, be directly used in its tubular form.
  • Electrospun materials produced via solution and melt spinning are generally sufficient for manipulation immediately following production and generally do not require any further treatment to provide the desired fiber characteristics.
  • the polymeric (e.g., PTFE) mat/sheet, tube, or covered device is generally somewhat fragile and typically must be heated and/or sintered to provide a sufficiently strong and durable material for use as a component of a prosthetic device according to the invention.
  • Heating generally serves to dry the material, volatilize and remove the fiberizing polymer, and/or to sinter the PTFE particles (e.g., by fusion of individual PTFE particles to produce a nonwoven, PTFE-based material).
  • the sintering of the material generally results in the formation of a stronger, more durable material.
  • the level of sintering can vary. During heating, the material can be monitored to evaluate the sintering level by various methods (e.g., calorimetry and/or visual inspection).
  • the material can be heated in place (i.e., by placing the entire collection surface in an oven) or by removing the electrospun material from the collection surface prior to heating and placing the free electrospun material in an oven.
  • the PTFE sheet or tube or PTFE-covered device can be heated and sintered alone, or in certain embodiments, it may be combined with other components of the composite device prior to heating.
  • the heating and sintering can occur at any stage of the process of assembly of the composite prosthetic device. It is noted that the components of the composite structure must be considered to ensure that the other components can withstand the conditions required to sinter the PTFE (or other dispersion-spun polymer).
  • the time and temperature at which the material is heated can vary.
  • the temperature of the oven is between about 250° C. and about 800° C., such as between about 300° C. and about 500° C. (e.g., between about 350° C. and about 485° C.).
  • the (or other dispersion-spun polymeric material) is generally exposed for a period of time such that any remaining water is evaporated and the fiberizing polymer undergoes decomposition and subsequent elimination of the residual material.
  • PTFE can be sintered in combination with one or more additional materials.
  • the time for which a dispersion-espun material is heated to sinter the material may depend, in part, on the temperature of the oven.
  • the material is sintered for a period of about an hour or less, about 30 minutes or less, about 20 minutes or less, about 15 minutes or less, or about 10 minutes or less.
  • the sintering is conducted for a time of between about 2 and about 30 minutes, preferably between about 5 and about 20 minutes. It is noted that more time may be required for sintering at lower temperature and less time may be required for sintering at a higher temperature.
  • the time required for drying and sintering can also depend on the thickness of the material, with thicker materials requiring more time to dry and/or sinter.
  • the drying, volatilizing, and sintering of a dispersion-spun material can occur simultaneously or in a series of steps. While not intended to be limited by any theory, it is believed that some drying (i.e., removal of the solvent) may occur upon completion of electrospinning. It is further believed that some small degree of fiber rearrangement may occur at this point. Then when the material is heated, preferably, the majority of the solvent and the fiberizing polymer (e.g., greater than about 80%, preferably greater than about 90% or 95%, and most preferably greater than about 98 or 99%) is removed from the PTFE material. It is understood that espun fabric generally undergoes shrinkage upon heating/sintering. While not limited to any theory, the shrinkage is believed to occur in two steps: the initial drying and fiber rearrangement following the electrospinning process, and the removal of solvent and fiberizing polymer by heating/sintering.
  • the method comprises assembling the one or more layers to be incorporated within the composite and applying heat and/or pressure to provide a composite prosthetic device.
  • the means by which the final structure is assembled can vary.
  • an electrospun polymer sheet or tube is produced independently and then combined with the one or more additional layers to form a composite structure.
  • the polymer sheet can be a single polymer sheet (e.g., a sintered PTFE mat, a PU mat, a PDMS mat, etc.).
  • a multi-layered espun polymer sheet (“combination sheet”) can be provided.
  • an espun PTFE mat is produced and sintered. Another polymer is then directly electrospun onto the sintered espun PTFE mat, producing a two-layered mat of electrospun polymer.
  • one espun PTFE mat in the preparation of mono-component composites, one espun PTFE mat can be prepared and another espun PTFE layer can be deposited directly thereon.
  • one espun PTFE mat in the preparation of multi-component composites, one espun PTFE mat can be prepared and another type of polymer can be directly electrospun thereon (e.g., PU or PDMS).
  • Such combination mats can be provided with varying combinations of espun polymeric layers and with varying numbers of such layers.
  • a mat (a single electrospun mat or a combination sheet) can, in certain embodiments, be “laminated” onto another material (e.g., onto a polymeric tube, a structural frame, or onto a covering thereon), e.g., by wrapping the mat around the other material.
  • This process generally involves layering or wrapping the espun mat or mats directly onto or around the material to be covered, giving a prosthetic composite device precursor, and applying heat and/or pressure thereto to provide a prosthetic composite device.
  • the layering or wrapping can be performed such that the sheet/layer is wrapped one time around a construct or multiple times around the construct (e.g., two times, three times, four times, or more times).
  • the number of wrappings of each sheet can affect the thickness of that layer of the final composite. For example, a device wherein a given electrospun mat is wrapped twice around a construct will give a thicker layer of that electrospun material in the final device than in a device wherein that electrospun mat is wrapped only once around the construct. The overall wall thickness of a device having a greater number of wrappings will thus be thicker as well. Where a combination sheet is used, the number of wraps will alter the number of layers of the two (or more) components comprising the combination sheet.
  • FIGS. 7A and 7B and FIGS. 7D and 7E are comparable to one another except that the number of wrappings of the outer two components are different, as will be described in greater detail below.
  • a polymer is directly spun onto another component of the composite prosthetic device.
  • electrospinning can be conducted such that a polymer covering is directly spun onto a construct (e.g., a polymeric tube or a structural frame, such as a stent).
  • two or more methods can be combined (e.g., a covering can be applied to a structural frame by directly electrospinning the covering thereon and the resulting device can be subsequently wrapped with a second covering and treated as described herein or a covering can be applied to a structural frame by wrapping and a second covering can be applied to the covered structural frame by directly electrospinning the second covering thereon).
  • the composite prosthetic devices of the present disclosure generally incorporate at least one tie layer, which can be incorporated within the device precursor as an unsintered dispersion-spun layer (which is subsequently sintered prior to use of the device) or which can be a solution-spun or melt-spun layer (which does not require sintering prior to use of the device).
  • the tie layer can be applied using any of the methods described herein.
  • the tie layer can serve as a “glue” to bind to another layer and preferably can be used to bind multiple layers together.
  • the tie layer can penetrate the open spaces in the structural frame and bond to the material on the other side of the structural frame (e.g., where the tie layer is provided on the outer surface of the structural frame, it can penetrate the frame and bond to the material comprising the inner diameter surface of the structural frame which may, in some embodiments, be a porous electrospun polymeric layer).
  • the tie layer may serve to bond and/or connect the material on the inner diameter surface of the composite device to the material on the outer diameter surface of the composite device.
  • a significant advantage to the presence of such a tie layer is that it can serve to create a better bond and/or seal between various layers of the composite device following the application of heat and/or pressure to the composite device precursor.
  • This bonding can be characterized, for example, by an enhanced peel strength between certain layers.
  • the preparation of composite devices of the present disclosure involves the incorporation of an unsintered PTFE tie layer.
  • the stage at which any unsintered PTFE present in the composite device is sintered must be such that no material is present that will be negatively affected by the temperatures required for the sintering of the PTFE.
  • any unsintered PTFE layer(s) applied to the device should be sintered prior to the application of the PU to avoid destroying the porous PU layer(s) during the sintering of the PTFE layer(s).
  • an unsintered PTFE layer is generally useful as a tie layer in composites only where the adjacent layers of the device precursor comprise PTFE or another, similar polymer (and not in composites wherein a PU or other, similar polymer is adjacent to the unsintered PTFE).
  • the preparation of composite devices of the present disclosure involves the incorporation of a solution-spun tie layer (e.g., including, but not limited to, PU or PDMS).
  • a solution-spun tie layer e.g., including, but not limited to, PU or PDMS.
  • Such tie layers which do not require sintering prior to use of the composite device, can be advantageous as the processing of the device does not require the structural frame, where present, to be exposed to the high temperatures required for sintering (as required for, e.g., a PTFE tie layer). In certain embodiment, avoidance of such high temperatures can serve to keep the mechanical properties and integrity of the device more intact.
  • the amounts and relative amounts of material in the layers of the composite prosthetic devices described herein can vary. It is noted that, with regard to the tie layer, in embodiments wherein a structural frame is present, the wire/strut diameter, spacing between the wires/struts struts, and/or the processing conditions may impact the amount of material required to ensure sufficient bonding of the tie layer to other layers and/or to the structural frame. For example, large wire or strut diameters or thicknesses may need more of the tie-layer espun polymer material as compared to smaller wire or strut diameters (which can be provided, e.g., by using a thicker espun sheet and/or by wrapping a sheet more times around the device).
  • a structural frame with minimal spacing between the wire or strut lattice may not perform as well due to minimal inner diameter and outer diameter contact, resulting in a poorly secured and embedded structural frame.
  • even structural frames with minimal spacing between the wire or strut lattice can perform well if enough tie layer espun polymer material is used and enough heat and/or pressure is applied to ensure that the tie layer espun polymer can penetrate the open spaces in the lattice.
  • tie layer material there is a certain amount of tie layer material that must be applied to the structural frame, a certain amount of processing (e.g., temperature and/or pressure) that must be applied to the structural frame, there must be a sufficient amount of open space in the frame to ensure that the frame is not “floating” within the composite and is adequately affixed onto or within the other layers of the composite, and the tie layer material must have sufficient properties (e.g., flowability and/or tackiness) to enable it to effectively penetrate the open spaces of the structural frame.
  • processing e.g., temperature and/or pressure
  • the device precursor is subjected to heat and/or pressure.
  • the application of heat and/or pressure to the precursors as intended herein generally results in some degree of fusion and/or merging of the various layers of the composite device precursor (e.g., via the tie layer penetrating through the open spaces in a structural frame and/or penetrating the pores of at least one of the adjacent layers).
  • the application of heat and/or pressure can also ensure that the inner diameter surface of a composite device is bonded to the outer diameter surface of the composite device.
  • application of heat and/or pressure can advantageously seal the frame within the composite device so that there is no delamination and/or so that the frame is completely covered by one or more polymeric layers.
  • application of heat and/or pressure can result in a decrease in effective pore size of the individual layers and/or composite as a whole and/or can result in a decrease in individual layer thickness and/or wall thickness of the composite as a whole.
  • the amount of heat and the method by which the heat is applied to the device precursor can also vary.
  • heat can be applied by heating the device precursor in various types of chambers (e.g., heating vessel or clamshell) or by heating the device in an oven.
  • heat applied at this stage is typically significantly lower than the heat required to sinter the dispersion-spun component or components (e.g., PTFE).
  • the temperature applied can vary depending on the makeup of the device precursor, as discussed in greater detail below.
  • the one or more dispersion-spun components are present in sintered form when the heat and/or pressure is applied to the multi-component device precursor.
  • the heating step can include sintering.
  • heat and/or pressure is applied to the device precursor to cause the unsintered dispersion-spun tie layer to penetrate the pores of one or both of the adjacent layers (and, optionally, to penetrate through the open pores of the structural frame, where present) and the heat applied can advantageously be sufficient to sinter the one or more unsintered dispersion-spun component.
  • the heat and/or pressure required to ensure penetration of one or more layers as described herein may be insufficient to sinter the unsintered dispersion-spun component
  • pressure can be applied by using a flat press, constricting wrap, and/or mechanical nip roller.
  • physical pressure is applied to the device precursor by wrapping the construct with a constricting wrap and applying pressure, either directly or indirectly.
  • the constricting wrap is maintained on the covered construct and the entire device precursor, including the constricting wrap, is heated; subsequently, the constriction wrap is removed to provide a compressed composite device.
  • pressure can be applied to the device precursor in a pressure vessel. Pressure vessels of varying design and size can be useful according to the methods provided herein.
  • the pressure vessel can be a heated pressure vessel, allowing heat and pressure to be applied to a device precursor simultaneously.
  • the pressure rating of the vessel can vary, so long as sufficient pressure may be applied to the device precursor to allow the tie layer to penetrate through the open spaces in a structural frame and/or to penetrate the pores of at least one of the adjacent layers.
  • Exemplary pressure vessels include, but are not limited to, Non-Stirred Pressure Vessels from Parr Instrument Company (Moline, Ill.). Other means for the application of pressure are intended to be encompassed herein as well. Due to the porosity of the composite device precursors described herein, it may be necessary, in certain embodiments, to enclose the device precursor in a non-porous material prior to introducing it into the chamber.
  • non-porous material must be based on the conditions to which the device precursor will be subjected in the chamber.
  • the non-porous material must be capable of withstanding the elevated pressure and/or temperature conditions within the chamber without negatively impacting the enclosed composite device precursor and/or device.
  • both heat and pressure are applied to the device precursor, it is not necessary for the heat and pressure to be applied simultaneously, but in some embodiments, they may be applied simultaneously (e.g., in a heated pressure vessel). Further, it is noted that the application of pressure and/or heat may be conducted at various stages of construction of the composite prosthetic device. In some embodiments, pressure is applied, followed by the application of pressure and heat. In some embodiments, the entire device is assembled and pressure and/or heat are applied to provide the final device. In other embodiments, the application of pressure and/or heat can be conducted at one or more stages during the assembly process.
  • the amount of heat and/or pressure advantageously applied to prepare the composite device precursor can depend on the makeup of the layers of the device.
  • the applied pressure is between about 500 and about 1500 PSI and the temperature is at least about 50° C. or at least about 100° C. (e.g., between about 75° C. and about 400° C. or between about 100° C. and about 300° C.).
  • the time and temperature are related, i.e., increasing the temperature at which the device precursor is treated may allow for a decrease in the pressure applied (particularly where the temperature and pressure are applied simultaneously).
  • the temperature can also depend on the makeup of the composite device precursor.
  • the composite device is preferably heated at a temperature sufficient to sinter the unsintered PTFE (e.g., about 385° C.).
  • a temperature sufficient to sinter the unsintered PTFE e.g., about 385° C.
  • the temperature applied is advantageously significant lower (e.g., between about 100° C. and about 200° C.).
  • the time at which heat and/or pressure is applied can also vary; generally, the device precursor must be exposed to the heat and/or pressure for a sufficient period of time to ensure that the tie layer can penetrate through the open spaces in a structural frame and/or can penetrate the pores of at least one of the adjacent polymeric layers (e.g., at least about 3 minutes, at least about 5 minutes, or at least about 7 minutes, including between about 3 and about 20 minutes, between about 5 and about 15 minutes, between about 5 and about 10 minutes, and between about 5 and about 7 minutes). Although such times are noted to be useful, it is understood that in some embodiments, the composite device can be heated for lesser or more amounts of time. Generally, the heat and/or pressure should be applied for a period of time sufficient for bonding.
  • the time is also related to the heat and/or pressure, such that in some embodiments, treatment of the device precursor at a higher temperature and/or pressure may require less time than treating that same device precursor at a lower temperature and/or pressure. It is understood, however, that there is some minimum temperature and/or pressure that will be required to ensure the device exhibits penetration of the tie layer through the open spaces in a structural frame and/or to ensure penetration of the tie layers into the pores of at least one of the adjacent layers (e.g., in certain embodiments, ensuring bonding between the inner diameter surface of the composite device and the outer diameter surface of the device).
  • the melt flow characteristics of a tie layer polymer may affect the choice of heat and/or pressure to be applied. For example, a tie layer comprising a polymer with a higher melt flow rate may require less heat and/or pressure to ensure that the tie layer effectively penetrate the pores of at least one of the adjacent layers, whereas a polymer with a tie layer comprising a lower melt flow rate may require more.
  • the presence of a structural frame may impact the amount of heat and/or pressure to be applied to the device precursor. In some embodiments, greater heat and/or pressure may be required to ensure that the tie layer can penetrate through the open spaces in the frame.
  • a composite device comprising a structural frame with a thick wire or strut may not be prepared in the same way as a device comprising a structural frame with a thin wire or strut.
  • a frame with a thick wire or strut or a frame with narrow spaced wires or struts may require more electrospun polymeric material (e.g., a thicker covering), may require the use of an electrospun polymeric material having a greater ability to flow and penetrate the open spaces (e.g., a polymer having a higher melt flow rate), and/or may require greater heating and/or pressure applied thereto to ensure that the covering can penetrate the open spaces within the frame.
  • the spacing between wires or struts of a structural frame may similarly affect the materials and parameters of the methods used to form a composite device comprising the frame.
  • the structural frame has widely-spaced wires or struts (e.g., with amplitudes spaced relatively far apart and/or having fewer wires or struts)
  • less heat and/or pressure may be required than for a comparable embodiment wherein the structural frame closely spaced wires or struts (e.g., with amplitudes closer together and/or having more wires or struts).
  • thermoset polymer is employed (e.g., as a tie layer) in the composite prosthetic device precursor
  • the thermoset polymer is advantageously heat-cured during the application of heat and/or pressure as described above. In some embodiments, this curing requires a higher temperature than those noted above, e.g., at least about 200° C.
  • a thermoset polymer is employed that is cured through radiation.
  • it is not cured until during or after the heat and/or pressure treatment described above, such that it can flow into the pores of one or more adjacent layers in uncured form and subsequently be cured to provide a composite prosthetic device.
  • tailoring refers to the ability to produce and use various materials with various properties.
  • tailoring relates to the process conditions used in espinning; by varying the parameters of the method, polymeric sheets, tubes, or covered constructs having different physical properties can be obtained. For example, where a thicker polymeric mat/tube (or a thicker covering directly spun onto a construct) is desired, the espinning process can be conducted for a longer period of time to deposit more material. As another example, where a polymeric mat with smaller pore size is desired, a thicker mat can be prepared, which typically results in a decreased pore size.
  • a smaller pore size can be obtained by decreasing the targeted fiber diameter.
  • tailoring relates to the method of assembly of the composite device. For example, where a thicker polymeric layer within the device is desired, a given polymeric mat can be wrapped around the composite device precursor a greater number of times. Thus, tailoring the properties of a given layer of the composite device can be done in various ways, relating to the production of the espun layer and/or the application of the espun layer to the composite device. In further embodiments, where a device having one or more impermeable portions is desired, a thermoplastic polymeric film may be incorporated within the composite device.
  • bioactive agents can be included in one or more of the layers of the device.
  • Such optional bioactive agents can be incorporated within composite devices in a variety of ways.
  • the one or more bioactive agents can be directly incorporated into the fibrous mats by including them in a dispersion, solution, or melt that is espun, or the one or more bioactive agents can be incorporated into a layer or into the composite device after the fibers are prepared, e.g., by applying the bioactive agents, e.g., in solution form, onto/into the layer or device.
  • Certain exemplary means for the incorporation of bioactive agents are described in U.S. application Ser. No.
  • the properties and characteristics of the final composite prosthetic device produced may be impacted by the application of heat and/or pressure.
  • the degree of heating i.e., time and temperature
  • the amount of pressure applied and the method by which the pressure is applied may affect the overall quality of the final composite. If there is not enough heat and/or pressure, poor bonding and delamination may occur, resulting in weak adhesion of the layers to each other. Additionally, without sufficient heat and/or pressure, some portion of the structural frame, where present, may be exposed (i.e., uncovered), which in certain embodiments is not desirable. Further, without sufficient heat and/or pressure, the structural frame, where present, may move within the composite device, which is typically undesirable.
  • the application of heat and/or pressure can have varying impacts on the composite prosthetic device.
  • the application of heat and/or pressure results in some degree of fusion and/or merging of the various layers of the composite device.
  • heat and/or pressure can serve to aid in the penetration of the material comprising the tie layer of the composite into the pores of one or both of the layers adjacent thereto.
  • the heat and/or pressure can, in some embodiments, cause the tie layer to penetrate the open spaces in the frame.
  • the heat and/or pressure is thus preferably such that the tie layer of the prosthetic device precursor is moldable or flows to some extent into the pores of adjacent layers (and, optionally, through the open spaces of a structural frame, where present).
  • the tie layer of the composite device precursor comprises an unsintered, dispersion-spun fibrous mat (e.g., PTFE)
  • additional heating is generally required to sinter the material.
  • the tie layer of the composite device precursor comprises a solution-spun material (e.g., PU or PDMS)
  • PU or PDMS solution-spun material
  • a tie layer as described above for example, in the form of an unsintered dispersion electrospun fibrous layer (e.g., PTFE) or a solution-spun fibrous layer (e.g., PU or PDMS)) between two or more other layers (and optionally through the open spaces of a structural frame) can provide significantly increased bonding between those layers following the application of heat and/or pressure (and, optionally, sintering, in the case of PTFE).
  • PTFE unsintered dispersion electrospun fibrous layer
  • PU or PDMS solution-spun fibrous layer
  • a tie layer can, in certain embodiments, bond through a structural frame to a porous electrospun polymeric layer comprising the internal diameter surface covering of the composite device.
  • the tie layer can also, in some embodiments, bond to an additional porous electrospun layer adjacent thereto, e.g., by penetrating the pores thereof.
  • the composite devices described herein can, in certain embodiments, exhibit greater peel strengths between adjacent layers, which can result in enhanced performance of the resulting composite.
  • the application of heat and/or pressure to the composite prosthetic device precursor can result in a decrease in effective pore size of the walls of the device and/or can result in a decrease in the overall wall thickness of the device.
  • the heat and/or pressure applied to the device precursor may impact the pore size and/or the thickness of one or more individual espun layers.
  • An increase in pressure and/or temperature may be associated with a decrease in pore size and/or a decrease in the layer thickness.
  • a PU or other meltable polymer would be expected to flow to some extent upon the application of heat and/or pressure, thus reducing the effective pore size of the PU layer relative to the PU layer prior to the application of heat and/or pressure.
  • polymers electrospun from solution e.g., PU and PDMS
  • PU and PDMS when incorporated within the composite structures by any of the means described herein, unexpectedly can exhibit some degree of porosity, even after the application of heat and/or pressure to ensure sufficient fusion between the layers of the final device.
  • the effective pore sizes of certain layers can thus be controlled to some extent by both electrospinning conditions used to prepare the electrospun layer and by the treatment to which the layers are subjected within the composite device.
  • the effective pore size of the composite as a whole may not be reflective of the combination of effective pore sizes of the individual layers. Consequently, in some embodiments, the methods described herein provide devices incorporating thermoplastic polymers or thermoset polymers which exhibit some overall degree of porosity.
  • varying the materials as well as the temperature and/or pressure at which the device is processed can provide devices exhibiting varying degrees of porosity, as evidenced by the ability to obtain effective pore size measurements of the device as a whole.
  • the materials and methods can be selected so as to ensure that porosity is maintained.
  • the retention of some degree of porosity in an electrospun mat can be impacted, for example, by the melting point of the polymer and/or by the melt flow viscosity.
  • Various parameters can affect these parameters including, but not limited to, the molecular weight of the polymer and the degree of branching within the polymer backbone. Consequently, a wide range of polymers can be tailored and optimized for use according to the present invention by varying these and other parameters and/or by blending two or more different types of polymers.
  • two composite devices can, in certain embodiments, be separately prepared and combined. Accordingly, in some embodiments, two composites devices or components thereof can be separately prepared; subsequently, one composite can be wrapped around or inserted into another composite, and pressure and/or heat can be applied the entire combined composite structure to form a single composite prosthetic device.
  • a polymer-based composite can be combined with a composite prosthetic device including a structural frame, e.g., by separately preparing the two device types and wrapping the polymer-based composite around the composite prosthetic device including a structural frame or inserting it into the inner diameter of the composite prosthetic device including a structural frame. Again, heat and/or pressure can then be applied to the entire structure to form a single composite prosthetic device. All combinations, as well as singular composite prosthetic devices as described herein are intended to be encompassed by the present disclosure.
  • FIGS. 7-11 Certain exemplary composite devices of the present disclosure and representative methods for preparing each are provided in FIGS. 7-11 . These are only exemplary constructions and exemplary means for preparing such constructions. These schematics provided in the figures and described herein are presented only to give exemplary means by which the principles described herein can be applied to certain specific components (to generate the representative constructs illustrated in FIGS. 7A-7F ).
  • FIG. 8 illustrates an exemplary preparation of the composite devices illustrated in FIGS. 7A and 7B .
  • an electrospun PTFE mat is prepared, sintered, and wrapped, e.g., around a hypotube, to form a tubular structure 70 .
  • a structural frame 72 is applied around structure 70 , giving a frame-containing structure 74 .
  • An unsintered mat of espun PTFE 76 is wrapped around the structural frame (e.g., to serve as a tie layer) and a sintered espun PTFE mat 78 is wrapped around unsintered mat 76 .
  • Pressure and heat are applied to the resulting composite device precursor 80 , sufficient to sinter the unsintered PTFE of tie layer 76 , giving a mono-component device 82 .
  • an electrospun PTFE sheet 84 is prepared and sintered; a combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84 .
  • the combination sheet is wrapped around mono-component construct 82 , with the PU layer laid directly against the outer surface of construct 82 .
  • the entire device precursor is then simultaneously subjected to pressure and heat.
  • the multi-component cross-section on the left ( 88 ) depicts the result of the above process wherein the combination sheet is wrapped twice around the construct and the multi-component cross-section on the right ( 90 ) depicts the result of the above process wherein the combination sheet is wrapped once around the construct.
  • the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; wrapping an unsintered poly(tetrafluoroethylene) mat around the structural frame (one or more times); wrapping a sintered poly(tetrafluoroethylene) mat around the unsintered poly(tetrafluoroethylene) mat (one or more times); and heating the resulting construct to sinter the unsintered poly(tetrafluoroethylene).
  • such a method can further comprise preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer surface of the mat in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 9 illustrates an exemplary preparation of the composite device illustrated in FIG. 7C .
  • the method is initially identical to that described above with regard to the method illustrated in FIG. 8 .
  • a single PU sheet 92 is independently prepared and wrapped around mono-component construct 82 , rather than the combination sheet depicted in FIG. 8 .
  • the entire device precursor is then subjected to pressure and heat to give a multi-component composite device 94 .
  • the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; wrapping an unsintered poly(tetrafluoroethylene) mat around the structural frame (one or more times); wrapping a sintered poly(tetrafluoroethylene) mat around the unsintered poly(tetrafluoroethylene) mat (one or more times); heating the resulting construct to sinter the unsintered poly(tetrafluoroethylene); wrapping an electrospun mat comprising a different polymer around the construct (one or more times) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 10 illustrates an exemplary preparation of the composite device illustrated in FIGS. 7D and 7E .
  • a frame-containing structure 74 is prepared by combining a sintered PTFE tube and a structural frame.
  • an electrospun PTFE sheet 84 is prepared and sintered;
  • a combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84 .
  • the combination sheet is wrapped around structure 74 , with the PU layer laid directly against the outer surface (i.e., the structural frame) of structure 74 .
  • the entire device precursor is then subjected to pressure and heat simultaneously.
  • the cross-section on the left ( 96 ) depicts the result of the above process wherein the combination sheet is wrapped once around the construct and the multi-component cross-section on the right ( 98 ) depicts the result of the above process wherein the combination sheet is wrapped twice around the construct.
  • the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer mat surface in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 11 illustrates an exemplary preparation of the composite device illustrated in FIG. 7F .
  • An electrospun PTFE sheet 100 is prepared and sintered; a combination PU/PTFE sheet 102 is prepared by electrospinning PU directly onto sheet 100 .
  • Combination sheet 102 is wrapped to form a tubular structure (with the PTFE on the interior of the structure), which is then compressed to give structure 104 .
  • a structural frame 72 is applied around the compressed, tubular material to give frame-containing structure 106 .
  • an additional espun PTFE sheet 84 is prepared and sintered and a second combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84 .
  • Sheet 86 is then wrapped around structure 106 , with the PU layer laid directly against the outer surface (i.e., the structural frame) of structure 106 .
  • the resulting device precursor is subjected to pressure and heat to give multi-component prosthetic device 108 .
  • the present disclosure provides a method for producing a composite prosthetic device comprising: preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; forming the combination electrospun mat into a tubular structure having two or more alternating layers, wherein the poly(tetrafluoroethylene) surface of the mat is on the inner surface of the tubular structure and the different polymer surface of the mat is on the outer surface of the tubular structure; applying a structural frame over the outer surface of the tubular structure; preparing a second combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer mat surface in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency.
  • a 0.002′′ thick stainless steel foil sheet (15.5′′ ⁇ 17.5′′) is mounted on a conductive fabric. The stainless foil is passed into the espinning chamber where PTFE fibers are to be deposited.
  • the dispersion is espun using a total potential of 80 kV to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil.
  • the stainless steel foil containing the PTFE membrane is removed from the fabric and sintered at 385° C. until fully sintered (e.g., about 5 minutes).
  • the 0.0008′′ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50′′ exterior diameter (OD) stainless steel hypotube.
  • the electrospinning process is repeated to give a second espun PTFE sheet.
  • the espun PTFE sheet, a 0.0018′′ unsintered espun PTFE sheet, is removed from the stainless foil and wrapped twice around the sintered espun PTFE layer.
  • the electrospinning process is repeated to give a third espun PTFE sheet, which is then sintered.
  • the third espun PTFE sheet a 0.0018′′ sintered espun PTFE sheet, is removed from the stainless foil after sintering and wrapped twice around the unsintered espun PTFE layer to create a tube assembly consisting of sintered espun PTFE/unsintered espun PTFE/sintered espun PTFE.
  • the entire construction is then compressed together and heated/sintered at 385° C. for about 5-15 minutes (until fully bonded, as evidenced by lack of delamination), followed by water quenching as a means to cool down the sample.
  • the composite device is then removed from the hypotube and tested for specified properties. The thickness of the construction was found to be approximately 0.005′′ and the effective pore size was found to be approximately 1.5 ⁇ m.
  • Example 2 is made similarly to Example 1 with the addition of a wire stent frame as an additional layer of the composite.
  • An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency.
  • a 0.002′′ thick stainless steel foil sheet (15.5′′ ⁇ 17.5′′) is mounted on a conductive fabric. The stainless foil is passed into the espinning chamber where PTFE fibers are to be deposited.
  • the dispersion is espun using a total potential of 80 kV to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil.
  • the stainless steel foil containing the PTFE membrane is removed from the fabric and sintered at 385° C. for 5 minutes.
  • the 0.0008′′ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50′′ exterior diameter (OD) stainless steel hypotube.
  • a metal stent frame is then applied over this 0.0008′′ sintered espun PTFE sheet.
  • the electrospinning process is repeated to give a second espun PTFE sheet.
  • the espun PTFE sheet, a 0.0018′′ unsintered espun PTFE sheet, is removed from the stainless foil and wrapped twice around the stent.
  • the electrospinning process is repeated to give a third espun PTFE sheet, which is then sintered.
  • the third espun PTFE sheet a 0.0018′′ sintered espun PTFE sheet, is removed from the stainless foil after sintering and wrapped twice around the unsintered espun PTFE layer to create a tube assembly consisting of sintered espun PTFE/stent/unsintered espun PTFE/sintered espun PTFE.
  • the entire construction is then compressed together and heated/sintered at 385° C. for 15 minutes, followed by water quenching as a means to cool down the sample.
  • the composite device is then removed from the hypotube and tested for specified properties. The thickness of such a construction is found to approximately 0.005′′ and the effective pore size was found to be approximately 1.5 ⁇ m.
  • a 0.0015′′ thick stainless foil sheet 17′′ ⁇ 18.5′′ is wrapped around a rotating drum.
  • the drum assembly is placed into a rotating chuck such that it is positioned to allow espinning along the entire length of the turning drum assembly.
  • An espinning solution based on a mixture of 25% Atofina Kynar 740 polyvinylidene fluoride (PVDF) and a 50/50 (by volume) mixture of acetone and dimethyl formamide is allowed to dissolve and mix using a heated stir plate set to 75° C. at 500 rpm for 1 hour.
  • a voltage of 15.0 kV is employed to facilitate formation of PVDF fibers, which collect in random formation on the stainless foil sheet.
  • the stainless soil sheet containing the PVDF mat is removed from the drum and dried for 1 hour at room temperature.
  • a 0.001′′ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50′′ exterior diameter (OD) stainless steel hypotube.
  • the 0.001′′ espun PVDF sheet, removed from the stainless foil is wrapped twice around the sintered espun PTFE layer.
  • a 0.001′′ sintered espun PTFE sheet is wrapped twice around the espun PVDF layer to create a tube assembly consisting of sintered espun PTFE/espun PVDF/sintered espun PTFE.
  • the entire construction is then compressed together prior to heating/sintering at 370° C. for 15 minutes followed by water quenching as a means to cool down the sample.
  • the composite is then removed from the hypotube and tested for specified properties.
  • Example 4 is made similarly to Example 3 with the addition of a wire stent frame as another support layer.
  • An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency.
  • a 0.002′′ thick stainless steel foil sheet (15.5′′ ⁇ 17.5′′) is mounted on a conductive fabric roll with a payoff and take-up mounted above a spinning electrode.
  • a total potential of 80 kV is employed to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil.
  • the stainless steel foil containing the PTFE membrane is removed from the fabric and sintered (if desired) at 385° C. for 5 minutes.
  • a 0.0015′′ thick stainless foil sheet 17′′ ⁇ 18.5′′ is wrapped around a rotating drum.
  • the drum assembly is placed into a rotating chuck such that it is positioned to allow espinning along the entire length of the turning drum assembly.
  • An espinning solution based on a mixture of 25% Atofina Kynar 740 polyvinylidene fluoride (PVDF) and a 50/50 (by volume) mixture of acetone and dimethyl formamide is allowed to dissolve and mix using a heated stir plate set to 75° C. at 500 rpm for 1 hour.
  • a voltage of 15.0 kV is employed to facilitate formation of PVDF fibers, which collect in random formation on the stainless foil sheet.
  • the stainless soil sheet containing the PVDF mat is removed from the drum and dried for 1 hour at room temperature.
  • a 0.001′′ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50′′ exterior diameter (OD) stainless steel hypotube.
  • a metal stent frame is then applied over this 0.001′′ sintered espun PTFE sheet.
  • the 0.001′′ espun PVDF sheet, removed from the stainless foil is wrapped twice around the metal stent.
  • a 0.001′′ sintered espun PTFE sheet is wrapped twice around the espun PVDF layer to create a tube assembly consisting of sintered espun PTFE/stent/espun PVDF/sintered espun PTFE.
  • the entire construction is then compressed together prior to heating/sintering at 370° C. for 15 minutes followed by water quenching as a means to cool down the sample.
  • the composite is then removed from the hypotube and tested for specified properties.
  • a sintered espun PTFE sheet, prepared as described herein, is wrapped twice (could be more or less) around a metal hypotube (of any diameter) and sintered at 385° C. for 5 minutes (to prevent the PTFE layers from delaminating from one another) to form a sintered, espun PTFE tube (inner diameter surface) around the metal hypotube.
  • a structural frame may or may not be applied over this sintered espun PTFE tube.
  • the OD surface consists of a wrapped sheet, wrapped twice (as shown in FIG. 7E , but could be more or less) around the metal frame or sintered espun PTFE tube (if no metal frame is present).
  • the wrapped sheet is a combination sheet that consists of PU espun (from solution) onto an espun PTFE sheet (prepared by spinning a dispersion), whereby the PU is in direct contact with the metal frame or sintered espun PTFE tube (if no metal frame is present).
  • the OD surface is a sandwich of alternating layers of PU and PTFE (the number of layers dependent on the number of wraps).
  • the espun PU can be either porous (more fiber-like) or non-porous (more film-like) depending on run conditions.
  • the espun PU layer can also range in thickness, being as thin as 0.0001′′. Pressure and heat are then applied simultaneously to the device to bond all layers into one component.
  • the thickness of the composite is based on the number of wraps and the thickness of the input material.
  • the pore size is dependent on the processing of the input material as well as number of wraps.
  • a sintered espun PTFE sheet, prepared as described herein, is wrapped twice (could be more or less) around a metal hypotube (of any diameter) and sintered at 385° C. for 5 minutes (to prevent the PTFE layers from delaminating from one another) to form a sintered, espun PTFE tube (inner diameter surface) around the metal hypotube.
  • a structural frame may or may not be applied over this sintered espun PTFE tube.
  • the OD surface consists of a sheet wrapped twice (could be more or less) around the metal frame or sintered espun PTFE tube (if no metal frame is present).
  • the wrapped sheet consists of PDMS espun (from solution) onto an espun PTFE sheet (prepared by spinning a dispersion), whereby the PDMS is in direct contact with the metal frame or sintered espun PTFE tube (if no metal frame is present).
  • the OD is a sandwich of alternating layers of PDMS and PTFE (the number of layers dependent on the number of wraps).
  • the espun PDMS can be either porous (more fiber-like) or non-porous (more film-like) depending on run conditions.
  • the espun PDMS layer can also range in thickness, being as thin as 0.0001′′. Pressure and heat are then applied simultaneously to the device to bond all layers into one component.
  • the thickness of the composite is based on the number of wraps and the thickness of the input material.
  • the pore size is dependent on the processing of the input material as well as number of wraps.

Abstract

The present disclosure provides composite prosthetic devices comprising two or more layers of electrospun polymers and methods of preparation thereof. In some embodiments, the two or more layers can be porous and in other embodiments, one or more components is nonporous. The composite prosthetic devices can comprise various materials and the properties of the prosthetic devices can be tailored for use in a range of different applications.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application claims priority to U.S. provisional patent application No. 61/620,633, filed Apr. 5, 2012 and U.S. provisional patent application No. 61/724,731, filed Nov. 9, 2012, which are both incorporated herein by reference in their entireties.
  • FIELD OF THE INVENTION
  • The invention is generally related to prosthetic devices and to methods of making and using such prosthetic devices.
  • BACKGROUND
  • The successful use of extruded tubes of expanded polytetrafluoroethylene (ePTFE) as synthetic implantable vascular prostheses or tubular grafts is well known and documented. ePTFE, which has been validated through numerous clinical studies, is particularly suited for this purpose as it exhibits superior bio-compatibility and can be mechanically manipulated to form a well-defined porous microstructure known to promote endothelialization. Further, ePTFE has been proven to exhibit a low thrombogenic response in vascular applications. When seeded or infused with an active agent, the microporous structure of ePTFE, comprising nodes and fibrils, controls natural tissue ingrowth and cell endothelialization when implanted in the vascular system. This ability contributes to patency of the tubular graft and long term healing.
  • In U.S. Pat. No. 6,436,135 to Goldfarb, the microstructure of a synthetic vascular prostheses formed of ePTFE is defined by irregularly spaced nodes interconnected by elongated fibrils. The methods by which these types of structures are produced have been known for more than three decades. In such a structure, the distance between the node surfaces spanned by the fibrils is defined as the inter-nodal distance (IND).
  • An ePTFE-based vascular prosthesis having a specific IND range can be developed with a given porosity and/or pore size range to enhance tissue ingrowth and cell endothelialization along the inner and outer surface of the prosthesis. The IND range is generally small enough to prevent transmural blood flow and thrombosis but is generally not less than the maximum dimension of the average red blood cell (e.g., between about 6 and 8 μm). Vascular prostheses based on ePTFE are thus inherently porous. The porosity of an ePTFE vascular prosthesis is controlled by the mechanical formation of the IND and/or the microporous structure of the tube.
  • One exemplary vascular prosthesis is a stent, which is a medical device commonly used to restore and maintain body passages, such as blood vessels. Often, biocompatible materials can be provided on the inner and/or outer surfaces of the stent to reduce reactions associated with contact between the stent and the body. However, it is difficult with conventional devices to manipulate certain properties such as mechanical properties, cellular proliferation, cellular permeability, fluid permeability, adhesion to a structural frame, and/or incorporation of one or more active therapeutic components. Although coverings can sometimes be used to alter the properties of devices, stents generally have complex geometries that cannot be readily covered with covering materials such as ePTFE. Thus, a need exists for materials and processes that address these concerns. Specifically, it would be beneficial to provide methods of providing implantable prosthetic devices, including stents, with properties that can be tailored for various purposes.
  • SUMMARY OF THE INVENTION
  • In accordance with certain embodiments of the present disclosure, composite prosthetic devices comprising one or more porous layers of electrospun polymeric materials are provided. Such porous layers can be, for example, on the inner diameter surface of a tubular prosthetic device, on the outer diameter surface of a tubular prosthetic device, or on both the inner diameter surface and outer diameter surfaces of a tubular prosthetic device. Composite devices can be provided having 2 layers, 3 layers, 4 layers, 5 layers, or more. In certain embodiments, a structural frame (e.g., a stent or other device) can be incorporated within the structure. At least one layer within the composite prosthetic device can, in some embodiments, comprise electrospun poly(tetrafluoroethylene) (PTFE). Advantageously, in certain embodiments, the composite prosthetic device exhibits some degree of porosity.
  • In one aspect of the disclosure is provided a multi-layered tubular composite prosthetic device comprising at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer. The makeup of the second electrospun polymer can be, for example, a solution-electrospun polymer (e.g., a thermoplastic polymer or a thermoset polymer, such as polyurethane, a silicone (e.g., PDMS), polyether block amide (PEBA), a polyamide, ultra-high molecular weight polyethylene (UHMWPE), a polyester, fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a tetrafluoroethylene/hexafluoropropylene/vinylidene fluoride copolymer (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlorotrifluoroethylene (ECTFE), PCTFE (polychlorotrifluoroethylene), or a copolymer, blend, or derivatives thereof). In other embodiments, the second electrospun polymer can be a dispersion-electrospun polymer, e.g., poly(tetrafluoroethylene). Advantageously, in some embodiments, the porous layer comprising a second electrospun polymer penetrates the pores of the porous layer comprising electrospun poly(tetrafluoroethylene).
  • Although the second electrospun polymer as described herein typically exhibits some degree of porosity, for certain applications, it may be desirable to provide one or more non-porous layers. Such non-porous layers may in some embodiments, be prepared by electrospinning or by other methods as described herein. Accordingly, in certain embodiments of the application are provided a multi-layered tubular composite prosthetic device comprising at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one non-porous layer comprising a second electrospun polymer. The preparation and use of non-porous as well as porous electrospun polymers will be described more thoroughly herein.
  • In certain embodiments, the composite prosthetic devices described herein can further comprise a structural frame (e.g., a stent). Preferably, such structural frames can comprise open spaces and, in some embodiments, the second electrospun polymer can penetrate through the open spaces of the structural frame.
  • The number of layers of the devices described herein can vary. In some embodiments, a device is provided which comprises at least two porous layers comprising electrospun poly(tetrafluoroethylene). In some embodiments, a device is provided which comprises at least two porous layers comprising the second electrospun polymer. In certain embodiments, at least one of the inner diameter and the outer diameter of the tubular device comprises a porous layer comprising electrospun poly(tetrafluoroethylene). In certain embodiments, the device can further comprise a non-porous polymeric layer.
  • Certain specific embodiments are described as follows. In one embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer.
  • In one embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer, between said first and second layers.
  • In another embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); and a second porous layer comprising a second electrospun polymer on the device outer diameter surface.
  • In a further embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(ethylene terephthalate) on the device outer diameter surface; and a third layer between said structural frame and said second layer comprising a different electrospun polymer, wherein the structural frame comprises open spaces through which the different electrospun polymer penetrates.
  • In a still further embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer between said first and second layers, wherein a layer comprising the different electrospun polymer is adjacent to the structural frame and the structural frame comprises open spaces through which the different electrospun polymer penetrates.
  • In one additional embodiment is provided a tubular composite prosthetic device, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer, wherein a structural frame is embedded in the third layer.
  • In another aspect of the invention is provided a method for producing a composite prosthetic device comprising: combining at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer to give a composite prosthetic device precursor; and applying pressure, heat, or both pressure and heat to the composite prosthetic device precursor to provide a composite prosthetic device.
  • The combining step can, in some embodiments, comprise wrapping the porous layer comprising the second electrospun polymer around the porous layer comprising the electrospun poly(tetrafluoroethylene). The combining step can, in some embodiments, comprise electrospinning the porous layer comprising a second electrospun polymer onto the porous layer comprising electrospun poly(tetrafluoroethylene).
  • The methods described herein can provide composite prosthetic devices with varying compositions and properties. In some embodiments, the second electrospun polymer comprises a solution-electrospun polymer. In some embodiments, the second electrospun polymer comprises unsintered poly(tetrafluoroethylene). Advantageously, where the composite device comprises unsintered poly(tetrafluoroethylene), the method further comprises sintering the composite prosthetic device following the applying step.
  • The applying step can, in some embodiments, comprise applying heat, pressure, or both heat and pressure for a time sufficient to result in the penetration of the second electrospun polymer into the pores of the at least one porous layer comprising electrospun poly(tetrafluoroethylene). In some embodiments, heat and pressure are applied sequentially or simultaneously. The pressure and/or temperature can vary. In certain embodiments, the pressure is between about 200 and about 2000 PSI (e.g., between about 500 PSI and about 1500 PSI) and the temperature is between about 100° C. and about 400° C. The applying step can be conducted, for example, in a pressure vessel. Further exemplary discussion of materials and methods as disclosed herein is provided in U.S. provisional patent application No. 61/620,633, filed Apr. 5, 2012 and U.S. provisional patent application No. 61/724,731, filed Nov. 9, 2012, which are both incorporated herein by reference in their entireties.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • A full and enabling disclosure, directed to one of ordinary skill in the art, is set forth more particularly in the remainder of the specification, which makes reference to the appended figures in which:
  • FIG. 1 is a schematic cross-sectional view of a wall of a mono-component composite device in accordance with the present disclosure;
  • FIG. 2 is a schematic cross-sectional view of a wall of a mono-component composite device comprising a structural frame in accordance with the present disclosure;
  • FIG. 3 is a schematic cross-sectional view of a wall of a multi-component composite device in accordance with the present disclosure;
  • FIG. 4 is a schematic cross-sectional view of a wall of a multi-component composite device comprising a structural frame in accordance with the present disclosure;
  • FIG. 5 is a schematic cross-sectional view of a wall of a multi-component composite device in accordance with the present disclosure;
  • FIG. 6 is a schematic cross-sectional view of a wall of a multi-component composite device comprising a structural frame in accordance with the present disclosure;
  • FIGS. 7A-F are schematic cross-sectional views of exemplary multi-component composite devices comprising structural frames in accordance with the present disclosure;
  • FIG. 8 is a schematic illustrating one exemplary process for the preparation of the exemplary composite devices of FIG. 7A and/or FIG. 7B;
  • FIG. 9 is a schematic illustrating one exemplary process for the preparation of the exemplary composite device of FIG. 7C;
  • FIG. 10 is a schematic illustrating one exemplary process for the preparation of the exemplary composite devices of FIGS. 7D and 7E; and
  • FIG. 11 is a schematic illustrating one exemplary process for the preparation of the exemplary composite device of FIG. 7F.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention will now be described more fully hereinafter with reference to the accompanying figures, in which some, but not all embodiments of the inventions are shown. Indeed, these inventions may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Each example is provided by way of explanation of the disclosure, and is not intended to be limiting of the disclosure. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in the present disclosure without departing from the scope or spirit of the invention. For instance, features illustrated or described as part of one embodiment can be used in the context of another embodiment to yield a further embodiment. Thus, it is intended that the present disclosure covers such modifications and variations as come within the scope of the disclosed embodiments and their equivalents.
  • Overview of Composite Prosthetic Devices According to the Present Disclosure
  • Generally, the present disclosure provides composite prosthetic devices comprising one or more layers of electrospun (also referred to herein as “espun”) fibers around a central lumen and methods of preparation thereof, wherein at least one layer comprises a dispersion-spun polymer. In some embodiments, the one or more layers of espun fibers can comprise the inner diameter surface, the outer diameter surface, or both the inner and outer diameter surfaces of a tubular composite prosthetic device. The focus of the application is on multi-layered structures comprising at least one layer of espun fibers on the inner diameter surface and at least one layer of espun fibers on the outer diameter surface; however, the disclosure is intended to also relate to structures comprising only one of these. For example, a structural frame having a single layer of espun fibers on the inner diameter surface is intended to be encompassed by the present disclosure and a structural frame having a single layer of espun fibers on the outer diameter surface is also intended to be encompassed by the present disclosure.
  • The composite prosthetic devices described herein can, in certain embodiments, offer a number of advantages over conventional devices. For example, in certain embodiments, the composite prosthetic devices provided herein advantageously exhibit one or more of: 1) the ability to incorporate layers with vastly different pore structures and sizes (allowing for the manipulation of various properties such as mechanical properties, cellular proliferation, cellular permeability, fluid permeability, adhesion to a structural frame, and/or possible incorporation of one or more active therapeutic components within different structural layers); 2) the ability to make a composite construction comprising at least two different components (even vastly different components, thus enabling a broad range of therapeutic uses and structures); 3) improved bonding between various layers, including the one or more espun layers, the optional structural frame, and/or other optional layers of the composite device; 4) the inclusion of a material (e.g., electrospun poly(tetrafluoroethylene) (PTFE)) that closely mimics that of the extracellular matrix, thus affording greater control of cellular response; and 5) the ability to provide a covering (layer) on devices having both simple and complex geometries, which can pose a challenge for covering with conventional materials.
  • The type of prosthetic device provided according to the present invention can vary and the device can be tailored so as to be used for any given purpose. Generally, prosthetic devices as intended herein are tubular prosthetic devices. By “tubular prosthetic device” is meant that the device has a 3-dimensional shape and this term is intended to cover devices of varying sizes (e.g., length, thickness, and/or diameter), shapes, and compositions. Such tubular prosthetic devices are generally characterized as having a central lumen. A tubular prosthetic device can generally be described as having both an inner diameter (“ID”) and an outer diameter (“OD”). “Tubular devices” is intended to be broadly construed to include stents, grafts, and stent grafts having typical cylindrical-shaped structures as well as structures having shapes including, but not limited to, non-linear-shaped, petal-shaped, saddle-shaped, Y-shaped, mushroom-shaped, flared shaped, bell-shaped, single horn-shaped, double horn-shaped, hourglass-shaped, single cup-mouth shaped, twin cup-mouth shaped, cup mouth-ball shaped, and the like. One or both ends of the prosthetic device can be coiled or otherwise shaped to prevent migration of the device within the body.
  • Generally, prosthetic devices are devices that can be placed into an artery, blood vessel, or other duct to hold the duct open or to redirect blood flow within the duct, or the like. In certain embodiments, the present disclosure is directed to vascular prosthetic devices (also referred to herein as “vascular prostheses”). Such devices can be vascular stents or vascular stent grafts. Representative vascular prostheses include coronary stents, coronary artery by-pass grafts, blood vessel stents, artificial by-pass grafts, by-pass shunts, arteriovenous grafts, homografts, pulmonary allografts, and/or pulmonary shunts. Other tubular prosthetic devices that may be provided according to the invention include, but are not limited to, hemodialysis tubes, ureteral stents, urethral or prostatic stents, prostatic/sphincter stents, esophageal stents, laryngeal stents, tracheal stents, biliary stents, duodenal stents, colonic stents, pancreatic stents, tracheobronchial stents, and gastrointestinal stents.
  • The composite prosthetic devices of the present disclosure can have varying compositions. Generally, the composite prosthetic devices described herein comprise one or more electrospun layers (including two or more electrospun layers). Electrospun layers are understood to be polymeric layers prepared via an electrospinning process as described herein. Electrospun layers typically comprise a plurality of fibers, which in some embodiments are in random orientation with respect to one another. In certain embodiments, electrospun layers can be described as fibrous and/or porous. The diameter of the fibers within an espun mat according to the present disclosure can vary. In certain embodiments, espun layers can comprise fibers having average diameters of at least about 0.01 μm. For example, the average diameter of fibers in each of the one or more espun layers of the composite devices can, in some embodiments, range from about 10 nm to about 2000 nm in size. In some embodiments, one or more of the espun layers, in final form, have fibers deposited in a density such that there is a range of distances of about 0.1 μm to about 50 μm between points of contact.
  • Further, the pore size of a given layer and of the composite device as a whole can vary. As used herein in reference to the espun layers, “pore size” is intended to refer to effective pore size (rather than actual pore size) as measured, for example, by air flow and/or water flow (e.g., as defined by ASTM F316 Pore Size Characterization by Bubble Point, which is incorporated herein by this reference). It is noted that, given the nature of the espun fiber mats, it is generally not possible to measure actual pore size of such materials using microscopy methods. The effective pore size of a given espun layer within a composite device as described herein can range from about 0.0 μm (e.g., a non-porous film) to about 50 μm, e.g., from about 0.05 μm to about 20 μm. Advantageously, the effective pore size of each layer is greater than about 0.0 μm as, in certain embodiments, it is desired to provide a composite device exhibiting some degree of porosity. It is noted that, in some embodiments, the effective pore size of a given layer may not be accurately known, such as, for example, where layers are applied and subsequently compressed and/or sintered within the composite device.
  • In some embodiments, the individual layers comprising a composite prosthetic device as described herein can have varying thicknesses. For example, in some embodiments, each layer can have an average thickness ranging from about 0.0001 inches to about 0.25 inches. In some embodiments, layers with thicknesses at the low end of this range are desirable (e.g., about 0.0001 inches to about 0.0010 inches, such as about 0.0003 inches to about 0.0005 inches) The thickness of a given layer can depend, in part, on the method of preparation of the layer and on the makeup of the layer. For example, in some embodiments, very thin espun layers of PU (e.g., between about 0.0001 inches and about 0.0005 inches) are readily obtained. Very thin espun layers of PTFE (e.g., about 0.0001 inches) are generally achieved only through direct application to a construct (i.e., by spin coating, as described below) although sheets of PTFE for lamination onto constructs as described herein may, for example, be prepared with thicknesses as low as about 0.0005 inches. Sheets or tubes prepared by electrospinning typically cannot exhibit such low thicknesses and generally exhibit thicknesses of about 0.0008 inches or greater. In preferred embodiments, the thickness of a given layer is relatively uniform throughout. The thickness of a given layer can also depend on the method by which the composite device is produced. For example, a polymeric sheet can be wrapped once, twice, three times, four times, five times, or more times around the device (or on the interior of the device) to obtain varying thicknesses of that layer.
  • Given this range of possible layer thicknesses, the wall thickness of the composite devices disclosed herein can vary accordingly, depending on the number of layers and on the thickness of each layer. For example, based on the layer thicknesses noted above, a 2-layer composite device can have a wall thickness ranging from about 0.0002 inches to about 0.50 inches, such as from about 0.001 inches to about 0.05 inches, including from about 0.003 inches to about 0.02 inches. It is to be understood that layers of varying thicknesses can be combined within the device. In preferred embodiments, the overall wall thickness of the composite device is relatively uniform throughout the length of the device and around the circumference of the device. However, in embodiments comprising a structural frame, the frame typically comprises an open structure formed from wires or struts and having spaces in between, and it is noted that the wire or strut diameter can impact the wall thickness where the wire or strut is present. Thus, for example, in considering the uniformity of a given composite, the layer thickness at one position on a composite must be compared to the layer thickness at a comparable position on that composite (i.e., by comparing a point at which the wire or strut is present with another point at which the wire or strut is present, or by comparing two points at which the wire or strut is not present). Further, it is understood that, in some embodiments, a seam may be present where one or more layers is wrapped around the device, which can be dependent on the processing conditions used to produce the composite device. Accordingly, in some embodiments, there may be one or more indentations (e.g., lines) or raised portions (e.g., lines) on the outer diameter surface of the device, and such embodiments are intended to be encompassed by “substantially uniform” as described herein.
  • The overall outer diameter of the device can vary. For example, the overall outer diameter can, in certain embodiments, range from about 0.005 inches to about 2 inches, although larger and smaller composites can be prepared without departing from the present disclosure. The final length can vary greatly as the composites can be produced as sheets or tubes at continuous roll lengths.
  • The composite devices described herein can have varying numbers of polymeric layers (e.g., 2-layered, 3-layered, 4-layered, 5-layered, 6-layered, 7 layered, 8-layered, 9-layered, 10-layered, or having even more layers). In certain embodiments, a layer on the inner diameter surface of a composite device may comprise between about 1 and about 5 wrappings (e.g., about 2 wrappings). In certain embodiments, a layer on the outer diameter surface of a composite device may comprise between about 2 and about 10 wrappings (e.g., about 4-8 wrappings or about 5-7 wrappings). It is noted that, although the components of the composite prosthetic devices described herein are described as comprising “layers,” these layers may not always be discrete layers. For example, although layers are advantageously continuous layers, in some embodiments, they may not always be continuous layers. Further, in some embodiments, the composites may exhibit some ingress of one “layer” into another “layer.” These scenarios are still intended to be encompassed by the term “layered.”
  • Generally, at least one layer within the composite prosthetic devices described herein functions as a “tie layer.” A tie layer is a layer that is incorporated into the composite device in a form such that it serves to adhere and/or bond two or more layers together. To fulfill this requirement, the tie layer component must exhibit some degree of flow, tackiness, and/or moldability at ambient temperature and/or at elevated temperature when it is incorporated within the device. Typically, a composite prosthetic device precursor, comprising all layers to be included in the final device, is prepared and the precursor is treated before use (i.e., by applying heat and/or pressure) such that the tie layer may not maintain these properties in the final composite device provided herein. In some embodiments, the tie layer comprises the same polymer type as the one or more layers adjacent thereto and, in some layers, the tie layer comprises a different polymer type. The tie layer can comprise, for example, any of the polymer types and in certain embodiments, may comprise PTFE, PU, or a silicone (e.g., PDMS). In certain embodiments, the tie layer penetrates the pores of one or both of the layers with which it is in contact and thus can provide a mechanical-type connection between the layers. In certain embodiments, the tie layer advantageously can penetrate at least a portion of the open spaces in a structural frame, where present. Where a frame is present, a tie layer may, in some embodiments, serve to connect and/or bond the material comprising the inner diameter surface of the composite device to the outer diameter surface (e.g., through the structural frame). The incorporation of such a layer will be described in greater detail herein.
  • As the presently described devices comprise two or more polymeric layers, a wide range of composite devices having varying properties are provided. By incorporating layers with different properties (e.g., composition, thickness, effective pore size, fiber size, etc.), devices with various combinations of properties are afforded. Means for adjusting these and other properties are described further herein. Further, the chemical makeup of the individual layers can provide an additional degree of tailoring. Due to the layered, “sandwich”-type construction of the composite devices of the present disclosure, physical properties such as thickness and pore size can vary from layer to layer within the cross section of the composite device, depending on the construction. An example would be an asymmetrical construction where pores change in size from large to small based on layer evaluations from surface to surface throughout the material.
  • As noted, the specific compositions of the composite prosthetic devices provided according to the present disclosure can vary, as described in greater detail herein. However, in all composite prosthetic devices disclosed herein, at least one layer of the device generally comprises a fibrous mat prepared via dispersion-based electrospinning (i.e., a “dispersion-spun component”). Exemplary materials and methods involved in dispersion-based electrospinning are described in greater detail below.
  • In certain embodiments, the fibrous mat prepared via dispersion-based electrospinning (i.e., the dispersion-spun component) is an electrospun fibrous mat comprising a fluorinated polymer (e.g., poly(tetrafluoroethylene) (PTFE)). Although much of the description of electrospinning provided herein focuses specifically on electrospinning PTFE and on electrospun mats comprising PTFE, it is noted that the methods and materials described herein may employ an alternative polymer in place of the PTFE. Exemplary fluorinated polymers that can be incorporated as a dispersion-spun component of the composite prosthetic devices described herein include, but are not limited to, fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a copolymer of tetrafluoroethylene, hexafluoropropylene and vinylidene fluoride (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlorotrifluoroethylene (ECTFE), PCTFE (polychlorotrifluoroethylene), and copolymers, blends, and derivatives thereof. Further, although the application as written is directed to embodiments wherein the dispersion-spun component comprises a fluorinated polymer, it is noted that other polymers that can be spun from a dispersion can alternatively or additionally be employed as a dispersion-spun component.
  • In some embodiments, a composite prosthetic device is provided wherein the two or more electrospun layers consist of one type of material, i.e., the same type of material (giving a “mono-component composite” prosthetic device), optionally in combination with a structural frame (e.g., a stent). In such embodiments, the composite prosthetic device comprises two or more layers of a dispersion-spun polymeric component. The tie layer of such devices thus consists of the same type of polymeric material as that of the one or more additional layers. For example, in one particular embodiment, an electrospun PTFE-based composite device is provided, wherein each of the two or more polymeric layers of the composite prosthetic device comprises electrospun PTFE. In such embodiments, the properties (e.g., thickness, pore size, fiber diameter, etc.) of each layer can vary such that different PTFE layers of the composite device can exhibit different properties. Although PTFE is exemplified, it is noted that other prosthetic composites consisting of or consisting essentially of one polymeric material other than PTFE may also be provided according to the present disclosure.
  • Exemplary mono-component composite prosthetic devices are illustrated in FIGS. 1 and 2. FIG. 1 illustrates a cross-sectional view of a wall of a composite prosthetic device 10, wherein the coverings on the inner (12) and outer (16) diameter surfaces of the device comprise the same dispersion-spun polymer (e.g., PTFE). Layer 14 is a tie layer, comprising the same type of polymer (e.g., PTFE), but layer 14 is initially incorporated into the structure in unsintered (tacky and moldable) form. It is noted that device 10 will be subjected to heat and/or pressure prior to use to provide layer 14 in sintered, fibrous form and to promote adhesion between layers (e.g., via penetration of layer 14 into the pores of layer 12 and/or layer 16). FIG. 2 illustrates a cross-sectional view of a wall of a composite prosthetic device 20, which is similar but further incorporates a structural frame 24. Again, layers 22, 26, and 28 comprise the same type of polymer (e.g., PTFE) and the tie layer (26) is initially incorporated in unsintered form. Here, the application of heating and pressure to the device precursor preferably causes the tie layer 26 to penetrate through interstices in structural frame 24, as well as into the pores of layer 22 and/or 28. In some embodiments, the application of heating and pressure can cause tie layer 26 to bond the material comprising the inner diameter surface of the composite device to the material comprising the outer diameter surface of the device. Again, the composite device precursor is preferably heated prior to use to provide layer 26 in sintered form in the final composite device (e.g., where the layer comprises PTFE).
  • In contrast, multi-component composite devices have at least two types of electrospun polymeric layers and can have any number of different types of polymeric materials therein (e.g., at least 2, at least 3, or at least 4). Each polymer type within the multi-component composite devices as described herein can be represented in one layer or more than one layer. For example, a composite device can have: one layer of a given first electrospun material and one layer of a given second electrospun material; two or more layers of a given first electrospun material and one layer of a given second electrospun material; or two or more layers of a given first electrospun material and two or more layers of a given second electrospun material. The multi-component composite devices provided herein, in addition to comprising one or more dispersion-spun layers, comprise one or more additional layers, which can be prepared via dispersion-based electrospinning, melt-based electrospinning, and/or solution-based electrospinning.
  • In certain embodiments, the one or more additional electrospun layers of the prosthetic device comprise an electrospun thermoplastic or thermoset polymer. A thermoplastic is understood to be any polymer that becomes moldable above a specific temperature and returns to a solid state upon cooling. A thermoset is understood to be a polymeric material that is initially moldable, but can cured (usually irreversibly) to give a solid (e.g., by the application of heat or radiation). In some embodiments, the thermoplastic or thermoset polymer is an elastomer. An elastomer is a polymer that can be repeatedly stretched and/or deformed without permanently deforming the shape thereof.
  • Certain exemplary polymers that can be incorporated as electrospun layers in the multi-component prosthetic devices disclosed herein are polyurethanes (PU) and silicones, e.g., polydimethylsiloxane (PDMS). Other polymers useful for this purpose include, but are not limited to, polyether block amide (PEBA, e.g., PEBAX®), polyamides, polyethylene (e.g., ultra-high molecular weight polyethylene, UHMWPE), polyesters, and copolymers, blends, and derivatives thereof. Additionally, certain fluorinated polymers such as fluorinated ethylene propylene (FEP), polyvinylidene fluoride (PVDF), perfluoroalkoxy (PFA), a copolymer of tetrafluoroethylene, hexafluoropropylene and vinylidene fluoride (THV), poly(ethylene-co-tetrafluoroethylene) (ETFE), ethylene chlorotrifluoroethylene (ECTFE), PCTFE (polychlorotrifluoroethylene), and copolymers, blends, and derivatives thereof which can be electrospun can be used. Generally, any thermoplastic or thermoset polymer that forms fibers upon electrospinning can be used in this regard as an additional polymeric component (in addition to the one or more dispersion-spun layers). Preferably, the additional polymeric component is selected such that the electrospun mat produced therefrom retains some degree of porosity when it is combined with the other component(s) of the multi-component composite device and when the resulting device precursor is treated (i.e., when it is exposed to elevated temperature and/or pressure) to provide a final composite device. However, in certain embodiments, it may be desirable to provide a final composite device that is non-porous. In such embodiments, one or more polymeric layers is a non-porous layer (which can be prepared in various ways as described herein, including, but not limited to, by electrospinning and/or by film formation).
  • Certain multi-component devices described herein exhibit enhanced properties relative to commercially available devices and/or to mono-component devices described herein. Properties that may be enhanced in certain embodiments, include, but are not limited to, robustness, flexibility, strength (e.g., radial strength and burst strength), crush/bend/kink resistance, and compression resistance, for example, as evaluated by testing methods including, but not limited to, air flow testing, torsion testing, tension/compression testing, abrasion resistance testing, burst strength testing, WEP testing, radial force expansion testing, kink resistant testing, 3-point bend testing, flex testing, crush resistance testing, recoil testing, and general physical evaluation.
  • Exemplary multi-component composite prosthetic devices are illustrated in FIGS. 3 and 4. FIG. 3 illustrates a cross-sectional view of a wall of a composite prosthetic device 30, wherein the coverings on the inner (32) and outer (36) diameter surfaces of the device comprise the same electrospun polymer (e.g., PTFE). Layer 34 is a tie layer, which comprises a different electrospun polymer than layers 32 and 36 (e.g., PU or PDMS). If layer 34 is a dispersion-spun material, layer 34 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If layer 34 is a solution-spun or melt-spun material, no sintering is required prior to use. However, in all embodiments, the device 30 will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 34 into the pores of layer 32 and/or layer 36). FIG. 4 illustrates a cross-sectional view of a wall of a composite prosthetic device 40, which is similar but further incorporates a structural frame 44. Layers 42 and 48 comprise the same electrospun polymer (e.g., PTFE) and the tie layer (46) comprises a different material. Again, if tie layer 46 is a dispersion-spun material, layer 46 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If tie layer 46 is a solution-spun or melt-spun material, no sintering is required prior to use. However, in all embodiments, the device precursor will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 46 into the pores of layer 42 and/or layer 48).
  • Further exemplary multi-component composite prosthetic devices are illustrated in FIGS. 5 and 6. FIG. 5 illustrates a cross-sectional view of a wall of a composite prosthetic device 50, wherein the coverings on the inner (52) and outer (56) diameter surfaces of the device comprise different polymers. Layer 54 is a tie layer, which may comprise the same polymer as layer 52 or 56 or may comprise a different material. If layer 54 is a dispersion-spun material, layer 54 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If layer 34 is a solution-spun or melt-spun material, no sintering is required prior to use. However, in all embodiments, the device 50 will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 54 into the pores of layer 52 and/or layer 56). FIG. 6 illustrates a cross-sectional view of a wall of a composite prosthetic device 60, which is similar but further incorporates a structural frame 64. Layers 62 and 68 comprise different polymers and the tie layer (66) can comprise the same polymer as layer 62 or 68 or may comprise a different material. Again, if tie layer 64 is a dispersion-spun material (e.g., PTFE), layer 64 is initially incorporated into the structure in unsintered (tacky and moldable) form and must be sintered before the composite device is used. If tie layer 64 is a solution-spun or melt-spun material, no sintering is required prior to use. However, in all embodiments, the device precursor will be subjected to heat and/or pressure prior to use to promote adhesion between layers (e.g., via penetration of layer 64 into the pores of layer 62 and/or layer 68).
  • FIGS. 7A-7F are schematic cross-sections of representative multi-component prosthetic devices according to the present disclosure, having greater than two layers. In each of these embodiments, two polymeric components are present; the grey layers represent the dispersion-spun component (e.g., PTFE) and the black layers represent a different type of polymeric material (e.g., PU or PDMS). The dashed lines represent structural frames. As exemplified in FIGS. 7A-7F, a wide range of embodiments having different cross-sections can be provided according to the methods and materials disclosed herein.
  • The structural frame, where present in the mono-component composite or multi-component composite, can vary. Structural frames can take various forms including, but not limited to, stents, occlusion coils or frames, regenerative medicine scaffolds, structural reinforcements, pacing or monitoring leads, tissue anchors or tacks, biological stimulation devices, biomimetic implants, signal receivers or transmitters, orthopedic fixation devices or any other metallic, polymeric, ceramic or other therapeutic devices. Various stent types and stent constructions may be employed in the present disclosure, including, but not limited to, self-expanding stents and balloon expandable stents. In certain embodiments, the stents may be capable of radially contracting as well. Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
  • The makeup of the structural frame, where present, can vary. In some embodiments, the structural frame is a metal structural frame, which can generally comprise any biocompatible metal. In certain embodiments, the metal structural frame can comprise stainless steel, platinum, gold, titanium, or a mixture thereof. In certain embodiments, the metal structural frame can comprise cobalt, chrome, or magnesium alloy. Nickel titanium alloy (“Nitinol”) is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature and thus may be useful in certain embodiments of the invention. In other embodiments, the structural frame can comprise another type of material, such as a ceramic.
  • The configuration of the structural frame (e.g., stent) may also be chosen from any suitable geometry. For example, wire stents can be fastened into a continuous helical pattern, with or without a wave-like feature or zig-zag in the wire, to form a radially deformable stent. Individual rings or circular members can be linked together by struts, sutures, welding, or interlacing or locking to form a single tubular stent. Individual rings or circular members may have no link and thus may serve as individual units in the composite that is provided upon the combination of such a frame with one or more layers of polymeric material according to the invention. In such cases, multiple ring segments are embedded and held in place by the composite material to comprise a single tubular composite device. Tubular prosthetic devices useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such devices are often referred to as “slotted” devices (e.g., slotted stents). Furthermore, devices may be formed by etching a pattern into a material or mold and depositing device material in the pattern, such as by chemical vapor deposition or the like. As will be apparent based on the disclosure herein, there may be some limit on the configuration of a structural frame in order to achieve enhanced bonding between adjacent polymeric layers through the structural frame in certain embodiments.
  • It is noted that the examples provided herein and the embodiments illustrated in FIG. 7A-7F contain a structural frame; however, this is not necessary. In some embodiments, a 100% electrospun polymer-based device is provided. In other embodiments, a device is provided consisting only of a structural frame and electrospun polymeric layers. Composite devices comprising additional types of materials, however, are not intended to be excluded from the present disclosure. It is possible according to the present invention to incorporate various additional non-electrospun components into the mono-component prosthetic devices and multi-component prosthetic devices described herein. For example, such further components include, but are not limited to, melt-processable polymers, e.g., polyamides, polyurethanes, and the like (including, but not limited to, perfluoroalkoxy (PFA), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), or tetrafluoroethylene hexafluoropropylene vinylidene fluoride (THV)) (which can provide a non-porous layer, e.g., as a self-sealing thermoplastic or elastomeric film); woven or nonwoven fabrics of natural or man-made fibers; plastic or ceramic membranes; metal, ceramic, or plastic meshes; expanded PTFE (ePTFE) layers as discussed for example in U.S. Patent Application Publication Nos. 2011/0030885 and 2011/0031656 to Anneaux et al., which are both incorporated herein by this reference in their entireties or combinations thereof.
  • Additionally, in some embodiments, the composite devices provided herein can comprise one or more bioactive agents. Examples of such bioactive agents that can be utilized in connection with the devices of the present disclosure include, but are not limited to: antibiotics, antifungals, and antivirals (such as erythromycin, tetracycline, aminoglycosides, cephalosporins, quinolones, penicillins, sulfonamides, ketoconazole, miconazole, acyclovir, ganciclovir, azidothymidine, and interferons); vitamins; anticonvulsants (such as phenytoin and valproic acid); antidepressants (such as amitriptyline and trazodone); antiparkinsonism drugs; cardiovascular agents (such as calcium channel blockers, antiarrhythmics, and beta blockers); antineoplastics (such as cisplatin and methotrexate), corticosteroids (such as dexamethasone, hydrocortisone, prednisolone, and triamcinolone); NSAIDs (such as ibuprofen, salicylates, indomethacin, and piroxicam); hormones (such as progesterone, estrogen, and testosterone); growth factors; carbonic anhydrase inhibitors (such as acetazolamide); prostaglandins; antiangiogenic agents; neuroprotectants; neurotrophins; growth factors; cytokines; chemokines; cells (such as stem cells, primary cells, and genetically engineered cells); tissues; other agents known to those skilled in the art; and combinations thereof. Bioactive agents can, in some embodiments, be as described in U.S. application Ser. No. 13/272,412 to Ballard et al., filed Oct. 13, 2011, which is incorporated herein by this reference in its entirety. The amount of optional bioactive agent incorporated within the tubular composite devices can vary but is generally that amount sufficient to elicit a desired response in the patient in whom the device is to be implanted. In some embodiments, a bioactive agent can be incorporated within only one layer or within more than one layer of the composite prosthetic device. The properties and characteristics of the final composite prosthetic devices of the present disclosure are a compilation of the properties of the one or more espun polymer layers and any other optional material(s) contained within the composite device (e.g., the optional one or more additional espun polymeric layers and the optional structural frame). The final composite devices of the present disclosure can, in certain embodiments, be prepared with controlled fiber sizes and the mechanical properties of the device can be tailored so as to improve such features as bond strength between components (e.g., layers) of the device, elongation properties, and tensile strength. Moreover, different pore sizes of the layers can be targeted for different intended application. Advantageously, the individual layers exhibit little to no delamination, indicative of strong adhesion of layers to each other. The composite devices of the present disclosure can, in some embodiments, exhibit additional desirable characteristics of enhanced radial tensile strength, suture hole tearing resistance and enhanced axial tear resistance as compared with commercially available products.
  • The ability to tailor such properties of the composite device of the present disclosure can have implications in designing prosthetic devices for particular applications. Advantageously, the properties of individual layers of the composite device can be modified to tailor the overall properties of the composite device for a given application. For example, modifying the pore sizes and/or thicknesses of the polymeric layers can serve to enhance or inhibit cellular ingrowth or attachment. For example, the device interior surface, or ID surface (generally the fluid-, e.g., blood-contacting region) and the device exterior surface, or OD surface (which is generally the tissue-contacting region) may, in certain embodiments, have different effective pore sizes. In certain embodiments, it may be desirable to enhance cellular ingrowth and/or attachment on the exterior of a composite device, whereas it may be desirable to inhibit such activity on the interior of a composite device to allow fluid to freely pass therethrough. Thus, in some embodiments, a composite can comprise a layer having a large pore size on the exterior of the device to facilitate ingrowth and a layer having a smaller pore size on the interior of the device. In some embodiments, the inverse is desired (i.e., a composite with minimal to no ingrowth on the exterior and enhanced ingrowth on the interior), which can be achieved by providing a composite comprising a layer having a small pore size on the exterior of the device and a layer having a larger pore size on the interior of the device.
  • Electrospinning Process
  • Electrospun mats useful according to the present disclosure can be prepared by drawing material by electrical charge from a polymer solution, from a polymer suspension/dispersion, or from a polymer melt. The fibers thus produced are typically collected in a random fashion to produce nonwoven materials. Various specific techniques are known for the production of electrospun fibers and electrospun materials (e.g., mats and/or coverings).
  • Dispersion-spun layers (e.g., PTFE and other fluorinated polymers discussed herein) can be prepared, for example, according to the following procedure. A dispersion comprising the desired polymeric particles is provided or prepared. The solids content of PTFE resins is preferably between 50% to about 80% by weight, and more preferably between about 55% and about 65% by weight. In one specific embodiment, an exemplary commercially available PTFE dispersion, Daikin D 210 PTFE, is used, which comprises about 59-61 wt % PTFE solids (measured according to ASTM D 4441), 6.0-7.2% wt % surfactant, a pH at 25° C. of 8.5 to 10.5, a specific gravity of 1.50 to 1.53 and a Brookfield viscosity maximum of 35 cP. The properties of the PTFE (e.g., molecular weight, polydispersity index, particle size, particle size distribution) can vary. In some embodiments, the average particle size of the PTFE can be between about 0.05 μm and about 1 μm (for example, between about 0.1 μm and about 0.5 μm). In some embodiments, the average particle size is less than about 0.5 μm, less than about 0.4 μm, less than about 0.3 μm, or less than about 0.2 μm. For example, the average particle size in certain embodiments may be about 0.13 μm, about 0.16 μm, about 0.23 μm, or about 0.25 μm. The solvent can be any solvent suitable for creating a dispersion; suitable such solvents include, but are not limited to, aqueous solutions or alcohol solutions (e.g., methanol, ethanol, or isopropanol).
  • A fiberizing polymer is typically added to the dispersion to facilitate fiber formation and is generally removed following the espinning process. The fiberizing polymer (or polymers) are typically selected such that they have a high solubility in the solvent of the dispersion (e.g., where the dispersion comprises water, any water-soluble polymer can be used, including, but not limited to, poly(ethylene oxide)). The amount of fiberizing polymer present in the dispersion can vary; for example, in certain embodiments, the dispersion comprises about 1% to about 10% by weight of a fiberizing polymer, based on the total weight of the dispersion. In certain embodiments, the weight ratio of fiberizing polymer to PTFE varies. For example, the amount of fiberizing polymer can be about 3.0% to about 5.5% that of the PTFE in the dispersion by weight. The amount of fiberizing polymer required according to the present invention may vary depending on the chemical makeup of the polymer.
  • In preferable embodiments, the viscosity of the dispersion is within a certain desirable range to allow for the formation of uniform and consistent fibers therefrom (e.g., greater than about 50,000 cP, such as between about 50,000 cP and about 300,000 cP or between about 70,000 cP and about 150,000 cP, as measured with a Brookfield Viscometer. The desired viscosity of the dispersion may vary depending on whether a free surfaced-based apparatus or an orifice (needle)-based apparatus (which requires a somewhat higher viscosity) is used. In one embodiment, free surface electrospinning from a wire, a cylinder in a trough (i.e., open bath), spike, sharp edge, or similar geometry spinning electrode or the like is used. For the open bath unit, the ejection volume is dependent upon the viscosity of the dispersion, the conductivity of the dispersion, the surface tension of the dispersion, the distance from bath to target, and the voltage. These factors can also affect the thickness of the fabric and the fiber diameter. The charge source is preferably connected to the positive side of a precision DC power supply. The negative side of the power supply is preferably connected to the collection surface. Alternatively, the collection surface can be at ground. The polarity can be reversed but this is not preferred. Voltage is applied (e.g., typically from about 40,000 volts to about 120,000 volts (e.g., about 40,000 to about 80,000 volts) over a typical collection distance of about 100 to about 400 mm) to uniformly draw out the dispersion and attract it to a collection surface. In a free surface electrospinning apparatus, the collection surface/target can be placed, for example, above the cylinder in the dispersion trough or the dispersion-coated wire and is typically moved in at least one direction such that the entire surface or the desired portion thereof becomes uniformly covered with fibers.
  • In other embodiments, orifice or needle spinning is used. This method is similar to that described above; however, the polymeric dispersion passes through one, two, or several orifices and forms espun fibers and fabrics in this way. The voltage on the power supply is increased to the desired voltage (usually from about 2,000 to about 20,000 volts) to uniformly draw out the dispersion and attract it to the collection surface. The collection surface is preferably placed perpendicular to the orifice and is rotated such that the entire surface is uniformly covered, with the fibers drawn towards the collection surface.
  • General information related to processes for processing and electrostatic spinning from dispersion (e.g., of PTFE from aqueous and other dispersions) is provided, for example, in U.S. Pat. Nos. 4,323,525 to Bornat and 4,044,404 to Martin et al., which are incorporated herein by reference in their entireties. In certain embodiments, electrospinning of PTFE may be based at least in part, on the process described in detail in U.S. Patent Appl. Publ. Nos. 2010/0193999 to Anneaux et al. and 2012/0114722 to Ballard et al., which are both incorporated herein by reference in their entireties. Various parameters of the nanofiber production process can be modified to alter the properties of the resulting dispersion-spun (e.g., PTFE) material. For example, increasing the length of time generally increase the thickness of the espun material.
  • As described above, the composite devices described herein can, in some embodiments be multi-component composite devices comprising at least one solution-spun or melt-spun component. Solution electrospinning is generally known in the art and, in some embodiments, can be conducted in a similar way as the dispersion-based electrospinning described above. Similar to dispersion-based electrospinning, an electrical charge is used to draw polymeric fibers from the solution, which are deposited, generally in a random fashion, on a collection surface.
  • In solution-based electrospinning, the solvent in which the polymer is dissolved and the parameters required to produce fibrous mats via electrospinning can vary, depending upon the nature of the polymer. For example, where the polymer is PU, any solution in which the polymer is dissolvable (e.g., tetrahydrofuran (THF), dimethylformamide (DMF), dimethylacetamide (DMAc), and combinations thereof) can be used. In some embodiments, it may be useful to use a combination of solvents such that one solvent evaporates more quickly than the other as the fibers are produced. The concentration of polymer in the solution can vary, but is generally relatively low (e.g., less than about 25% by weight, less than about 10% by weight, such as between about 1% and about 10% by weight).
  • Parameters such as makeup of the solution (e.g., the solvent, the composition and molecular weight of the polymer used, any additives, the concentration of the polymer in the solution, the solubility of the polymer in the solvent, etc.), the charge applied to the solution, the time period of electrospinning, etc. can impact the fibrous mat thus produced. Exemplary methods are described, for example, in U.S. Pat. Nos. 1,975,504; 2,160,962; and 2,187,306, all to Formhals; Demi et al., Polymer 43: 3303-3309 (2002); Greiner et al., Angew. Chem. Int. Ed. Engl. 46(30: 5670-5703 (2007), and Bhardwaj et al., Biotech. Adv. 28(3): 325-327, which are all incorporated herein by reference in their entireties. These and other methods for the preparation of electrospun mats from solution can be used according to the present disclosure.
  • Melt electrospinning is similar to dispersion and solution electrospinning, but involves electrospinning fibers from melted polymer. Any polymer that can be placed in melt form has the potential to be electrospun by this method. A melted polymer sample to be spun can be prepared, for example, by heating from resistance heating, circulating fluids, air heating, or lasers. The temperature at which melt spinning is conducted will vary depending upon the melting point of the polymer or polymers used.
  • In all types of electrospinning (i.e., solution-based, dispersion-based, and melt-based electrospinning, the collection surface onto which the spun fibers are deposited can vary and can be dependent upon the type of electrospinning setup used. In certain embodiments, the collection surface is a sheet, the surface of which can be, e.g., any metal or polymeric material, with stainless steel being a particularly preferred material. In other embodiments, the collection surface is a tubular prosthetic device (e.g., in the form of a stent, stent-graft, or graft). In certain embodiments, the collection surface is a drum (i.e., a cylinder around which a collection sheet can be wrapped), which may be rotated during collection to generate a tubular structure. The tubular structure can be cut along the length of the tube to provide a sheet. In certain embodiments, the collection surface is a rod or tube (i.e., a mandrel around which a collection sheet may be wrapped or on which the fibers may be collected directly) which may be rotated during the collection to generate a tubular structure. Such a tubular structure can, in certain embodiments, be directly used in its tubular form.
  • Electrospun materials produced via solution and melt spinning are generally sufficient for manipulation immediately following production and generally do not require any further treatment to provide the desired fiber characteristics. However, in dispersion-based electrospinning, the polymeric (e.g., PTFE) mat/sheet, tube, or covered device is generally somewhat fragile and typically must be heated and/or sintered to provide a sufficiently strong and durable material for use as a component of a prosthetic device according to the invention. Heating generally serves to dry the material, volatilize and remove the fiberizing polymer, and/or to sinter the PTFE particles (e.g., by fusion of individual PTFE particles to produce a nonwoven, PTFE-based material). The sintering of the material generally results in the formation of a stronger, more durable material. The level of sintering can vary. During heating, the material can be monitored to evaluate the sintering level by various methods (e.g., calorimetry and/or visual inspection).
  • The material can be heated in place (i.e., by placing the entire collection surface in an oven) or by removing the electrospun material from the collection surface prior to heating and placing the free electrospun material in an oven. As will be described in greater detail herein, the PTFE sheet or tube or PTFE-covered device can be heated and sintered alone, or in certain embodiments, it may be combined with other components of the composite device prior to heating. Thus, the heating and sintering can occur at any stage of the process of assembly of the composite prosthetic device. It is noted that the components of the composite structure must be considered to ensure that the other components can withstand the conditions required to sinter the PTFE (or other dispersion-spun polymer).
  • The time and temperature at which the material is heated can vary. For example, in typical embodiments, to sinter a PTFE material (e.g., sheet, tube, or covered device), the temperature of the oven is between about 250° C. and about 800° C., such as between about 300° C. and about 500° C. (e.g., between about 350° C. and about 485° C.). The (or other dispersion-spun polymeric material) is generally exposed for a period of time such that any remaining water is evaporated and the fiberizing polymer undergoes decomposition and subsequent elimination of the residual material. It is noted that, in some embodiments, PTFE can be sintered in combination with one or more additional materials. This advantageously is only conducted where the characteristics of the one or more additional materials are such that the material or materials can withstand the high temperatures required for PTFE heating/sintering). It is important to distinguish sintering and heating steps. Sintering is generally used only where unsintered espun PTFE (or similar dispersion-espun polymer) is present and must be conducted in the absence of other material that may be negatively affected by the high temperatures required for sintering.
  • The time for which a dispersion-espun material is heated to sinter the material may depend, in part, on the temperature of the oven. In some embodiments, the material is sintered for a period of about an hour or less, about 30 minutes or less, about 20 minutes or less, about 15 minutes or less, or about 10 minutes or less. For example, in certain embodiments, the sintering is conducted for a time of between about 2 and about 30 minutes, preferably between about 5 and about 20 minutes. It is noted that more time may be required for sintering at lower temperature and less time may be required for sintering at a higher temperature. The time required for drying and sintering can also depend on the thickness of the material, with thicker materials requiring more time to dry and/or sinter.
  • The drying, volatilizing, and sintering of a dispersion-spun material can occur simultaneously or in a series of steps. While not intended to be limited by any theory, it is believed that some drying (i.e., removal of the solvent) may occur upon completion of electrospinning. It is further believed that some small degree of fiber rearrangement may occur at this point. Then when the material is heated, preferably, the majority of the solvent and the fiberizing polymer (e.g., greater than about 80%, preferably greater than about 90% or 95%, and most preferably greater than about 98 or 99%) is removed from the PTFE material. It is understood that espun fabric generally undergoes shrinkage upon heating/sintering. While not limited to any theory, the shrinkage is believed to occur in two steps: the initial drying and fiber rearrangement following the electrospinning process, and the removal of solvent and fiberizing polymer by heating/sintering.
  • Preparation and Use of Composite Prosthetic Devices
  • There are various means for producing the components of the composite prosthetic devices described herein and for combining the components to form composite devices, which will be described in further detail herein. In general, the method comprises assembling the one or more layers to be incorporated within the composite and applying heat and/or pressure to provide a composite prosthetic device.
  • Depending on the chemical makeup of the components and the physical form of the one or more electrospun materials (i.e., whether in a sheet form, tubular form, or as a covering directly spun onto a device) to be incorporated within the composite device, the means by which the final structure is assembled can vary.
  • In certain embodiments, an electrospun polymer sheet or tube is produced independently and then combined with the one or more additional layers to form a composite structure. The polymer sheet can be a single polymer sheet (e.g., a sintered PTFE mat, a PU mat, a PDMS mat, etc.). In other embodiments, a multi-layered espun polymer sheet (“combination sheet”) can be provided. For example, in certain embodiments, an espun PTFE mat is produced and sintered. Another polymer is then directly electrospun onto the sintered espun PTFE mat, producing a two-layered mat of electrospun polymer. For example, in the preparation of mono-component composites, one espun PTFE mat can be prepared and another espun PTFE layer can be deposited directly thereon. In the preparation of multi-component composites, one espun PTFE mat can be prepared and another type of polymer can be directly electrospun thereon (e.g., PU or PDMS). Such combination mats can be provided with varying combinations of espun polymeric layers and with varying numbers of such layers.
  • A mat (a single electrospun mat or a combination sheet) can, in certain embodiments, be “laminated” onto another material (e.g., onto a polymeric tube, a structural frame, or onto a covering thereon), e.g., by wrapping the mat around the other material. This process generally involves layering or wrapping the espun mat or mats directly onto or around the material to be covered, giving a prosthetic composite device precursor, and applying heat and/or pressure thereto to provide a prosthetic composite device. The layering or wrapping can be performed such that the sheet/layer is wrapped one time around a construct or multiple times around the construct (e.g., two times, three times, four times, or more times). In some embodiments, (i.e., where a single electrospun mat is wrapped), the number of wrappings of each sheet can affect the thickness of that layer of the final composite. For example, a device wherein a given electrospun mat is wrapped twice around a construct will give a thicker layer of that electrospun material in the final device than in a device wherein that electrospun mat is wrapped only once around the construct. The overall wall thickness of a device having a greater number of wrappings will thus be thicker as well. Where a combination sheet is used, the number of wraps will alter the number of layers of the two (or more) components comprising the combination sheet. For example, a combination sheet wrapped once around a construct adds two additional layers (i.e., having different compositions from the two polymers comprising the combination sheet). A combination sheet wrapped twice around a construct adds four additional layers (i.e., alternating the two compositions from the two polymers comprising the combination sheet). FIGS. 7A and 7B and FIGS. 7D and 7E are comparable to one another except that the number of wrappings of the outer two components are different, as will be described in greater detail below.
  • Although in certain embodiments, the wrapping methods described above are useful in preparing mono-component and multi-component prosthetic devices according to the present disclosure, the disclosure is not intended to be limited to such methods of preparation. In some embodiments, a polymer is directly spun onto another component of the composite prosthetic device. For example, electrospinning can be conducted such that a polymer covering is directly spun onto a construct (e.g., a polymeric tube or a structural frame, such as a stent). In certain embodiments, two or more methods can be combined (e.g., a covering can be applied to a structural frame by directly electrospinning the covering thereon and the resulting device can be subsequently wrapped with a second covering and treated as described herein or a covering can be applied to a structural frame by wrapping and a second covering can be applied to the covered structural frame by directly electrospinning the second covering thereon).
  • As noted above, the composite prosthetic devices of the present disclosure generally incorporate at least one tie layer, which can be incorporated within the device precursor as an unsintered dispersion-spun layer (which is subsequently sintered prior to use of the device) or which can be a solution-spun or melt-spun layer (which does not require sintering prior to use of the device). The tie layer can be applied using any of the methods described herein. The tie layer can serve as a “glue” to bind to another layer and preferably can be used to bind multiple layers together. In embodiments wherein a structural frame is present, the tie layer can penetrate the open spaces in the structural frame and bond to the material on the other side of the structural frame (e.g., where the tie layer is provided on the outer surface of the structural frame, it can penetrate the frame and bond to the material comprising the inner diameter surface of the structural frame which may, in some embodiments, be a porous electrospun polymeric layer). Thus, in certain embodiments, the tie layer may serve to bond and/or connect the material on the inner diameter surface of the composite device to the material on the outer diameter surface of the composite device. In some embodiments, a significant advantage to the presence of such a tie layer is that it can serve to create a better bond and/or seal between various layers of the composite device following the application of heat and/or pressure to the composite device precursor. This bonding can be characterized, for example, by an enhanced peel strength between certain layers.
  • For example, in certain embodiments, the preparation of composite devices of the present disclosure involves the incorporation of an unsintered PTFE tie layer. The stage at which any unsintered PTFE present in the composite device is sintered must be such that no material is present that will be negatively affected by the temperatures required for the sintering of the PTFE. For example, where PU is to be included in a multi-component composite device, any unsintered PTFE layer(s) applied to the device should be sintered prior to the application of the PU to avoid destroying the porous PU layer(s) during the sintering of the PTFE layer(s). For this reason, it is noted that an unsintered PTFE layer is generally useful as a tie layer in composites only where the adjacent layers of the device precursor comprise PTFE or another, similar polymer (and not in composites wherein a PU or other, similar polymer is adjacent to the unsintered PTFE).
  • In certain embodiments, the preparation of composite devices of the present disclosure involves the incorporation of a solution-spun tie layer (e.g., including, but not limited to, PU or PDMS). Such tie layers, which do not require sintering prior to use of the composite device, can be advantageous as the processing of the device does not require the structural frame, where present, to be exposed to the high temperatures required for sintering (as required for, e.g., a PTFE tie layer). In certain embodiment, avoidance of such high temperatures can serve to keep the mechanical properties and integrity of the device more intact.
  • The amounts and relative amounts of material in the layers of the composite prosthetic devices described herein can vary. It is noted that, with regard to the tie layer, in embodiments wherein a structural frame is present, the wire/strut diameter, spacing between the wires/struts struts, and/or the processing conditions may impact the amount of material required to ensure sufficient bonding of the tie layer to other layers and/or to the structural frame. For example, large wire or strut diameters or thicknesses may need more of the tie-layer espun polymer material as compared to smaller wire or strut diameters (which can be provided, e.g., by using a thicker espun sheet and/or by wrapping a sheet more times around the device). It is noted that a structural frame with minimal spacing between the wire or strut lattice may not perform as well due to minimal inner diameter and outer diameter contact, resulting in a poorly secured and embedded structural frame. However, even structural frames with minimal spacing between the wire or strut lattice can perform well if enough tie layer espun polymer material is used and enough heat and/or pressure is applied to ensure that the tie layer espun polymer can penetrate the open spaces in the lattice. Generally, there is a certain amount of tie layer material that must be applied to the structural frame, a certain amount of processing (e.g., temperature and/or pressure) that must be applied to the structural frame, there must be a sufficient amount of open space in the frame to ensure that the frame is not “floating” within the composite and is adequately affixed onto or within the other layers of the composite, and the tie layer material must have sufficient properties (e.g., flowability and/or tackiness) to enable it to effectively penetrate the open spaces of the structural frame.
  • Following the wrapping or other means of applying one or more layers (including one or more tie layers) to produce a mono-component or multi-component composite prosthetic device precursor, the device precursor is subjected to heat and/or pressure. The application of heat and/or pressure to the precursors as intended herein generally results in some degree of fusion and/or merging of the various layers of the composite device precursor (e.g., via the tie layer penetrating through the open spaces in a structural frame and/or penetrating the pores of at least one of the adjacent layers). In some embodiments, the application of heat and/or pressure can also ensure that the inner diameter surface of a composite device is bonded to the outer diameter surface of the composite device. In embodiments wherein a structural frame is present, application of heat and/or pressure can advantageously seal the frame within the composite device so that there is no delamination and/or so that the frame is completely covered by one or more polymeric layers. In certain embodiments, application of heat and/or pressure can result in a decrease in effective pore size of the individual layers and/or composite as a whole and/or can result in a decrease in individual layer thickness and/or wall thickness of the composite as a whole.
  • The amount of heat and the method by which the heat is applied to the device precursor can also vary. In certain embodiments, heat can be applied by heating the device precursor in various types of chambers (e.g., heating vessel or clamshell) or by heating the device in an oven. Where a multi-component prosthetic device precursor is provided, heat applied at this stage is typically significantly lower than the heat required to sinter the dispersion-spun component or components (e.g., PTFE). The temperature applied can vary depending on the makeup of the device precursor, as discussed in greater detail below. Thus, in certain embodiments, the one or more dispersion-spun components are present in sintered form when the heat and/or pressure is applied to the multi-component device precursor. Where a mono-component prosthetic device precursor is provided, having one or more unsintered, dispersion-spun layers therein, the heating step can include sintering. In such embodiments, heat and/or pressure is applied to the device precursor to cause the unsintered dispersion-spun tie layer to penetrate the pores of one or both of the adjacent layers (and, optionally, to penetrate through the open pores of the structural frame, where present) and the heat applied can advantageously be sufficient to sinter the one or more unsintered dispersion-spun component. Although, in such embodiments, the heat and/or pressure required to ensure penetration of one or more layers as described herein may be insufficient to sinter the unsintered dispersion-spun component, it is advantageous in some embodiments to apply heat and/or pressure and sinter simultaneously, i.e., by ensuring that the heat applied is sufficient to sinter the dispersion-spun component.
  • In some embodiments, pressure can be applied by using a flat press, constricting wrap, and/or mechanical nip roller. In certain embodiments, physical pressure is applied to the device precursor by wrapping the construct with a constricting wrap and applying pressure, either directly or indirectly. In some embodiments, the constricting wrap is maintained on the covered construct and the entire device precursor, including the constricting wrap, is heated; subsequently, the constriction wrap is removed to provide a compressed composite device. In some embodiments, pressure can be applied to the device precursor in a pressure vessel. Pressure vessels of varying design and size can be useful according to the methods provided herein. In some embodiments, the pressure vessel can be a heated pressure vessel, allowing heat and pressure to be applied to a device precursor simultaneously. The pressure rating of the vessel can vary, so long as sufficient pressure may be applied to the device precursor to allow the tie layer to penetrate through the open spaces in a structural frame and/or to penetrate the pores of at least one of the adjacent layers. Exemplary pressure vessels include, but are not limited to, Non-Stirred Pressure Vessels from Parr Instrument Company (Moline, Ill.). Other means for the application of pressure are intended to be encompassed herein as well. Due to the porosity of the composite device precursors described herein, it may be necessary, in certain embodiments, to enclose the device precursor in a non-porous material prior to introducing it into the chamber. It is to be understood that selection of the non-porous material must be based on the conditions to which the device precursor will be subjected in the chamber. For example, the non-porous material must be capable of withstanding the elevated pressure and/or temperature conditions within the chamber without negatively impacting the enclosed composite device precursor and/or device.
  • In embodiments wherein both heat and pressure are applied to the device precursor, it is not necessary for the heat and pressure to be applied simultaneously, but in some embodiments, they may be applied simultaneously (e.g., in a heated pressure vessel). Further, it is noted that the application of pressure and/or heat may be conducted at various stages of construction of the composite prosthetic device. In some embodiments, pressure is applied, followed by the application of pressure and heat. In some embodiments, the entire device is assembled and pressure and/or heat are applied to provide the final device. In other embodiments, the application of pressure and/or heat can be conducted at one or more stages during the assembly process.
  • The amount of heat and/or pressure advantageously applied to prepare the composite device precursor can depend on the makeup of the layers of the device. In specific embodiments, the applied pressure is between about 500 and about 1500 PSI and the temperature is at least about 50° C. or at least about 100° C. (e.g., between about 75° C. and about 400° C. or between about 100° C. and about 300° C.). It is understood that the time and temperature are related, i.e., increasing the temperature at which the device precursor is treated may allow for a decrease in the pressure applied (particularly where the temperature and pressure are applied simultaneously). The temperature can also depend on the makeup of the composite device precursor. For example, where at least one component of the precursor comprises unsintered PTFE, the composite device is preferably heated at a temperature sufficient to sinter the unsintered PTFE (e.g., about 385° C.). Where no unsintered espun PTFE is present in the device (e.g., where the tie layer comprises PU or PDMS), the temperature applied is advantageously significant lower (e.g., between about 100° C. and about 200° C.).
  • The time at which heat and/or pressure is applied can also vary; generally, the device precursor must be exposed to the heat and/or pressure for a sufficient period of time to ensure that the tie layer can penetrate through the open spaces in a structural frame and/or can penetrate the pores of at least one of the adjacent polymeric layers (e.g., at least about 3 minutes, at least about 5 minutes, or at least about 7 minutes, including between about 3 and about 20 minutes, between about 5 and about 15 minutes, between about 5 and about 10 minutes, and between about 5 and about 7 minutes). Although such times are noted to be useful, it is understood that in some embodiments, the composite device can be heated for lesser or more amounts of time. Generally, the heat and/or pressure should be applied for a period of time sufficient for bonding. The time is also related to the heat and/or pressure, such that in some embodiments, treatment of the device precursor at a higher temperature and/or pressure may require less time than treating that same device precursor at a lower temperature and/or pressure. It is understood, however, that there is some minimum temperature and/or pressure that will be required to ensure the device exhibits penetration of the tie layer through the open spaces in a structural frame and/or to ensure penetration of the tie layers into the pores of at least one of the adjacent layers (e.g., in certain embodiments, ensuring bonding between the inner diameter surface of the composite device and the outer diameter surface of the device).
  • In some embodiments, the melt flow characteristics of a tie layer polymer may affect the choice of heat and/or pressure to be applied. For example, a tie layer comprising a polymer with a higher melt flow rate may require less heat and/or pressure to ensure that the tie layer effectively penetrate the pores of at least one of the adjacent layers, whereas a polymer with a tie layer comprising a lower melt flow rate may require more. Further, the presence of a structural frame may impact the amount of heat and/or pressure to be applied to the device precursor. In some embodiments, greater heat and/or pressure may be required to ensure that the tie layer can penetrate through the open spaces in the frame.
  • Additionally, a composite device comprising a structural frame with a thick wire or strut may not be prepared in the same way as a device comprising a structural frame with a thin wire or strut. For example, in some embodiments, a frame with a thick wire or strut or a frame with narrow spaced wires or struts may require more electrospun polymeric material (e.g., a thicker covering), may require the use of an electrospun polymeric material having a greater ability to flow and penetrate the open spaces (e.g., a polymer having a higher melt flow rate), and/or may require greater heating and/or pressure applied thereto to ensure that the covering can penetrate the open spaces within the frame. The spacing between wires or struts of a structural frame may similarly affect the materials and parameters of the methods used to form a composite device comprising the frame. For example, in some embodiments, where the structural frame has widely-spaced wires or struts (e.g., with amplitudes spaced relatively far apart and/or having fewer wires or struts), less heat and/or pressure may be required than for a comparable embodiment wherein the structural frame closely spaced wires or struts (e.g., with amplitudes closer together and/or having more wires or struts).
  • In embodiments wherein a thermoset polymer is employed (e.g., as a tie layer) in the composite prosthetic device precursor, the thermoset polymer is advantageously heat-cured during the application of heat and/or pressure as described above. In some embodiments, this curing requires a higher temperature than those noted above, e.g., at least about 200° C. In some embodiments, a thermoset polymer is employed that is cured through radiation. Advantageously, in embodiments wherein a thermoset polymer is used, it is not cured until during or after the heat and/or pressure treatment described above, such that it can flow into the pores of one or more adjacent layers in uncured form and subsequently be cured to provide a composite prosthetic device.
  • The layered approach to preparing the composite devices described herein provides the ability to tailor devices for particular applications. Tailoring as used herein refers to the ability to produce and use various materials with various properties. In some embodiments, tailoring relates to the process conditions used in espinning; by varying the parameters of the method, polymeric sheets, tubes, or covered constructs having different physical properties can be obtained. For example, where a thicker polymeric mat/tube (or a thicker covering directly spun onto a construct) is desired, the espinning process can be conducted for a longer period of time to deposit more material. As another example, where a polymeric mat with smaller pore size is desired, a thicker mat can be prepared, which typically results in a decreased pore size. In some embodiments, a smaller pore size can be obtained by decreasing the targeted fiber diameter. In some embodiments, tailoring relates to the method of assembly of the composite device. For example, where a thicker polymeric layer within the device is desired, a given polymeric mat can be wrapped around the composite device precursor a greater number of times. Thus, tailoring the properties of a given layer of the composite device can be done in various ways, relating to the production of the espun layer and/or the application of the espun layer to the composite device. In further embodiments, where a device having one or more impermeable portions is desired, a thermoplastic polymeric film may be incorporated within the composite device.
  • Further, as noted above, various additives, e.g., bioactive agents, can be included in one or more of the layers of the device. Such optional bioactive agents can be incorporated within composite devices in a variety of ways. For example, in some embodiments, the one or more bioactive agents can be directly incorporated into the fibrous mats by including them in a dispersion, solution, or melt that is espun, or the one or more bioactive agents can be incorporated into a layer or into the composite device after the fibers are prepared, e.g., by applying the bioactive agents, e.g., in solution form, onto/into the layer or device. Certain exemplary means for the incorporation of bioactive agents are described in U.S. application Ser. No. 13/272,412 to Ballard et al., filed Oct. 13, 2011, which is incorporated herein by this reference in its entirety. Although the referenced application is directed to the incorporation of antimicrobial agents, the antimicrobial agent could be replaced with the desired bioactive agent in the methods described herein.
  • The properties and characteristics of the final composite prosthetic device produced may be impacted by the application of heat and/or pressure. For example, the degree of heating (i.e., time and temperature), the amount of pressure applied, and the method by which the pressure is applied may affect the overall quality of the final composite. If there is not enough heat and/or pressure, poor bonding and delamination may occur, resulting in weak adhesion of the layers to each other. Additionally, without sufficient heat and/or pressure, some portion of the structural frame, where present, may be exposed (i.e., uncovered), which in certain embodiments is not desirable. Further, without sufficient heat and/or pressure, the structural frame, where present, may move within the composite device, which is typically undesirable.
  • The application of heat and/or pressure can have varying impacts on the composite prosthetic device. Generally, the application of heat and/or pressure results in some degree of fusion and/or merging of the various layers of the composite device. Advantageously, heat and/or pressure can serve to aid in the penetration of the material comprising the tie layer of the composite into the pores of one or both of the layers adjacent thereto. Where a structural frame is present, the heat and/or pressure can, in some embodiments, cause the tie layer to penetrate the open spaces in the frame. The heat and/or pressure is thus preferably such that the tie layer of the prosthetic device precursor is moldable or flows to some extent into the pores of adjacent layers (and, optionally, through the open spaces of a structural frame, where present). Where the tie layer of the composite device precursor comprises an unsintered, dispersion-spun fibrous mat (e.g., PTFE), additional heating is generally required to sinter the material. However, where the tie layer of the composite device precursor comprises a solution-spun material (e.g., PU or PDMS), such high temperatures are not required to provide the final product.
  • Use of a tie layer as described above (for example, in the form of an unsintered dispersion electrospun fibrous layer (e.g., PTFE) or a solution-spun fibrous layer (e.g., PU or PDMS)) between two or more other layers (and optionally through the open spaces of a structural frame) can provide significantly increased bonding between those layers following the application of heat and/or pressure (and, optionally, sintering, in the case of PTFE). This is especially noted in embodiments incorporating a tie layer adjacent to a structural frame, where the tie layer can bond to an additional polymeric layer (of various types) through the structural frame, in some embodiments, encapsulating the structural frame within the device. For example, a tie layer can, in certain embodiments, bond through a structural frame to a porous electrospun polymeric layer comprising the internal diameter surface covering of the composite device. The tie layer can also, in some embodiments, bond to an additional porous electrospun layer adjacent thereto, e.g., by penetrating the pores thereof. The composite devices described herein can, in certain embodiments, exhibit greater peel strengths between adjacent layers, which can result in enhanced performance of the resulting composite.
  • In certain embodiments, the application of heat and/or pressure to the composite prosthetic device precursor can result in a decrease in effective pore size of the walls of the device and/or can result in a decrease in the overall wall thickness of the device. In certain embodiments, the heat and/or pressure applied to the device precursor may impact the pore size and/or the thickness of one or more individual espun layers. An increase in pressure and/or temperature may be associated with a decrease in pore size and/or a decrease in the layer thickness. For example, a PU or other meltable polymer would be expected to flow to some extent upon the application of heat and/or pressure, thus reducing the effective pore size of the PU layer relative to the PU layer prior to the application of heat and/or pressure. However, polymers electrospun from solution (e.g., PU and PDMS), when incorporated within the composite structures by any of the means described herein, unexpectedly can exhibit some degree of porosity, even after the application of heat and/or pressure to ensure sufficient fusion between the layers of the final device. The effective pore sizes of certain layers can thus be controlled to some extent by both electrospinning conditions used to prepare the electrospun layer and by the treatment to which the layers are subjected within the composite device. In some embodiments, the effective pore size of the composite as a whole may not be reflective of the combination of effective pore sizes of the individual layers. Consequently, in some embodiments, the methods described herein provide devices incorporating thermoplastic polymers or thermoset polymers which exhibit some overall degree of porosity.
  • In some embodiments, varying the materials as well as the temperature and/or pressure at which the device is processed can provide devices exhibiting varying degrees of porosity, as evidenced by the ability to obtain effective pore size measurements of the device as a whole. As, in many embodiments, it is desirable to maintain pores in the final device, the materials and methods can be selected so as to ensure that porosity is maintained. The retention of some degree of porosity in an electrospun mat can be impacted, for example, by the melting point of the polymer and/or by the melt flow viscosity. Various parameters can affect these parameters including, but not limited to, the molecular weight of the polymer and the degree of branching within the polymer backbone. Consequently, a wide range of polymers can be tailored and optimized for use according to the present invention by varying these and other parameters and/or by blending two or more different types of polymers.
  • Exemplary preparation methods for certain composite prosthetic devices according to the present disclosure are further described and exemplified below. It is noted that these categories are not intended to be exclusive. In other words, two composite devices can, in certain embodiments, be separately prepared and combined. Accordingly, in some embodiments, two composites devices or components thereof can be separately prepared; subsequently, one composite can be wrapped around or inserted into another composite, and pressure and/or heat can be applied the entire combined composite structure to form a single composite prosthetic device. As another example, a polymer-based composite can be combined with a composite prosthetic device including a structural frame, e.g., by separately preparing the two device types and wrapping the polymer-based composite around the composite prosthetic device including a structural frame or inserting it into the inner diameter of the composite prosthetic device including a structural frame. Again, heat and/or pressure can then be applied to the entire structure to form a single composite prosthetic device. All combinations, as well as singular composite prosthetic devices as described herein are intended to be encompassed by the present disclosure.
  • Certain exemplary composite devices of the present disclosure and representative methods for preparing each are provided in FIGS. 7-11. These are only exemplary constructions and exemplary means for preparing such constructions. These schematics provided in the figures and described herein are presented only to give exemplary means by which the principles described herein can be applied to certain specific components (to generate the representative constructs illustrated in FIGS. 7A-7F).
  • FIG. 8 illustrates an exemplary preparation of the composite devices illustrated in FIGS. 7A and 7B. Briefly, an electrospun PTFE mat is prepared, sintered, and wrapped, e.g., around a hypotube, to form a tubular structure 70. A structural frame 72 is applied around structure 70, giving a frame-containing structure 74. An unsintered mat of espun PTFE 76 is wrapped around the structural frame (e.g., to serve as a tie layer) and a sintered espun PTFE mat 78 is wrapped around unsintered mat 76. Pressure and heat are applied to the resulting composite device precursor 80, sufficient to sinter the unsintered PTFE of tie layer 76, giving a mono-component device 82.
  • Independently, an electrospun PTFE sheet 84 is prepared and sintered; a combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84. The combination sheet is wrapped around mono-component construct 82, with the PU layer laid directly against the outer surface of construct 82. The entire device precursor is then simultaneously subjected to pressure and heat. The multi-component cross-section on the left (88) depicts the result of the above process wherein the combination sheet is wrapped twice around the construct and the multi-component cross-section on the right (90) depicts the result of the above process wherein the combination sheet is wrapped once around the construct.
  • As such, in one embodiment, the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; wrapping an unsintered poly(tetrafluoroethylene) mat around the structural frame (one or more times); wrapping a sintered poly(tetrafluoroethylene) mat around the unsintered poly(tetrafluoroethylene) mat (one or more times); and heating the resulting construct to sinter the unsintered poly(tetrafluoroethylene). In certain embodiments, such a method can further comprise preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer surface of the mat in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 9 illustrates an exemplary preparation of the composite device illustrated in FIG. 7C. The method is initially identical to that described above with regard to the method illustrated in FIG. 8. However, a single PU sheet 92 is independently prepared and wrapped around mono-component construct 82, rather than the combination sheet depicted in FIG. 8. The entire device precursor is then subjected to pressure and heat to give a multi-component composite device 94.
  • As such, in one embodiment, the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; wrapping an unsintered poly(tetrafluoroethylene) mat around the structural frame (one or more times); wrapping a sintered poly(tetrafluoroethylene) mat around the unsintered poly(tetrafluoroethylene) mat (one or more times); heating the resulting construct to sinter the unsintered poly(tetrafluoroethylene); wrapping an electrospun mat comprising a different polymer around the construct (one or more times) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 10 illustrates an exemplary preparation of the composite device illustrated in FIGS. 7D and 7E. As in the methods of FIGS. 8 and 9, a frame-containing structure 74 is prepared by combining a sintered PTFE tube and a structural frame. Independently, an electrospun PTFE sheet 84 is prepared and sintered; a combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84. The combination sheet is wrapped around structure 74, with the PU layer laid directly against the outer surface (i.e., the structural frame) of structure 74. The entire device precursor is then subjected to pressure and heat simultaneously. The cross-section on the left (96) depicts the result of the above process wherein the combination sheet is wrapped once around the construct and the multi-component cross-section on the right (98) depicts the result of the above process wherein the combination sheet is wrapped twice around the construct.
  • As such, in one embodiment, the present disclosure provides a method for producing a composite prosthetic device comprising: applying a structural frame over a porous electrospun poly(tetrafluoroethylene) tubular structure; preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer mat surface in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • FIG. 11 illustrates an exemplary preparation of the composite device illustrated in FIG. 7F. An electrospun PTFE sheet 100 is prepared and sintered; a combination PU/PTFE sheet 102 is prepared by electrospinning PU directly onto sheet 100. Combination sheet 102 is wrapped to form a tubular structure (with the PTFE on the interior of the structure), which is then compressed to give structure 104. A structural frame 72 is applied around the compressed, tubular material to give frame-containing structure 106. Independently, an additional espun PTFE sheet 84 is prepared and sintered and a second combination PU/PTFE sheet 86 is prepared by electrospinning PU directly onto sheet 84. Sheet 86 is then wrapped around structure 106, with the PU layer laid directly against the outer surface (i.e., the structural frame) of structure 106. The resulting device precursor is subjected to pressure and heat to give multi-component prosthetic device 108.
  • As such, in one embodiment, the present disclosure provides a method for producing a composite prosthetic device comprising: preparing a combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; forming the combination electrospun mat into a tubular structure having two or more alternating layers, wherein the poly(tetrafluoroethylene) surface of the mat is on the inner surface of the tubular structure and the different polymer surface of the mat is on the outer surface of the tubular structure; applying a structural frame over the outer surface of the tubular structure; preparing a second combination electrospun mat by electrospinning a different polymer onto a sintered poly(tetrafluoroethylene) mat; wrapping the combination electrospun mat around the construct (one or more times, with the different polymer mat surface in contact with the construct) to give a precursor; and applying heat and pressure to provide a composite prosthetic device.
  • EXAMPLES Mono-Component Devices Example 1 Espun PTFE/Espun PTFE/Espun PTFE
  • An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency. A 0.002″ thick stainless steel foil sheet (15.5″×17.5″) is mounted on a conductive fabric. The stainless foil is passed into the espinning chamber where PTFE fibers are to be deposited. The dispersion is espun using a total potential of 80 kV to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil. The stainless steel foil containing the PTFE membrane is removed from the fabric and sintered at 385° C. until fully sintered (e.g., about 5 minutes).
  • The 0.0008″ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50″ exterior diameter (OD) stainless steel hypotube. The electrospinning process is repeated to give a second espun PTFE sheet. The espun PTFE sheet, a 0.0018″ unsintered espun PTFE sheet, is removed from the stainless foil and wrapped twice around the sintered espun PTFE layer. The electrospinning process is repeated to give a third espun PTFE sheet, which is then sintered. The third espun PTFE sheet, a 0.0018″ sintered espun PTFE sheet, is removed from the stainless foil after sintering and wrapped twice around the unsintered espun PTFE layer to create a tube assembly consisting of sintered espun PTFE/unsintered espun PTFE/sintered espun PTFE. The entire construction is then compressed together and heated/sintered at 385° C. for about 5-15 minutes (until fully bonded, as evidenced by lack of delamination), followed by water quenching as a means to cool down the sample. The composite device is then removed from the hypotube and tested for specified properties. The thickness of the construction was found to be approximately 0.005″ and the effective pore size was found to be approximately 1.5 μm.
  • Example 2 Espun PTFE/Stent/Espun PTFE/Espun PTFE
  • Example 2 is made similarly to Example 1 with the addition of a wire stent frame as an additional layer of the composite. An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency. A 0.002″ thick stainless steel foil sheet (15.5″×17.5″) is mounted on a conductive fabric. The stainless foil is passed into the espinning chamber where PTFE fibers are to be deposited. The dispersion is espun using a total potential of 80 kV to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil. The stainless steel foil containing the PTFE membrane is removed from the fabric and sintered at 385° C. for 5 minutes.
  • The 0.0008″ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50″ exterior diameter (OD) stainless steel hypotube. A metal stent frame is then applied over this 0.0008″ sintered espun PTFE sheet. The electrospinning process is repeated to give a second espun PTFE sheet. The espun PTFE sheet, a 0.0018″ unsintered espun PTFE sheet, is removed from the stainless foil and wrapped twice around the stent. The electrospinning process is repeated to give a third espun PTFE sheet, which is then sintered. The third espun PTFE sheet, a 0.0018″ sintered espun PTFE sheet, is removed from the stainless foil after sintering and wrapped twice around the unsintered espun PTFE layer to create a tube assembly consisting of sintered espun PTFE/stent/unsintered espun PTFE/sintered espun PTFE. The entire construction is then compressed together and heated/sintered at 385° C. for 15 minutes, followed by water quenching as a means to cool down the sample. The composite device is then removed from the hypotube and tested for specified properties. The thickness of such a construction is found to approximately 0.005″ and the effective pore size was found to be approximately 1.5 μm.
  • Multi-Component Devices Example 3 Espun PTFE/Espun PVDF/Espun PTFE
  • An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency. A 0.002″ thick stainless steel foil sheet (15.5″×17.5″) is mounted on a conductive fabric roll with a payoff and take-up mounted above a spinning electrode. A total potential of 80 kV is employed to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil. The stainless steel foil containing the PTFE membrane is removed from the fabric and sintered (if desired) at 385° C. for 5 minutes.
  • A 0.0015″ thick stainless foil sheet 17″×18.5″ is wrapped around a rotating drum. The drum assembly is placed into a rotating chuck such that it is positioned to allow espinning along the entire length of the turning drum assembly. An espinning solution based on a mixture of 25% Atofina Kynar 740 polyvinylidene fluoride (PVDF) and a 50/50 (by volume) mixture of acetone and dimethyl formamide is allowed to dissolve and mix using a heated stir plate set to 75° C. at 500 rpm for 1 hour. A voltage of 15.0 kV is employed to facilitate formation of PVDF fibers, which collect in random formation on the stainless foil sheet. The stainless soil sheet containing the PVDF mat is removed from the drum and dried for 1 hour at room temperature.
  • A 0.001″ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50″ exterior diameter (OD) stainless steel hypotube. The 0.001″ espun PVDF sheet, removed from the stainless foil, is wrapped twice around the sintered espun PTFE layer. Finally, a 0.001″ sintered espun PTFE sheet is wrapped twice around the espun PVDF layer to create a tube assembly consisting of sintered espun PTFE/espun PVDF/sintered espun PTFE. The entire construction is then compressed together prior to heating/sintering at 370° C. for 15 minutes followed by water quenching as a means to cool down the sample. The composite is then removed from the hypotube and tested for specified properties.
  • Example 4 Espun PTFE/Stent/Espun PVDF/Espun PTFE
  • Example 4 is made similarly to Example 3 with the addition of a wire stent frame as another support layer. An espinning dispersion based on a mixture of 5.2% (PEO/PTFE) 300,000 amu polyethylene oxide and Daikin DX-9030, 60% PTFE dispersion in water is prepared, allowed to homogenize, and turned and filtered to achieve a smooth consistency. A 0.002″ thick stainless steel foil sheet (15.5″×17.5″) is mounted on a conductive fabric roll with a payoff and take-up mounted above a spinning electrode. A total potential of 80 kV is employed to facilitate formation of PTFE fibers, which collect in random formation on the stainless steel foil. The stainless steel foil containing the PTFE membrane is removed from the fabric and sintered (if desired) at 385° C. for 5 minutes.
  • A 0.0015″ thick stainless foil sheet 17″×18.5″ is wrapped around a rotating drum. The drum assembly is placed into a rotating chuck such that it is positioned to allow espinning along the entire length of the turning drum assembly. An espinning solution based on a mixture of 25% Atofina Kynar 740 polyvinylidene fluoride (PVDF) and a 50/50 (by volume) mixture of acetone and dimethyl formamide is allowed to dissolve and mix using a heated stir plate set to 75° C. at 500 rpm for 1 hour. A voltage of 15.0 kV is employed to facilitate formation of PVDF fibers, which collect in random formation on the stainless foil sheet. The stainless soil sheet containing the PVDF mat is removed from the drum and dried for 1 hour at room temperature.
  • A 0.001″ sintered espun PTFE sheet, removed from the stainless foil, is wrapped twice around a 0.50″ exterior diameter (OD) stainless steel hypotube. A metal stent frame is then applied over this 0.001″ sintered espun PTFE sheet. The 0.001″ espun PVDF sheet, removed from the stainless foil, is wrapped twice around the metal stent. Finally, a 0.001″ sintered espun PTFE sheet is wrapped twice around the espun PVDF layer to create a tube assembly consisting of sintered espun PTFE/stent/espun PVDF/sintered espun PTFE. The entire construction is then compressed together prior to heating/sintering at 370° C. for 15 minutes followed by water quenching as a means to cool down the sample. The composite is then removed from the hypotube and tested for specified properties.
  • Example 5 Espun PTFE/Stent/Espun PU/Espun PTFE
  • A sintered espun PTFE sheet, prepared as described herein, is wrapped twice (could be more or less) around a metal hypotube (of any diameter) and sintered at 385° C. for 5 minutes (to prevent the PTFE layers from delaminating from one another) to form a sintered, espun PTFE tube (inner diameter surface) around the metal hypotube. This represents the ID surface of the device. A structural frame may or may not be applied over this sintered espun PTFE tube. The OD surface consists of a wrapped sheet, wrapped twice (as shown in FIG. 7E, but could be more or less) around the metal frame or sintered espun PTFE tube (if no metal frame is present). The wrapped sheet is a combination sheet that consists of PU espun (from solution) onto an espun PTFE sheet (prepared by spinning a dispersion), whereby the PU is in direct contact with the metal frame or sintered espun PTFE tube (if no metal frame is present). Thus, the OD surface is a sandwich of alternating layers of PU and PTFE (the number of layers dependent on the number of wraps). The espun PU can be either porous (more fiber-like) or non-porous (more film-like) depending on run conditions. The espun PU layer can also range in thickness, being as thin as 0.0001″. Pressure and heat are then applied simultaneously to the device to bond all layers into one component. The thickness of the composite is based on the number of wraps and the thickness of the input material. The pore size is dependent on the processing of the input material as well as number of wraps.
  • Example 6 Espun PTFE/Stent/Espun PDMS/Espun PTFE
  • A sintered espun PTFE sheet, prepared as described herein, is wrapped twice (could be more or less) around a metal hypotube (of any diameter) and sintered at 385° C. for 5 minutes (to prevent the PTFE layers from delaminating from one another) to form a sintered, espun PTFE tube (inner diameter surface) around the metal hypotube. This represents the ID surface of the device. A structural frame may or may not be applied over this sintered espun PTFE tube. The OD surface consists of a sheet wrapped twice (could be more or less) around the metal frame or sintered espun PTFE tube (if no metal frame is present). The wrapped sheet consists of PDMS espun (from solution) onto an espun PTFE sheet (prepared by spinning a dispersion), whereby the PDMS is in direct contact with the metal frame or sintered espun PTFE tube (if no metal frame is present). Thus, the OD is a sandwich of alternating layers of PDMS and PTFE (the number of layers dependent on the number of wraps). The espun PDMS can be either porous (more fiber-like) or non-porous (more film-like) depending on run conditions. The espun PDMS layer can also range in thickness, being as thin as 0.0001″. Pressure and heat are then applied simultaneously to the device to bond all layers into one component. The thickness of the composite is based on the number of wraps and the thickness of the input material. The pore size is dependent on the processing of the input material as well as number of wraps.
  • Many modifications and other embodiments of the invention will come to mind to one skilled in the art to which this disclosure pertains having the benefit of the teachings presented in the foregoing description. Therefore, it is to be understood that the invention is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.

Claims (35)

1. A multi-layered tubular composite prosthetic device comprising at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer.
2. The composite prosthetic device of claim 1, wherein the second electrospun polymer comprises a solution-electrospun polymer.
3. The composite prosthetic device of claim 1, wherein the second electrospun polymer comprises a thermoplastic polymer or a thermoset polymer.
4. The composite prosthetic device of claim 1, wherein the second electrospun polymer layer comprises a polyurethane or a silicone.
5. The composite prosthetic device of claim 1, wherein the second electrospun polymer is selected from the group consisting of polyether block amide, a polyamide, ultra-high molecular weight polyethylene, a polyester, fluorinated ethylene propylene, polyvinylidene fluoride, perfluoroalkoxy, a tetrafluoroethylene/hexafluoropropylene/vinylidene fluoride copolymer, poly(ethylene-co-tetrafluoroethylene), ethylene chlorotrifluoroethylene, polychlorotrifluoroethylene, and copolymers, blends, and derivatives thereof.
6. The composite prosthetic device of claim 1, wherein the second electrospun polymer comprises poly(tetrafluoroethylene).
7. The composite prosthetic device of claim 1, wherein the porous layer comprising a second electrospun polymer penetrates the pores of the porous layer comprising electrospun poly(tetrafluoroethylene).
8. The composite prosthetic device of claim 1, further comprising a structural frame.
9. The composite prosthetic device of claim 8, wherein the structural frame comprises a stent.
10. The composite prosthetic device of claim 8, wherein the structural frame comprises open spaces through which the second electrospun polymer penetrates.
11. The composite prosthetic device of claim 1, wherein the device comprises at least two porous layers comprising electrospun poly(tetrafluoroethylene).
12. The composite prosthetic device of claim 1, wherein the device comprises at least two porous layers comprising a second electrospun polymer.
13. The composite prosthetic device of claim 1, wherein at least one of the inner diameter and the outer diameter of the tubular device comprises a porous layer comprising electrospun poly(tetrafluoroethylene).
14. The composite prosthetic device of claim 1, wherein the device further comprises a non-porous polymeric layer.
15. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electro spun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer.
16. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer, between said first and second layers.
17. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame embedded in the porous layer comprising electrospun poly(tetrafluoroethylene); and a second porous layer comprising a second electrospun polymer on the device outer diameter surface.
18. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(ethylene terephthalate) on the device outer diameter surface; and a third layer between said structural frame and said second layer comprising a different electrospun polymer, wherein the structural frame comprises open spaces through which the different electrospun polymer penetrates.
19. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a structural frame situated around and adjacent to said first porous layer; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and at least two alternating layers of electrospun poly(tetrafluoroethylene) and a different electrospun polymer between said first and second layers, wherein a layer comprising the different electrospun polymer is adjacent to the structural frame and the structural frame comprises open spaces through which the different electrospun polymer penetrates.
20. The composite prosthetic device of claim 1, wherein the cross-section of the device comprises: a lumen surrounded by a first porous layer comprising electrospun poly(tetrafluoroethylene) on the device inner diameter surface; a second porous layer comprising electrospun poly(tetrafluoroethylene) on the device outer diameter surface; and a third layer between said first and second layers, comprising a different electrospun polymer, wherein a structural frame is embedded in the third layer.
21. A method for producing a composite prosthetic device comprising:
combining at least one porous layer comprising electrospun poly(tetrafluoroethylene) and at least one porous layer comprising a second electrospun polymer to give a composite prosthetic device precursor; and
applying pressure, heat, or both pressure and heat to the composite prosthetic device precursor to provide a composite prosthetic device.
22. The method of claim 21, further comprising placing a structural frame around the porous layer comprising electrospun poly(tetrafluoroethylene).
23. The method of claim 22, wherein the structural frame is a stent.
24. The method of claim 22, wherein the structural frame comprises open spaces through which the second electrospun polymer penetrates.
25. The method of claim 21, wherein the combining comprises wrapping the porous layer comprising a second electrospun polymer around the porous layer comprising electrospun poly(tetrafluoroethylene).
26. The method of claim 21, wherein the combining comprises electrospinning the porous layer comprising a second electrospun polymer onto the porous layer comprising electrospun poly(tetrafluoroethylene).
27. The method of claim 21, wherein the second electrospun polymer comprises a solution-electrospun polymer.
28. The method of claim 21, wherein the second electrospun polymer comprises a thermoplastic polymer or a thermoset polymer.
29. The method of claim 21, wherein the second electrospun polymer layer comprises a polyurethane or a silicone.
30. The method of claim 21, wherein the second electrospun polymer is selected from the group consisting of polyether block amide, a polyamide, ultra-high molecular weight polyethylene, a polyester, fluorinated ethylene propylene, polyvinylidene fluoride, perfluoroalkoxy, tetrafluoroethylene/hexafluoropropylene/vinylidene fluoride copolymer, poly(ethylene-co-tetrafluoroethylene), ethylene chlorotrifluoroethylene, polychlorotrifluoroethylene, and copolymers, blends, and derivatives thereof.
31. The method of claim 21, wherein the second electrospun polymer comprises unsintered poly(tetrafluoroethylene) and the method further comprising sintering the composite prosthetic device following the applying step.
32. The method of claim 21, wherein the applying step comprises applying pressure, heat, or both pressure and heat for a time sufficient to result in the penetration of the second electrospun polymer into the pores of the at least one porous layer comprising electrospun poly(tetrafluoroethylene).
33. The method of claim 21, wherein both pressure and heat are applied, sequentially or simultaneously.
34. The method of claim 21, wherein the pressure is between about 500 and about 1500 PSI and the temperature is between about 100° C. and about 400° C.
35. The method of claim 21, wherein the applying step is conducted in a pressure vessel.
US13/803,892 2009-01-16 2013-03-14 Composite prosthetic devices Abandoned US20130268062A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US13/803,892 US20130268062A1 (en) 2012-04-05 2013-03-14 Composite prosthetic devices
CN201380017906.8A CN104203150B (en) 2012-04-05 2013-03-18 Composite prosthesis device
CN201710978132.5A CN107736952A (en) 2012-04-05 2013-03-18 Composite prosthesis device
JP2015504605A JP6490575B2 (en) 2012-04-05 2013-03-18 Artificial composite device
EP13772707.9A EP2833826B1 (en) 2012-04-05 2013-03-18 Composite prosthetic devices
PCT/US2013/032771 WO2013151778A1 (en) 2012-04-05 2013-03-18 Composite prosthetic devices
US14/520,368 US10010395B2 (en) 2012-04-05 2014-10-22 Composite prosthetic devices
US14/858,556 US20160067374A1 (en) 2009-01-16 2015-09-18 Composite prosthetic devices

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261620633P 2012-04-05 2012-04-05
US201261724731P 2012-11-09 2012-11-09
US13/803,892 US20130268062A1 (en) 2012-04-05 2013-03-14 Composite prosthetic devices

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/446,300 Continuation-In-Part US20130023175A1 (en) 2009-01-16 2012-04-13 Electrospinning of ptfe with high viscosity materials

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/520,368 Continuation US10010395B2 (en) 2009-01-16 2014-10-22 Composite prosthetic devices

Publications (1)

Publication Number Publication Date
US20130268062A1 true US20130268062A1 (en) 2013-10-10

Family

ID=49292939

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/803,892 Abandoned US20130268062A1 (en) 2009-01-16 2013-03-14 Composite prosthetic devices
US14/520,368 Active 2033-05-13 US10010395B2 (en) 2009-01-16 2014-10-22 Composite prosthetic devices

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/520,368 Active 2033-05-13 US10010395B2 (en) 2009-01-16 2014-10-22 Composite prosthetic devices

Country Status (5)

Country Link
US (2) US20130268062A1 (en)
EP (1) EP2833826B1 (en)
JP (1) JP6490575B2 (en)
CN (2) CN104203150B (en)
WO (1) WO2013151778A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130085565A1 (en) * 2011-01-28 2013-04-04 Merit Medical System, Inc. Electrospun ptfe coated stent and method of use
US20130325140A1 (en) * 2010-06-02 2013-12-05 Nonwo Tecc Medical Gmbh Device for placement in a hollow organ, in particular for holding open said hollow organ and method for producing such device
US20140081414A1 (en) * 2012-09-19 2014-03-20 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
WO2015112489A1 (en) * 2014-01-21 2015-07-30 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
WO2016100666A1 (en) * 2014-12-18 2016-06-23 Cardiac Pacemakers, Inc. Fibrous joinery interface between structures
US9415206B2 (en) 2011-08-12 2016-08-16 Cardiac Pacemakers, Inc. Method for coating devices using electrospinning
US20160250048A1 (en) * 2015-02-26 2016-09-01 Merit Medical Systems, Inc. Layered medical appliances and methods
WO2017055926A1 (en) * 2015-10-01 2017-04-06 Xeltis Bv Methods for electrospin coating and laminating of endoluminal prostheses
US20170319325A1 (en) * 2015-11-12 2017-11-09 Biostage, Inc. Systems and Methods for Producing Gastrointestinal Tissues at an Anstomosis or Other Physiological Location
US9827703B2 (en) 2013-03-13 2017-11-28 Merit Medical Systems, Inc. Methods, systems, and apparatuses for manufacturing rotational spun appliances
US9855415B2 (en) 2015-07-25 2018-01-02 Cardiac Pacemakers, Inc. Medical electrical lead with biostable PVDF-based materials
US9987833B2 (en) 2012-01-16 2018-06-05 Merit Medical Systems, Inc. Rotational spun material covered medical appliances and methods of manufacture
CN109069279A (en) * 2016-01-09 2018-12-21 埃因霍温科技大学 Fiber tubular conduit for stent applications
US20190000602A1 (en) * 2015-12-11 2019-01-03 Poly-Med, Inc. Synthetic implant device replicating natural tissue structure and methods of making same
US10377150B2 (en) * 2016-01-29 2019-08-13 Canon Kabushiki Kaisha Porous body, ink jet recording method, and ink jet recording apparatus
US10465318B2 (en) 2016-12-27 2019-11-05 Boston Scientific Scimed Inc Degradable scaffolding for electrospinning
US20200129285A1 (en) * 2015-07-31 2020-04-30 Cook Medical Technologies Llc Methods of making a prosthesis with a smooth covering
CN111247280A (en) * 2017-11-29 2020-06-05 金伯利-克拉克环球有限公司 Fibrous sheet with improved properties
WO2020156711A1 (en) * 2019-01-29 2020-08-06 Xeltis Ag Electrospun cover layer for medical implants
US10799617B2 (en) 2013-03-13 2020-10-13 Merit Medical Systems, Inc. Serially deposited fiber materials and associated devices and methods
US11155933B2 (en) 2013-07-22 2021-10-26 Cardiac Pacemakers, Inc. Lubricious, biocompatible hydrophilic thermoset coating using interpenetrating hydrogel networks
US20220054255A1 (en) * 2011-08-16 2022-02-24 The University Of Kansas Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair
US20220305240A1 (en) * 2019-07-02 2022-09-29 Biotronik Ag Functionalized balloon surface
US20220372659A1 (en) * 2021-05-19 2022-11-24 Panasonic Intellectual Property Management Co., Ltd. Device and method for manufacturing fiber assembly

Families Citing this family (313)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9060770B2 (en) 2003-05-20 2015-06-23 Ethicon Endo-Surgery, Inc. Robotically-driven surgical instrument with E-beam driver
US20070084897A1 (en) 2003-05-20 2007-04-19 Shelton Frederick E Iv Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US8215531B2 (en) 2004-07-28 2012-07-10 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a medical substance dispenser
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US10159482B2 (en) 2005-08-31 2018-12-25 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US20070106317A1 (en) 2005-11-09 2007-05-10 Shelton Frederick E Iv Hydraulically and electrically actuated articulation joints for surgical instruments
US20120292367A1 (en) 2006-01-31 2012-11-22 Ethicon Endo-Surgery, Inc. Robotically-controlled end effector
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US20110290856A1 (en) 2006-01-31 2011-12-01 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical instrument with force-feedback capabilities
US7845537B2 (en) 2006-01-31 2010-12-07 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US8708213B2 (en) 2006-01-31 2014-04-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US7753904B2 (en) 2006-01-31 2010-07-13 Ethicon Endo-Surgery, Inc. Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US8322455B2 (en) 2006-06-27 2012-12-04 Ethicon Endo-Surgery, Inc. Manually driven surgical cutting and fastening instrument
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US8684253B2 (en) 2007-01-10 2014-04-01 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US8540128B2 (en) 2007-01-11 2013-09-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with a curved end effector
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US8727197B2 (en) 2007-03-15 2014-05-20 Ethicon Endo-Surgery, Inc. Staple cartridge cavity configuration with cooperative surgical staple
US8931682B2 (en) 2007-06-04 2015-01-13 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US11857181B2 (en) 2007-06-04 2024-01-02 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US7753245B2 (en) 2007-06-22 2010-07-13 Ethicon Endo-Surgery, Inc. Surgical stapling instruments
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
US7866527B2 (en) 2008-02-14 2011-01-11 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US9179912B2 (en) 2008-02-14 2015-11-10 Ethicon Endo-Surgery, Inc. Robotically-controlled motorized surgical cutting and fastening instrument
BRPI0901282A2 (en) 2008-02-14 2009-11-17 Ethicon Endo Surgery Inc surgical cutting and fixation instrument with rf electrodes
US7819298B2 (en) 2008-02-14 2010-10-26 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features operable with one hand
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US9770245B2 (en) 2008-02-15 2017-09-26 Ethicon Llc Layer arrangements for surgical staple cartridges
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US8210411B2 (en) 2008-09-23 2012-07-03 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US9386983B2 (en) 2008-09-23 2016-07-12 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument
US8608045B2 (en) 2008-10-10 2013-12-17 Ethicon Endo-Sugery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
US8517239B2 (en) 2009-02-05 2013-08-27 Ethicon Endo-Surgery, Inc. Surgical stapling instrument comprising a magnetic element driver
CN102341048A (en) 2009-02-06 2012-02-01 伊西康内外科公司 Driven surgical stapler improvements
US8851354B2 (en) 2009-12-24 2014-10-07 Ethicon Endo-Surgery, Inc. Surgical cutting instrument that analyzes tissue thickness
US8783543B2 (en) 2010-07-30 2014-07-22 Ethicon Endo-Surgery, Inc. Tissue acquisition arrangements and methods for surgical stapling devices
US9386988B2 (en) 2010-09-30 2016-07-12 Ethicon End-Surgery, LLC Retainer assembly including a tissue thickness compensator
US11812965B2 (en) 2010-09-30 2023-11-14 Cilag Gmbh International Layer of material for a surgical end effector
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US11849952B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US9282962B2 (en) 2010-09-30 2016-03-15 Ethicon Endo-Surgery, Llc Adhesive film laminate
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US9016542B2 (en) 2010-09-30 2015-04-28 Ethicon Endo-Surgery, Inc. Staple cartridge comprising compressible distortion resistant components
US9211120B2 (en) 2011-04-29 2015-12-15 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a plurality of medicaments
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US8695866B2 (en) 2010-10-01 2014-04-15 Ethicon Endo-Surgery, Inc. Surgical instrument having a power control circuit
CA2834649C (en) 2011-04-29 2021-02-16 Ethicon Endo-Surgery, Inc. Staple cartridge comprising staples positioned within a compressible portion thereof
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
BR112014024102B1 (en) 2012-03-28 2022-03-03 Ethicon Endo-Surgery, Inc CLAMP CARTRIDGE ASSEMBLY FOR A SURGICAL INSTRUMENT AND END ACTUATOR ASSEMBLY FOR A SURGICAL INSTRUMENT
CN104379068B (en) 2012-03-28 2017-09-22 伊西康内外科公司 Holding device assembly including tissue thickness compensation part
BR112014024098B1 (en) 2012-03-28 2021-05-25 Ethicon Endo-Surgery, Inc. staple cartridge
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
US11278284B2 (en) 2012-06-28 2022-03-22 Cilag Gmbh International Rotary drive arrangements for surgical instruments
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
BR112014032776B1 (en) 2012-06-28 2021-09-08 Ethicon Endo-Surgery, Inc SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM
JP6290201B2 (en) 2012-06-28 2018-03-07 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Lockout for empty clip cartridge
US9282974B2 (en) 2012-06-28 2016-03-15 Ethicon Endo-Surgery, Llc Empty clip cartridge lockout
US20140001231A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Firing system lockout arrangements for surgical instruments
US9226751B2 (en) 2012-06-28 2016-01-05 Ethicon Endo-Surgery, Inc. Surgical instrument system including replaceable end effectors
JP6345707B2 (en) 2013-03-01 2018-06-20 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Surgical instrument with soft stop
JP6382235B2 (en) 2013-03-01 2018-08-29 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Articulatable surgical instrument with a conductive path for signal communication
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
US9844368B2 (en) 2013-04-16 2017-12-19 Ethicon Llc Surgical system comprising first and second drive systems
BR112015026109B1 (en) 2013-04-16 2022-02-22 Ethicon Endo-Surgery, Inc surgical instrument
JP6416260B2 (en) 2013-08-23 2018-10-31 エシコン エルエルシー Firing member retractor for a powered surgical instrument
US20150053746A1 (en) 2013-08-23 2015-02-26 Ethicon Endo-Surgery, Inc. Torque optimization for surgical instruments
US9733663B2 (en) 2014-03-26 2017-08-15 Ethicon Llc Power management through segmented circuit and variable voltage protection
BR112016021943B1 (en) 2014-03-26 2022-06-14 Ethicon Endo-Surgery, Llc SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE
BR112016023825B1 (en) 2014-04-16 2022-08-02 Ethicon Endo-Surgery, Llc STAPLE CARTRIDGE FOR USE WITH A SURGICAL STAPLER AND STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT
US20150297223A1 (en) 2014-04-16 2015-10-22 Ethicon Endo-Surgery, Inc. Fastener cartridges including extensions having different configurations
JP6532889B2 (en) 2014-04-16 2019-06-19 エシコン エルエルシーEthicon LLC Fastener cartridge assembly and staple holder cover arrangement
JP6636452B2 (en) 2014-04-16 2020-01-29 エシコン エルエルシーEthicon LLC Fastener cartridge including extension having different configurations
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US10111679B2 (en) 2014-09-05 2018-10-30 Ethicon Llc Circuitry and sensors for powered medical device
BR112017004361B1 (en) 2014-09-05 2023-04-11 Ethicon Llc ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT
US10105142B2 (en) 2014-09-18 2018-10-23 Ethicon Llc Surgical stapler with plurality of cutting elements
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
JP6648119B2 (en) 2014-09-26 2020-02-14 エシコン エルエルシーEthicon LLC Surgical stapling buttress and accessory materials
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
US10004501B2 (en) 2014-12-18 2018-06-26 Ethicon Llc Surgical instruments with improved closure arrangements
MX2017008108A (en) 2014-12-18 2018-03-06 Ethicon Llc Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge.
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
JP2020121162A (en) 2015-03-06 2020-08-13 エシコン エルエルシーEthicon LLC Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement
US10548504B2 (en) 2015-03-06 2020-02-04 Ethicon Llc Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression
US10441279B2 (en) 2015-03-06 2019-10-15 Ethicon Llc Multiple level thresholds to modify operation of powered surgical instruments
US10213201B2 (en) 2015-03-31 2019-02-26 Ethicon Llc Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw
US20170065223A1 (en) * 2015-09-04 2017-03-09 Mehdi Razavi Systems and methods for failure detection of endovascular stents
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
US10285699B2 (en) 2015-09-30 2019-05-14 Ethicon Llc Compressible adjunct
US10327777B2 (en) 2015-09-30 2019-06-25 Ethicon Llc Implantable layer comprising plastically deformed fibers
US11890015B2 (en) 2015-09-30 2024-02-06 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
BR112018016098B1 (en) 2016-02-09 2023-02-23 Ethicon Llc SURGICAL INSTRUMENT
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US20170296173A1 (en) 2016-04-18 2017-10-19 Ethicon Endo-Surgery, Llc Method for operating a surgical instrument
US10368867B2 (en) 2016-04-18 2019-08-06 Ethicon Llc Surgical instrument comprising a lockout
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
CN106584836B (en) * 2016-11-30 2019-06-21 广州博敏科技有限公司 Compound 3D printing formation system, forming method and intravascular stent
US20180168615A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
US10918385B2 (en) 2016-12-21 2021-02-16 Ethicon Llc Surgical system comprising a firing member rotatable into an articulation state to articulate an end effector of the surgical system
US10588631B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical instruments with positive jaw opening features
MX2019007311A (en) 2016-12-21 2019-11-18 Ethicon Llc Surgical stapling systems.
US11090048B2 (en) 2016-12-21 2021-08-17 Cilag Gmbh International Method for resetting a fuse of a surgical instrument shaft
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
CN110099619B (en) 2016-12-21 2022-07-15 爱惜康有限责任公司 Lockout device for surgical end effector and replaceable tool assembly
US10973516B2 (en) 2016-12-21 2021-04-13 Ethicon Llc Surgical end effectors and adaptable firing members therefor
US20180168625A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Surgical stapling instruments with smart staple cartridges
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
US10568624B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaws that are pivotable about a fixed axis and include separate and distinct closure and firing systems
JP7010956B2 (en) 2016-12-21 2022-01-26 エシコン エルエルシー How to staple tissue
US10959727B2 (en) 2016-12-21 2021-03-30 Ethicon Llc Articulatable surgical end effector with asymmetric shaft arrangement
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
US20180368844A1 (en) 2017-06-27 2018-12-27 Ethicon Llc Staple forming pocket arrangements
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
US11478242B2 (en) 2017-06-28 2022-10-25 Cilag Gmbh International Jaw retainer arrangement for retaining a pivotable surgical instrument jaw in pivotable retaining engagement with a second surgical instrument jaw
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US11484310B2 (en) 2017-06-28 2022-11-01 Cilag Gmbh International Surgical instrument comprising a shaft including a closure tube profile
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
EP3420947B1 (en) 2017-06-28 2022-05-25 Cilag GmbH International Surgical instrument comprising selectively actuatable rotatable couplers
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
US11944300B2 (en) 2017-08-03 2024-04-02 Cilag Gmbh International Method for operating a surgical system bailout
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US11179152B2 (en) 2017-12-21 2021-11-23 Cilag Gmbh International Surgical instrument comprising a tissue grasping system
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
NZ765664A (en) * 2017-12-22 2023-12-22 Polynovo Biomaterials Pty Ltd Tissue repair laminates
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
CN109371478B (en) * 2018-10-26 2021-06-08 杭州萧元纺纱有限公司 3D stacked electrospinning fiber spraying method for experiment and application
CN109847101B (en) * 2018-12-28 2022-04-12 广州市妇女儿童医疗中心 Tissue engineering urethral stent and preparation process thereof
CN109914036A (en) * 2019-01-16 2019-06-21 武汉杨森生物技术有限公司 The preparation method of puncture-resistant artificial blood vessel material and thus obtained artificial blood vessel
IT201900000981A1 (en) * 2019-01-23 2020-07-23 Giancarlo Salsano ENDOVASCULAR DEVICE FOR DYSFUNCTIONAL FISTULAS
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11853835B2 (en) 2019-06-28 2023-12-26 Cilag Gmbh International RFID identification systems for surgical instruments
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11350938B2 (en) 2019-06-28 2022-06-07 Cilag Gmbh International Surgical instrument comprising an aligned rfid sensor
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
TWI749395B (en) * 2019-11-08 2021-12-11 高鼎精密材料股份有限公司 Method for fabricating polymer fiber tubular structure with high patency rate
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11931033B2 (en) 2019-12-19 2024-03-19 Cilag Gmbh International Staple cartridge comprising a latch lockout
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
CN111821065B (en) * 2020-06-01 2021-11-16 北京爱霖医疗科技有限公司 Preparation method of tectorial membrane implant
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
US20220031320A1 (en) 2020-07-28 2022-02-03 Cilag Gmbh International Surgical instruments with flexible firing member actuator constraint arrangements
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
US11931025B2 (en) 2020-10-29 2024-03-19 Cilag Gmbh International Surgical instrument comprising a releasable closure drive lock
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11944296B2 (en) 2020-12-02 2024-04-02 Cilag Gmbh International Powered surgical instruments with external connectors
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11950779B2 (en) 2021-02-26 2024-04-09 Cilag Gmbh International Method of powering and communicating with a staple cartridge
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11950777B2 (en) 2021-02-26 2024-04-09 Cilag Gmbh International Staple cartridge comprising an information access control system
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11925349B2 (en) 2021-02-26 2024-03-12 Cilag Gmbh International Adjustment to transfer parameters to improve available power
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US20220280281A1 (en) * 2021-03-05 2022-09-08 Mentor Worldwide Llc Systems, devices and methods of making prosthetic implants having self-sealing membranes for closing punctures and preventing leaks
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
CN117062635A (en) * 2021-03-23 2023-11-14 谢尔蒂斯股份公司 Anti-kink tubular implant
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11944336B2 (en) 2021-03-24 2024-04-02 Cilag Gmbh International Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11826047B2 (en) 2021-05-28 2023-11-28 Cilag Gmbh International Stapling instrument comprising jaw mounts
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters
US11937816B2 (en) 2021-10-28 2024-03-26 Cilag Gmbh International Electrical lead arrangements for surgical instruments
DE102022125942A1 (en) 2022-10-07 2024-04-18 Acandis Gmbh Medical device, set with a medical device and method for manufacturing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100944A1 (en) * 2001-11-28 2003-05-29 Olga Laksin Vascular graft having a chemicaly bonded electrospun fibrous layer and method for making same
US20030114917A1 (en) * 2001-12-14 2003-06-19 Holloway Ken A. Layered stent-graft and methods of making the same

Family Cites Families (232)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2158416A (en) 1937-07-28 1939-05-16 Richard Schrelber Gastell Method and apparatus for the production of artificial fibers
US4143196A (en) 1970-06-29 1979-03-06 Bayer Aktiengesellschaft Fibre fleece of electrostatically spun fibres and methods of making same
US4096227A (en) 1973-07-03 1978-06-20 W. L. Gore & Associates, Inc. Process for producing filled porous PTFE products
GB1527592A (en) 1974-08-05 1978-10-04 Ici Ltd Wound dressing
GB1530990A (en) * 1974-08-05 1978-11-01 Ici Ltd Electrostatically spun tubular product
GB1522605A (en) 1974-09-26 1978-08-23 Ici Ltd Preparation of fibrous sheet product
US6436135B1 (en) 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
CH620483A5 (en) 1977-12-22 1980-11-28 Battelle Memorial Institute
DE2806030C2 (en) 1978-02-14 1984-02-02 B. Braun Melsungen Ag, 3508 Melsungen Process for the production of a tubular blood vessel prosthesis
DE2960875D1 (en) 1978-04-19 1981-12-10 Ici Plc A method of preparing a tubular product by electrostatic spinning
DE2965672D1 (en) 1978-10-10 1983-07-21 Ici Plc Production of electrostatically spun products
US4432916A (en) 1982-01-15 1984-02-21 Morrison-Knudsen Forest Products Company, Inc. Method and apparatus for the electrostatic orientation of particulate materials
GB2121286B (en) 1982-06-02 1985-11-06 Ethicon Inc Improvements in synthetic vascular grafts, and methods of manufacturing such grafts
US5162074A (en) 1987-10-02 1992-11-10 Basf Corporation Method of making plural component fibers
JP3000654B2 (en) 1990-10-19 2000-01-17 ダイキン工業株式会社 Polytetrafluoroethylene fine particles and powder
CA2074349C (en) 1991-07-23 2004-04-20 Shinji Tamaru Polytetrafluoroethylene porous film and preparation and use thereof
US5328946A (en) 1991-08-29 1994-07-12 E. I. Du Pont De Nemours And Company Solvents for tetrafluoroethylene polymers
JPH0571379A (en) 1991-09-10 1993-03-23 Nissan Motor Co Ltd Device for feeding fuel during start of internal combustion engine
DE4130356C2 (en) 1991-09-12 1995-01-26 Bitterfeld Wolfen Chemie PTFE fiber material and process for its manufacture
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
CN1064093C (en) 1993-04-05 2001-04-04 达金工业株式会社 Polytetrafluoroethylene fiber, cottony material containing the same, and process for producing the same
US5735892A (en) 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
EP0714270B1 (en) 1993-08-18 2002-09-04 W.L. Gore & Associates, Inc. A tubular intraluminally insertable graft
CA2182500A1 (en) 1994-02-17 1995-08-24 Norman J. Sharber A carvable ptfe implant material
DE69529746T2 (en) 1994-06-30 2003-09-04 Daikin Ind Ltd VOLUMINOUS LONG FIBER AND SPLIT YARN FROM POLYTETRAFLUORETHYTEN, METHOD FOR THE PRODUCTION AND PRODUCTION OF COTTON-LIKE MATERIAL USING THIS FIBER AND THIS YARN AND FABRIC FOR DUST FILTERS
US6175571B1 (en) 1994-07-22 2001-01-16 Network Peripherals, Inc. Distributed memory switching hub
US5509902A (en) 1994-07-25 1996-04-23 Raulerson; J. Daniel Subcutaneous catheter stabilizing devices and methods for securing a catheter using the same
JP3486905B2 (en) 1994-10-04 2004-01-13 ダイキン工業株式会社 Mixed cotton-like material, non-woven fabric obtained therefrom and method for producing them
US5507770A (en) 1994-11-23 1996-04-16 Aeroquip Corporation Intraluminal grafting stent and method for implanting same in a blood vessel
US6124523A (en) 1995-03-10 2000-09-26 Impra, Inc. Encapsulated stent
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US5476589A (en) 1995-03-10 1995-12-19 W. L. Gore & Associates, Inc. Porpous PTFE film and a manufacturing method therefor
US6579314B1 (en) 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
AU707727B2 (en) 1995-08-24 1999-07-15 Impra, Inc. Covered endoluminal stent and method of assembly
US5665428A (en) 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
US5788626A (en) 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5806633A (en) 1995-12-22 1998-09-15 Macuga; Henry J. Elevator safety system incorporating false pit
EP0955954B1 (en) 1996-01-05 2005-03-16 Medtronic, Inc. Expansible endoluminal prostheses
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5702658A (en) 1996-02-29 1997-12-30 Owens-Corning Fiberglas Technology, Inc. Bicomponent polymer fibers made by rotary process
US5874165A (en) 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US20050113909A1 (en) 1996-07-03 2005-05-26 Shannon Donald T. Polymer coated stents
EP0934035B8 (en) 1996-09-26 2006-01-18 Boston Scientific Scimed, Inc. Support structure/membrane composite medical device
US5824046A (en) 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US6010529A (en) 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5961545A (en) 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
WO1998038947A1 (en) 1997-03-05 1998-09-11 Scimed Life Systems, Inc. Conformal laminate stent device
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
JPH11204114A (en) 1998-01-20 1999-07-30 Daikin Ind Ltd Electrode material
DE69933545T2 (en) 1998-02-24 2007-06-21 Asahi Glass Co., Ltd. Aqueous polytetrafluoroethylene dispersion composition
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
DE69836200T2 (en) 1998-04-14 2007-08-23 Tranquil Prospects Ltd. Implant material and process for its preparation
US6265333B1 (en) 1998-06-02 2001-07-24 Board Of Regents, University Of Nebraska-Lincoln Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
JP4399585B2 (en) 1998-06-02 2010-01-20 クック インコーポレイティド Multi-sided medical device
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US20030069343A1 (en) 1998-08-06 2003-04-10 Paul Smith Melt-processible poly(tetrafluoroethylene)
US6156064A (en) 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US7235096B1 (en) * 1998-08-25 2007-06-26 Tricardia, Llc Implantable device for promoting repair of a body lumen
US7815763B2 (en) 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US6547814B2 (en) 1998-09-30 2003-04-15 Impra, Inc. Selective adherence of stent-graft coverings
CA2329214A1 (en) 1999-01-22 2000-07-27 Gore Enterprise Holdings, Inc. A biliary stent-graft
AU774924B2 (en) 1999-01-22 2004-07-15 W.L. Gore & Associates, Inc. Covered endoprosthesis and delivery system
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6558414B2 (en) 1999-02-02 2003-05-06 Impra, Inc. Partial encapsulation of stents using strips and bands
US6364903B2 (en) 1999-03-19 2002-04-02 Meadox Medicals, Inc. Polymer coated stent
US6547915B2 (en) 1999-04-15 2003-04-15 Kimberly-Clark Worldwide, Inc. Creep resistant composite elastic material with improved aesthetics, dimensional stability and inherent latency and method of producing same
US6673103B1 (en) 1999-05-20 2004-01-06 Scimed Life Systems, Inc. Mesh and stent for increased flexibility
US6478814B2 (en) 1999-06-14 2002-11-12 Scimed Life Systems, Inc. Stent securement sleeves and optional coatings and methods of use
US6652570B2 (en) 1999-07-02 2003-11-25 Scimed Life Systems, Inc. Composite vascular graft
US6402779B1 (en) 1999-07-26 2002-06-11 Endomed, Inc. Balloon-assisted intraluminal stent graft
US20010018609A1 (en) 1999-08-11 2001-08-30 Scott Smith Seamless braided or spun stent cover
GB2353739A (en) * 1999-09-04 2001-03-07 Federal Mogul Technology Ltd Applying a low friction and low wear coating
US6312462B1 (en) 1999-09-22 2001-11-06 Impra, Inc. Prosthesis for abdominal aortic aneurysm repair
US7947069B2 (en) 1999-11-24 2011-05-24 University Of Washington Medical devices comprising small fiber biomaterials, and methods of use
US7220276B1 (en) 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
US6392567B2 (en) 2000-03-31 2002-05-21 Fijitsu Limited Apparatus for repeatedly compressing a data string and a method thereof
US7300662B2 (en) 2000-05-12 2007-11-27 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US6808533B1 (en) 2000-07-28 2004-10-26 Atrium Medical Corporation Covered stent and method of covering a stent
AU2001286731A1 (en) 2000-08-25 2002-03-04 Kensey Nash Corporation Covered stents, systems for deploying covered stents
US6743273B2 (en) 2000-09-05 2004-06-01 Donaldson Company, Inc. Polymer, polymer microfiber, polymer nanofiber and applications including filter structures
US7118592B1 (en) 2000-09-12 2006-10-10 Advanced Cardiovascular Systems, Inc. Covered stent assembly for reduced-shortening during stent expansion
US7416559B2 (en) 2000-10-27 2008-08-26 Poly-Med, Inc. Micromantled drug-eluting stent
US6833153B1 (en) 2000-10-31 2004-12-21 Advanced Cardiovascular Systems, Inc. Hemocompatible coatings on hydrophobic porous polymers
US6770086B1 (en) 2000-11-02 2004-08-03 Scimed Life Systems, Inc. Stent covering formed of porous polytetraflouroethylene
US20020084178A1 (en) * 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
US20070031607A1 (en) 2000-12-19 2007-02-08 Alexander Dubson Method and apparatus for coating medical implants
US20040030377A1 (en) * 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
US6641773B2 (en) 2001-01-10 2003-11-04 The United States Of America As Represented By The Secretary Of The Army Electro spinning of submicron diameter polymer filaments
US6899727B2 (en) 2001-01-22 2005-05-31 Gore Enterprise Holdings, Inc. Deployment system for intraluminal devices
BR0208247A (en) 2001-03-13 2004-03-02 Du Pont Dispersion, fluoropolymer powder, coating composition, coated substrate, self-supporting film and batch process
US6673105B1 (en) 2001-04-02 2004-01-06 Advanced Cardiovascular Systems, Inc. Metal prosthesis coated with expandable ePTFE
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
US7560006B2 (en) 2001-06-11 2009-07-14 Boston Scientific Scimed, Inc. Pressure lamination method for forming composite ePTFE/textile and ePTFE/stent/textile prostheses
US7510571B2 (en) 2001-06-11 2009-03-31 Boston Scientific, Scimed, Inc. Pleated composite ePTFE/textile hybrid covering
US7105124B2 (en) 2001-06-19 2006-09-12 Aaf-Mcquay, Inc. Method, apparatus and product for manufacturing nanofiber media
US6939372B2 (en) 2001-07-03 2005-09-06 Scimed Life Systems, Inc. Low profile, high stretch, low dilation knit prosthetic device
JP2005500642A (en) 2001-08-13 2005-01-06 スリーエム イノベイティブ プロパティズ カンパニー Article for optical recording medium and fixing method thereof
DE10143963A1 (en) 2001-09-07 2003-03-27 Basf Ag Cosmetic and dermatological preparations in the form of W / O emulsions containing an amino-substituted hydroxybenzophenone
IN2014DN10834A (en) 2001-09-17 2015-09-04 Psivida Inc
US6827737B2 (en) 2001-09-25 2004-12-07 Scimed Life Systems, Inc. EPTFE covering for endovascular prostheses and method of manufacture
JP4332329B2 (en) 2002-02-26 2009-09-16 三菱レイヨン株式会社 Hollow fiber membrane module manufacturing apparatus and manufacturing method
US20030211135A1 (en) 2002-04-11 2003-11-13 Greenhalgh Skott E. Stent having electrospun covering and method
US20030195611A1 (en) 2002-04-11 2003-10-16 Greenhalgh Skott E. Covering and method using electrospinning of very small fibers
US20050187605A1 (en) 2002-04-11 2005-08-25 Greenhalgh Skott E. Electrospun skin capable of controlling drug release rates and method
US20040051201A1 (en) 2002-04-11 2004-03-18 Greenhalgh Skott E. Coated stent and method for coating by treating an electrospun covering with heat or chemicals
US7485141B2 (en) 2002-05-10 2009-02-03 Cordis Corporation Method of placing a tubular membrane on a structural frame
US7270675B2 (en) 2002-05-10 2007-09-18 Cordis Corporation Method of forming a tubular membrane on a structural frame
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US6863852B1 (en) 2002-05-30 2005-03-08 Zeus Industrial Products, Inc. Fluoropolymer extrusions based on novel combinations of process parameters and clay minerals
US7789908B2 (en) 2002-06-25 2010-09-07 Boston Scientific Scimed, Inc. Elastomerically impregnated ePTFE to enhance stretch and recovery properties for vascular grafts and coverings
JP2004028261A (en) 2002-06-27 2004-01-29 Fuji Koki Corp Expansion valve
US7550004B2 (en) 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
US7879085B2 (en) 2002-09-06 2011-02-01 Boston Scientific Scimed, Inc. ePTFE crimped graft
US7083697B2 (en) 2002-12-30 2006-08-01 Boston Scientific Scimed, Inc. Porous spun polymeric structures and method of making same
US7744792B2 (en) 2003-03-27 2010-06-29 Robert Roberts Methods for continuous processing polytetrafluoroethylene (PTFE) resin
US7524527B2 (en) 2003-05-19 2009-04-28 Boston Scientific Scimed, Inc. Electrostatic coating of a device
US8021418B2 (en) 2003-06-19 2011-09-20 Boston Scientific Scimed, Inc. Sandwiched radiopaque marker on covered stent
US7790135B2 (en) 2003-07-02 2010-09-07 Physical Sciences, Inc. Carbon and electrospun nanostructures
WO2005018600A2 (en) 2003-08-22 2005-03-03 Cube Medical A/S Method of treating a patient suffering from a solid tumour
US20050053782A1 (en) 2003-09-04 2005-03-10 Ayusman Sen Process for forming polymeric micro and nanofibers
WO2005034807A1 (en) 2003-10-10 2005-04-21 William A. Cook Australia Pty. Ltd Composite stent graft
US20070207179A1 (en) 2003-10-14 2007-09-06 Erik Andersen Medical Device
WO2005055834A1 (en) 2003-11-20 2005-06-23 Nmt Medical, Inc. Device, with electrospun fabric, for a percutaneous transluminal procedure, and methods thereof
US20050113886A1 (en) 2003-11-24 2005-05-26 Fischell David R. Implantable medical system with long range telemetry
US20050124242A1 (en) 2003-12-03 2005-06-09 Jean Norvell Novel polymer films and textile laminates containing such polymer films
US7347960B2 (en) 2003-12-31 2008-03-25 E. I. Du Pont De Nemours And Company Dispersion spinning core-shell fluoropolymers
US8057841B2 (en) 2004-02-12 2011-11-15 University Of Akron Mechanically attached medical device coatings
US7108912B2 (en) 2004-03-09 2006-09-19 Yeu Ming Tai Chemical Industrial Co., Ltd. Polytetrafluoroethylene fiber and method for manufacturing the same
WO2005095684A1 (en) 2004-03-25 2005-10-13 Massachusetts Institute Of Technology Production of submicron diameter fibers by two-fluid electrospinning process
EP1732619A1 (en) 2004-03-26 2006-12-20 SurModics, Inc. Composition and method for preparing biocompatible surfaces
EP1730332B1 (en) 2004-04-01 2012-08-08 E.I. Du Pont De Nemours And Company Rotary process for forming uniform material
US7297158B2 (en) 2004-06-14 2007-11-20 Thoratec Corporation Multilayer composite vascular access graft
US7794490B2 (en) 2004-06-22 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices with antimicrobial and biodegradable matrices
US7727271B2 (en) 2004-06-24 2010-06-01 Boston Scientific Scimed, Inc. Implantable prosthesis having reinforced attachment sites
US20080296808A1 (en) 2004-06-29 2008-12-04 Yong Lak Joo Apparatus and Method for Producing Electrospun Fibers
US8308789B2 (en) 2004-07-16 2012-11-13 W. L. Gore & Associates, Inc. Deployment system for intraluminal devices
US20060020328A1 (en) 2004-07-23 2006-01-26 Tan Sharon M L Composite vascular graft having bioactive agent
US7413575B2 (en) 2004-08-30 2008-08-19 Phaneuf Matthew D Nanofibrous biocomposite prosthetic vascular graft
US7641681B2 (en) 2004-12-28 2010-01-05 Boston Scientific Scimed, Inc. Low profile stent-graft attachment
US7922761B2 (en) * 2005-01-25 2011-04-12 Nicast Ltd. Artificial vascular prosthesis
DE102005008926A1 (en) 2005-02-24 2006-11-16 Philipps-Universität Marburg Process for the preparation of nano- and mesofibres by electrospinning of colloidal dispersions
US8691543B2 (en) 2009-11-25 2014-04-08 Worcester Polytechnic Institute Nanofibrous scaffold comprising immobilized cells
US8771582B2 (en) 2005-03-04 2014-07-08 BioScurfaces, Inc. Electrospinning process for making a textile suitable for use as a medical article
US20060200232A1 (en) 2005-03-04 2006-09-07 Phaneuf Matthew D Nanofibrous materials as drug, protein, or genetic release vehicles
US20070043428A1 (en) 2005-03-09 2007-02-22 The University Of Tennessee Research Foundation Barrier stent and use thereof
US20060213829A1 (en) 2005-03-25 2006-09-28 Rutledge Gregory C Production of submicron diameter fibers by two-fluid electrospinning process
JP5037034B2 (en) 2005-04-26 2012-09-26 日東電工株式会社 Filter filter medium, its production method and method of use, and filter unit
US7799262B1 (en) 2005-05-02 2010-09-21 Industrial Cooperation Foundation Chonbuk National University Method of manufacturing a continuous filament by electrospinning
KR20080008364A (en) 2005-05-05 2008-01-23 헤모텍 아게 All-over coating of vessel stents
JP2008540022A (en) 2005-05-17 2008-11-20 ナイキャスト リミテッド Implantable charged medical device
US7306729B2 (en) 2005-07-18 2007-12-11 Gore Enterprise Holdings, Inc. Porous PTFE materials and articles produced therefrom
US7655584B2 (en) 2005-07-29 2010-02-02 Gore Enterprise Holdings, Inc. Highly porous self-cohered web materials
US7604668B2 (en) 2005-07-29 2009-10-20 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
WO2007028112A2 (en) 2005-09-02 2007-03-08 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
KR100785378B1 (en) 2005-09-05 2007-12-14 주식회사 바이오레인 Multi-layered antiadhesion barrier
US8906285B2 (en) 2005-10-31 2014-12-09 The Trustees Of Princeton University Electrohydrodynamic printing and manufacturing
US7981353B2 (en) 2005-12-12 2011-07-19 University Of Washington Method for controlled electrospinning
US9517123B2 (en) * 2005-12-29 2016-12-13 Cook Medical Technologies Llc Endovascular prosthesis and a method of connecting a structural component and a woven graft material
JP4890049B2 (en) 2006-02-24 2012-03-07 日本バイリーン株式会社 Extra fine fiber assembly
US8585753B2 (en) 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
US8303874B2 (en) 2006-03-28 2012-11-06 E I Du Pont De Nemours And Company Solution spun fiber process
PL1998798T3 (en) 2006-03-28 2013-08-30 Lnk Chemsolutions Llc Method of manufacturing fibrous hemostatic bandages
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US7790273B2 (en) 2006-05-24 2010-09-07 Nellix, Inc. Material for creating multi-layered films and methods for making the same
JP5049519B2 (en) 2006-06-15 2012-10-17 日本ゴア株式会社 Stretchable composite fabric and stretched porous polytetrafluoroethylene film
US7722665B2 (en) 2006-07-07 2010-05-25 Graft Technologies, Inc. System and method for providing a graft in a vascular environment
US9139940B2 (en) 2006-07-31 2015-09-22 3M Innovative Properties Company Bonded nonwoven fibrous webs comprising softenable oriented semicrystalline polymeric fibers and apparatus and methods for preparing such webs
US20080033522A1 (en) 2006-08-03 2008-02-07 Med Institute, Inc. Implantable Medical Device with Particulate Coating
KR100820162B1 (en) 2006-08-07 2008-04-10 한국과학기술연구원 Ultrafine fibrous separator with heat resistance and the fabrication method thereof, and secondary battery using the same
KR100845239B1 (en) 2006-08-07 2008-07-10 한국과학기술연구원 Separator having ultrafine fibrous layer with heat resistance and secondary battery having the same
EP2057307A2 (en) 2006-08-21 2009-05-13 Basf Se Process for producing nano- and mesofibres by electrospinning colloidal dispersions
US9622888B2 (en) 2006-11-16 2017-04-18 W. L. Gore & Associates, Inc. Stent having flexibly connected adjacent stent elements
US10188534B2 (en) 2006-11-17 2019-01-29 Covidien Lp Stent having reduced passage of emboli and stent delivery system
US9011754B2 (en) 2006-12-05 2015-04-21 Nanyang Technological University Manufacturing three-dimensional scaffolds using electrospinning at low temperatures
US7857608B2 (en) 2006-12-08 2010-12-28 Spindynamics, Inc. Fiber and nanofiber spinning apparatus
EP2101779A1 (en) 2006-12-13 2009-09-23 Angiotech Pharmaceuticals, Inc. Medical implants with a combination of compounds
US9339593B2 (en) 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
CN101003917A (en) 2007-01-19 2007-07-25 中国民航大学 Complex type electrostatic spinning method with positive and negative electrodes in same electric field, and application
EP2111185B1 (en) 2007-01-30 2017-12-20 University of Pittsburgh - Of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
US20080208325A1 (en) 2007-02-27 2008-08-28 Boston Scientific Scimed, Inc. Medical articles for long term implantation
US8257459B2 (en) 2007-02-28 2012-09-04 Hollingsworth & Vose Company Waved filter media and elements
US8765255B2 (en) 2007-03-06 2014-07-01 E I Du Pont De Nemours And Company Breathable waterproof garment
US8277711B2 (en) 2007-03-29 2012-10-02 E I Du Pont De Nemours And Company Production of nanofibers by melt spinning
US8303693B2 (en) 2007-04-26 2012-11-06 The Hong Kong Polytechnic University Nanofiber filter facemasks and cabin filters
EP2160153A1 (en) 2007-06-11 2010-03-10 Nanovasc, Inc. Stents
KR100932688B1 (en) 2007-07-06 2009-12-21 한국과학기술연구원 Tubular porous scaffold with double membrane structure for artificial blood vessel and its manufacturing method
CZ2007485A3 (en) 2007-07-17 2009-04-22 Elmarco, S. R. O. Method for spinning the liquid matrix, device for production of nanofibres through electrostatic spinning of liquid matrix and spinning electrode for such device
US8978899B2 (en) 2007-08-01 2015-03-17 Donaldson Company, Inc. Fluoropolymer fine fiber
US8906081B2 (en) 2007-09-13 2014-12-09 W. L. Gore & Associates, Inc. Stented vascular graft
US8637144B2 (en) 2007-10-04 2014-01-28 W. L. Gore & Associates, Inc. Expandable TFE copolymers, method of making, and porous, expended articles thereof
US9040646B2 (en) 2007-10-04 2015-05-26 W. L. Gore & Associates, Inc. Expandable TFE copolymers, methods of making, and porous, expanded articles thereof
US8992471B2 (en) 2007-11-05 2015-03-31 Nanocopoeia, Inc. Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
US7799261B2 (en) 2007-11-30 2010-09-21 Cook Incorporated Needle-to-needle electrospinning
US9834865B2 (en) 2007-12-17 2017-12-05 E I Du Pont De Nemours And Company Centrifugal solution spun nanofiber process
WO2009086015A2 (en) 2007-12-21 2009-07-09 Boston Scientific Scimed, Inc. Flexible stent-graft device having patterned polymeric coverings
WO2009091899A2 (en) 2008-01-17 2009-07-23 Boston Scientific Scimed, Inc. Stent with anti-migration feature
KR100988816B1 (en) 2008-01-29 2010-10-20 신경민 A stent
CA2718897A1 (en) 2008-03-17 2009-09-17 The Board Of Regents Of The University Of Texas System Superfine fiber creating spinneret and uses thereof
US20090248131A1 (en) 2008-03-31 2009-10-01 Medtronic Vascular, Inc. Covered Stent and Method of Making Same
CZ2008226A3 (en) 2008-04-15 2009-10-29 Elmarco S.R.O. Process for producing nanofibers from fluorinated copolymers and terpolymers by electrostatic spinning, nanofibers and fabrics per se
US8551182B2 (en) 2008-04-28 2013-10-08 Urotech, Inc. Retrievable urethra sparing prosthetic stent and kidney stone intervention system
US8114147B2 (en) 2008-06-16 2012-02-14 Boston Scientific Scimed, Inc. Continuous double layered stent for migration resistance
US9023376B2 (en) 2008-06-27 2015-05-05 The University Of Akron Nanofiber-reinforced composition for application to surgical wounds
CN101350413B (en) 2008-07-22 2010-09-15 山东东岳神舟新材料有限公司 Fiber-reinforced multilayer fluorine-containing cross-linking ionic membrane and preparation method thereof
WO2010038362A1 (en) 2008-10-02 2010-04-08 パナソニック株式会社 Method and apparatus for manufacturing nanofiber
US8178030B2 (en) 2009-01-16 2012-05-15 Zeus Industrial Products, Inc. Electrospinning of PTFE with high viscosity materials
US8206481B2 (en) 2009-02-27 2012-06-26 Bha Group, Inc. HEPA (H-10) performance synthetic nonwoven and nanofiber composite filter media
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US9139669B2 (en) 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
CN101530750A (en) 2009-04-20 2009-09-16 浙江理工大学 Preparation method of polytetrafluoroethylene superfine fiber porous membrane
WO2010132636A1 (en) 2009-05-13 2010-11-18 President And Fellows Of Harvard College Methods and devices for the fabrication of 3d polymeric fibers
JP2013501539A (en) * 2009-08-07 2013-01-17 ゼウス インダストリアル プロダクツ インコーポレイテッド Prosthetic device comprising an electrospun fiber layer and method for producing the same
CN101994161A (en) * 2009-08-25 2011-03-30 东丽纤维研究所(中国)有限公司 Method for preparing polytetrafluoroethylene superfine fiber
EP2496274B1 (en) * 2009-11-03 2015-10-28 Moses S.R.L. Substrate of polymeric material and method of carrying out thereof
US8637109B2 (en) 2009-12-03 2014-01-28 Cook Medical Technologies Llc Manufacturing methods for covering endoluminal prostheses
DE102010010553A1 (en) 2010-03-05 2011-09-08 Carl Freudenberg Kg Process for the preparation of fibers from polymer dispersions
EP2563956A4 (en) 2010-10-14 2013-09-18 Zeus Ind Products Inc Antimicrobial substrate
JP6203639B2 (en) 2011-01-28 2017-09-27 メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. Electrospun PTFE coated stent and method of use
US8609249B2 (en) 2011-02-09 2013-12-17 Phillips Scientific Inc. Thin wall expandable polymer tubes having improved axial and radial strength, and a method of manufacturing thereof
BR112013023067A2 (en) 2011-03-09 2017-07-25 Univ Texas fiber production apparatus and methods
KR101268447B1 (en) * 2011-04-13 2013-06-04 (주)시지바이오 Double coated stent and manufacturing method using the same
CN104114201A (en) 2012-01-16 2014-10-22 美国医疗设备有限公司 Rotational spun material covered medical appliances and methods of manufacture
US20140012304A1 (en) 2012-07-03 2014-01-09 Merit Medical Systems, Inc. Multilayered balloon
US10507268B2 (en) 2012-09-19 2019-12-17 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
EP3988278A1 (en) 2013-03-13 2022-04-27 Merit Medical Systems, Inc. Serially deposited fiber materials and associated devices and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100944A1 (en) * 2001-11-28 2003-05-29 Olga Laksin Vascular graft having a chemicaly bonded electrospun fibrous layer and method for making same
US20030114917A1 (en) * 2001-12-14 2003-06-19 Holloway Ken A. Layered stent-graft and methods of making the same

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130325140A1 (en) * 2010-06-02 2013-12-05 Nonwo Tecc Medical Gmbh Device for placement in a hollow organ, in particular for holding open said hollow organ and method for producing such device
US10653511B2 (en) * 2011-01-28 2020-05-19 Merit Medical Systems, Inc. Electrospun PTFE coated stent and method of use
US10653512B2 (en) 2011-01-28 2020-05-19 Merit Medical Systems, Inc. Electrospun PTFE coated stent and method of use
US9655710B2 (en) 2011-01-28 2017-05-23 Merit Medical Systems, Inc. Process of making a stent
US20130085565A1 (en) * 2011-01-28 2013-04-04 Merit Medical System, Inc. Electrospun ptfe coated stent and method of use
US9415206B2 (en) 2011-08-12 2016-08-16 Cardiac Pacemakers, Inc. Method for coating devices using electrospinning
US11432922B2 (en) * 2011-08-16 2022-09-06 The University Of Kansas Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair
US20220054255A1 (en) * 2011-08-16 2022-02-24 The University Of Kansas Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair
US11623438B2 (en) 2012-01-16 2023-04-11 Merit Medical Systems, Inc. Rotational spun material covered medical appliances and methods of manufacture
US10675850B2 (en) 2012-01-16 2020-06-09 Merit Medical Systems, Inc. Rotational spun material covered medical appliances and methods of manufacture
US10005269B2 (en) 2012-01-16 2018-06-26 Merit Medical Systems, Inc. Rotational spun material covered medical appliances and methods of manufacture
US9987833B2 (en) 2012-01-16 2018-06-05 Merit Medical Systems, Inc. Rotational spun material covered medical appliances and methods of manufacture
US10507268B2 (en) * 2012-09-19 2019-12-17 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US11541154B2 (en) 2012-09-19 2023-01-03 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US20140081414A1 (en) * 2012-09-19 2014-03-20 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
US9827703B2 (en) 2013-03-13 2017-11-28 Merit Medical Systems, Inc. Methods, systems, and apparatuses for manufacturing rotational spun appliances
US10799617B2 (en) 2013-03-13 2020-10-13 Merit Medical Systems, Inc. Serially deposited fiber materials and associated devices and methods
US10953586B2 (en) 2013-03-13 2021-03-23 Merit Medical Systems, Inc. Methods, systems, and apparatuses for manufacturing rotational spun appliances
US11155933B2 (en) 2013-07-22 2021-10-26 Cardiac Pacemakers, Inc. Lubricious, biocompatible hydrophilic thermoset coating using interpenetrating hydrogel networks
US10874843B2 (en) * 2014-01-21 2020-12-29 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability
AU2015209579B2 (en) * 2014-01-21 2017-07-13 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability
US20180264248A1 (en) * 2014-01-21 2018-09-20 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability
US9987478B2 (en) 2014-01-21 2018-06-05 Cardiac Pacemakers, Inc. Method for making a tubular medical device
CN105916529A (en) * 2014-01-21 2016-08-31 心脏起搏器股份公司 Medical device hybrid polymeric structures and coatings with improved lubricity and durability
WO2015112489A1 (en) * 2014-01-21 2015-07-30 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability
CN107257700A (en) * 2014-12-18 2017-10-17 心脏起搏器股份公司 Fiber joint interface between structure
US11597164B2 (en) 2014-12-18 2023-03-07 Cardiac Pacemakers, Inc. Fibrous joinery interface between structures
JP2017537742A (en) * 2014-12-18 2017-12-21 カーディアック ペースメイカーズ, インコーポレイテッド Fibrous inter-structure interface
AU2015364546B2 (en) * 2014-12-18 2018-05-10 Cardiac Pacemakers, Inc. Fibrous joinery interface between structures
WO2016100666A1 (en) * 2014-12-18 2016-06-23 Cardiac Pacemakers, Inc. Fibrous joinery interface between structures
US11026777B2 (en) 2015-02-26 2021-06-08 Merit Medical Systems, Inc. Layered medical appliances and methods
US20160250048A1 (en) * 2015-02-26 2016-09-01 Merit Medical Systems, Inc. Layered medical appliances and methods
US10028852B2 (en) * 2015-02-26 2018-07-24 Merit Medical Systems, Inc. Layered medical appliances and methods
US9855415B2 (en) 2015-07-25 2018-01-02 Cardiac Pacemakers, Inc. Medical electrical lead with biostable PVDF-based materials
US20200129285A1 (en) * 2015-07-31 2020-04-30 Cook Medical Technologies Llc Methods of making a prosthesis with a smooth covering
CN108136078A (en) * 2015-10-01 2018-06-08 谢尔蒂斯有限公司 The method that electrostatic spinning applies and inner cavity prosthese is laminated
WO2017055926A1 (en) * 2015-10-01 2017-04-06 Xeltis Bv Methods for electrospin coating and laminating of endoluminal prostheses
US10876222B2 (en) 2015-10-01 2020-12-29 Xeltis Ag Methods for electrospin coating and laminating of endoluminal prostheses
US20170319325A1 (en) * 2015-11-12 2017-11-09 Biostage, Inc. Systems and Methods for Producing Gastrointestinal Tissues at an Anstomosis or Other Physiological Location
US10888407B2 (en) * 2015-12-11 2021-01-12 Poly-Med, Inc. Method for forming a multi-layer construct
US20190000602A1 (en) * 2015-12-11 2019-01-03 Poly-Med, Inc. Synthetic implant device replicating natural tissue structure and methods of making same
CN109069279A (en) * 2016-01-09 2018-12-21 埃因霍温科技大学 Fiber tubular conduit for stent applications
US10377150B2 (en) * 2016-01-29 2019-08-13 Canon Kabushiki Kaisha Porous body, ink jet recording method, and ink jet recording apparatus
US10465318B2 (en) 2016-12-27 2019-11-05 Boston Scientific Scimed Inc Degradable scaffolding for electrospinning
US11255051B2 (en) 2017-11-29 2022-02-22 Kimberly-Clark Worldwide, Inc. Fibrous sheet with improved properties
CN111247280A (en) * 2017-11-29 2020-06-05 金伯利-克拉克环球有限公司 Fibrous sheet with improved properties
CN113365671A (en) * 2019-01-29 2021-09-07 谢尔蒂斯股份公司 Electrospun coverings for medical implants
WO2020156711A1 (en) * 2019-01-29 2020-08-06 Xeltis Ag Electrospun cover layer for medical implants
US20220305240A1 (en) * 2019-07-02 2022-09-29 Biotronik Ag Functionalized balloon surface
US11771874B2 (en) * 2019-07-02 2023-10-03 Biotronik Ag Functionalized balloon surface
US20220372659A1 (en) * 2021-05-19 2022-11-24 Panasonic Intellectual Property Management Co., Ltd. Device and method for manufacturing fiber assembly
US11773513B2 (en) * 2021-05-19 2023-10-03 Panasonic Intellectual Property Management Co., Ltd. Device and method for manufacturing fiber assembly

Also Published As

Publication number Publication date
EP2833826A4 (en) 2015-11-18
US20160081783A1 (en) 2016-03-24
CN104203150B (en) 2017-10-17
JP2015515322A (en) 2015-05-28
EP2833826B1 (en) 2020-02-12
EP2833826A1 (en) 2015-02-11
CN104203150A (en) 2014-12-10
WO2013151778A1 (en) 2013-10-10
CN107736952A (en) 2018-02-27
US10010395B2 (en) 2018-07-03
JP6490575B2 (en) 2019-03-27

Similar Documents

Publication Publication Date Title
US10010395B2 (en) Composite prosthetic devices
US20160067374A1 (en) Composite prosthetic devices
US20220047783A1 (en) Electrospun material covered medical appliances and methods of manufacture
US9034031B2 (en) Prosthetic device including electrostatically spun fibrous layer and method for making the same
US20210290416A1 (en) Layered medical appliances and methods
US20160296351A1 (en) Electrospun ptfe encapsulated stent and method of manufacture

Legal Events

Date Code Title Description
AS Assignment

Owner name: ZEUS INDUSTRIAL PRODUCTS, INC., SOUTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PUCKETT, SABRINA D.;MANASCO, JOSHUA L.;BALLARD, ROBERT L.;AND OTHERS;SIGNING DATES FROM 20130319 TO 20130325;REEL/FRAME:030106/0043

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION